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 In pathological states such as osteoarthritis, the complex metabolic balance of 
cartilage is disrupted leading to a loss in the integrity and biomechanical function of 
cartilage1.  Osteoarthritis affects more than 20 million Americans, costing the United 
States economy over $60 billion yearly2.  Risk factors for osteoarthritis include age, 
excessive joint loading, and joint injury.  Tissue engineering offers a potential solution 
for the replacement of diseased and/or damaged cartilage3,4.  Unfortunately, plentiful 
donor cell populations are difficult to assemble, as chondrocytes have a well 
characterized lack of expansion potential5.  Mesenchymal progenitor cells (MPCs) offer 
an alternative with a high expansion potential capable of supplying large quantities of 
cells.  Using an immature bovine model, the chondrogenic differentiation of articular 
chondrocytes (BACs) and bone marrow stromal cells was found to be scaffold, media and 
mechanical stimulation dependent.  Mechanisms modulating mechanotransduction in 
BACs were explored, including ion-channel and TGF-β signaling.   
TGF-β signaling participated in the response of articular chondrocytes to dynamic 
compressive loading, as well as enhanced the chondrogenesis of bovine BMSCs, through 
interactions between loading and TGF-β/Smad signaling.  Also, dynamic loading altered 
gene expression, matrix synthesis rates and intracellular phosphorylation for bovine 
BMSCs.  However the response of the cells to dynamic loading depends on both media 
supplementation and the duration of unloaded culture.  These studies establish signaling 
through the TGF-beta pathway as a mechanotransduction pathway for chondrocytes and 
chondroprogenitors in 3D culture.    
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In pathological states such as osteoarthritis, the complex metabolic balance of 
cartilage is disrupted leading to a loss in the integrity and biomechanical function of 
cartilage1.  Osteoarthritis affects more than 20 million Americans, costing the United 
States economy over $60 billion yearly2.  Risk factors for osteoarthritis include age, 
excessive joint loading, and joint injury.  Tissue engineering offers a potential solution 
for the replacement of diseased and/or damaged cartilage3,4.  Unfortunately, plentiful 
donor cell populations are difficult to assemble, if not impossible.  Chondrocytes have a 
well characterized lack of expansion potential5.  Mesenchymal progenitor cells (MPCs) 
offer an alternative with a high expansion potential capable of supplying large quantities 
of cells.  MPCs can be easily isolated, offer high proliferation potential and are capable of 
differentiating into a distinct phenotype through a series of discrete steps, finishing with 
cells involved in the production of a distinct tissue type6,7.  Understanding the behavior of 
chondrocytes and chondroprogenitors in response to physiologically relevant 
biomechanical and biochemical stimuli is central to understanding normal tissue 
maintenance, as well as elucidating potential mechanisms for repair of diseased or 





1.2 RESEARCH OBJECTIVES 
 The overall goal of this dissertation is to elucidate the mechanotransduction of 
bovine articular chondrocytes (BACs) and bone marrow stromal cells (BMSCs) through 
the interaction between TGF-β signaling and dynamic compression.  The central 
hypothesis of this dissertation is that interactions between loading and TGF-β/Smad 
signaling will regulate the response of articular chondrocytes to dynamic compressive 
loading, as well as enhance the chondrogenesis of bovine BMSCs. 
 
1.2.1 Specific Aims  
There were three hypotheses and five specific aims to elucidate the 
mechanotransduction of BMSCs through the interaction between TGF-β signaling and 
dynamic compression.  Bovine articular chondrocytes (BACs) were used to establish a 
3D model for investigating mechanotransduction in specific aims 2 and 3.  The 3D model 
developed with BACs was used to investigate the relationship and interaction between 
TGF-β signaling and dynamic compression in BMSCs in specific aim 5.  The work 
identified in specific aim 1 focused on investigating the influence of scaffold choice on 
ECM production by BACs.  The work identified in specific aim 4 focused on establishing 
in vitro conditions for the chondrogenic differentiation of bovine BMSCs.  The results 
from specific aims 1 and 4 provided justification for cell isolation and seeding procedures 
of subsequent studies in the dissertation and aided in the interpretation of results.  
 
Specific Aim 1:  Examine the influence of various tissue engineering scaffold materials 
on the extracellular matrix production by bovine articular chondrocytes. 
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Multiple scaffold materials have been used for tissue engineering cartilage.  In 
specific aim 1, scaffold materials commonly used for cartilage tissue engineering were 
evaluated to determine whether scaffold material directly or indirectly influences 
chondrocyte matrix synthesis, specifically glycosaminoglycan (GAG) ∆-disaccharide 
composition.  Articular chondrocytes from two donors were isolated and seeded at 
15x106 cells/mL into the following tissue engineering scaffolds:.  1.5% LMP agarose, 
0.75% sodium alginate, 2 mg/mL type I collagen (rat tail), and 50 mg/mL fibrin 
(n=8/scaffold/timepoint).  Cells were also seeded on polyglycolic acid (PGA) felt at a 
target density of 15x106 cells/mL, although poor seeding efficiency yielded 
approximately 1/3 of the intended density.  Native cartilage samples from the same joints 
were maintained in identical culture conditions for the comparison of the GAG ∆-
disaccharide composition.  Constructs were cultured for either 20 or 40 days, after which 
they were assayed for total DNA and sGAG contents, as well as for ∆-disaccharide 
composition using fluorophore-assisted carbohydrate electrophoresis (FACE).   
 
Hypothesis 1: Mechanotransduction mechanisms established with articular chondrocytes 
in monolayer will be critical in the response of articular chondrocytes in 3D culture 
subjected to dynamic compressive loading.  Perturbing these pathways will inhibit the 




Specific Aim 2: Examine the influence of various ion-channel mechanotransduction 
pathways on the biosynthesis of bovine articular chondrocytes. 
 
Mechanotransduction studies have been performed on chondrocytes in 
monolayer.  However, important differences exist between chondrocyte behavior in 
monolayer and 3D (3D) cultures.  The extent to which these same ion channels are 
involved in the transduction of mechanical stimuli in 3D culture has not yet been 
addressed.  In specific aim 2, the roles four ion-channels play in the signal transduction of 
bovine articular cartilage and BACs was investigated using inhibitory media supplements 
including:  4-Aminopyridine (4AP), a potassium channel blocker; Nifedipine (Nf), a 
calcium channel blocker; Gadolinium (Gd), a stretch-activated channel blocker; and 
Thapsigargin (Tg), which releases intracellular Ca2+ stores by inhibiting  ATP-dependent 
Ca2+ pumps.   
The response of bovine articular cartilage to stimulation with a range of ion 
channel inhibitor doses was examined using articular cartilage tissue explants using 
radiolabel incorporation to monitor both protein and sGAG synthesis rates and 
LIVE/DEAD® imaging to investigate cell viability.  Recovery from the inhibition of 
protein and sGAG synthesis rates was examined over 3 days post-exposure to a single 
level of each inhibitor.  Agarose gels seeded with 20x106 BACs/mL were mechanically 
stimulated in the presence of a single level of each of ion channel inhibitor.  To examine 
the influence of the ion-channels on the response of chondrocytes to mechanical 
stimulation, agarose gels seeded with 20x106 BACs/mL chondrocytes were cultured for 5 
weeks prior to the application of mechanical stimulation.  Constructs were then cultured 
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in basal media supplemented with both an inhibitor and radiolabeled precursors under the 
following conditions: static compression (10%), 1Hz oscillatory compression (10%±3%) 
and unloaded.   
 
Hypothesis 2: TGF-β1 modulated pathways regulate the response of bovine articular 
chondrocytes to dynamic compressive loading through the Smad2/3 signaling pathway.  
Perturbing TGF-β signaling through chemical inhibition will inhibit the upregulation of 
protein and PG synthesis and gene expression due to loading. 
 
Specific Aim 3: Examine the influence of the TGF-β signaling pathway on the 
chondrocyte response to dynamic compressive loading. 
 
Transforming growth factor-beta 1 (TGF-β1) has been shown to have an anabolic 
affect on articular chondrocytes.  In specific aim 3, the role the TGF-β1/Smad signaling 
pathway has in the BAC response to dynamic compressive loading was investigated.  
BACs seeded at 20x106 cells/mL in 3% agarose were used the study.  This study 
examined the effects of mechanical loading in the absence or presence of the TGF-β1 
inhibitor SB431542.  SB431542 is proposed to block the signaling cascade of TGF-β and 
activin type receptors after ligand binding occurs by inhibiting the kinase activity of the 
TGF-β type I Receptor (ALK5).  Four concentrations of SB431542 were used ranging 
from 100nM-100µM, as well as a no-inhibitor control, to establish a dose response of the 
inhibitor on both protein and sGAG synthesis rates.  Recovery from the inhibition of 
protein and sGAG synthesis rates was examined over 3 days post-exposure to a single 
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level of the inhibitor.  To examine the influence of TGF-β1 signaling pathway on the 
response of BACs to mechanical stimulation, agarose gels were cultured for 24 hours 
prior to the application of mechanical stimulation.  Constructs were then cultured in basal 
media ± 1 µM SB431542 under the following conditions: static compression (10%), 1Hz 
oscillatory compression (10%±3%) and unloaded controls.   Following growth factor 
supplementation and/or dynamic loading, samples will be taken down and assayed for 
radiolabel incorporation and gene expression. 
 
Specific Aim 4: Examine effects of passaging, media supplements and scaffold 
environment on chondrogenesis of bovine BMSCs. 
 
 Previous studies have shown that members of the transforming growth factor 
(TGF) family induce chondrogenic differentiation of stromal cells, but the optimal in 
vitro conditions within which BMSCs can achieve the most chondrogenic response have 
yet to be explored in depth for the bovine model.  In specific aim 4, various media 
conditions, passage number, seeding density and the temporal differentiation of BMSCs 
were examined in alginate and agarose gel systems.  The results from this aim were used 
to pursue specific aim 5.  A 2% alginate gel system was used to examine the effects of 
passaging, seeding density and temporal differentiation due to the ease and consistency of 
obtaining RNA from these samples.  The temporal differentiation was also investigated in 
3% agarose due to the ease of getting consistent dimension suitable for loading.  
Following growth factor supplementation, samples were assayed for sulfated GAG 
(sGAG) content, DNA content, gene expression, and cell viability.   
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Hypothesis 3: Modulation of the chondrogenic differentiation of bovine BMSCs by 
dynamic compressive loading is dependent on TGF-β1 signaling through the Smad2/3 
signaling pathway.  Dynamic compressive loading will increase Smad2/3 
phosphorylation and nuclear accumulation, leading to an increase in chondrogenic genes 
and protein production. 
 
Specific Aim 5: Examine the influence and interaction of TGF-β1 and dynamic 
compressive loading on the chondrogenic differentiation of bovine BMSCs. 
 
 The differentiation of BMSCs can be influenced by various stimuli including 
growth factors, cell-cell interactions, and cell-matrix interactions.  Mechanical 
stimulation has been shown to be important in the development of certain tissues and may 
influence differentiation of BMSCs.  It has been suggested that the combination of 
chondrogenic media and dynamic compressive loading may enhance chondrogenesis of 
BMSCs over the addition of exogenous factors alone.  In specific aim 5, the influence of 
TGF-β1 and oscillatory compressive loading on the gene expression, matrix synthesis 
rates and Smad phosphorylation/translocation of BMSCs was investigated.  This study 
examined the response of agarose gels seeded with BMSCs to oscillatory compression 
with and without TGF-β1 supplementation.  Constructs were cultured in basal media 
consisting of high glucose DMEM plus antibiotic/antimycotic, non-essential amino acids, 
1% ITS+, 50µg/mL ascorbate and 0.4mM proline (BASAL), basal media plus 10ng/mL 
TGF-β1 (TGF-β1), or basal media plus 10ng/mL TGF-β1 and 100nM dexamethasone 
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(TGF-β1+DEX).  After a preculture period of either 8 or 16 days, samples were either left 
unloaded or subjected to 10% static compression or 10%±3% oscillatory compression.  
Samples were analyzed for gene expression, matrix synthesis rates and Smad 
phosphorylation and translocation.  The effects of long term loading from day 8 to day 16 
were also investigated.  Samples were analyzed for sGAG accumulation and 
immunohistochemistry (IHC) for collagen I and II localization.   
 
 
1.3 SCIENTIFIC CONTRIBUTION 
 Investigation of the influence of transforming growth factor β1 (TGF-β1) 
signaling in the response of chondrocytes and BMSCs to dynamic compressive loading 
may provide clues to the mechanisms involved in chondrocyte differentiation and define 
other potential targets to regulate this process.  The mechanisms through which 
mechanotransduction occurs in chondrocytes and chondroprogenitor cells remain largely 
elusive.  This work addresses a potential pathway through which mechanotransduction 
occurs in these cells. 
The work presented in this dissertation demonstrates that there are marked 
differences in the phenotypic expressions between the responses of BACs and bovine 
BMSCs to mechanical stimulation in 3D culture.  Additionally, interactions between 
TGF-β signaling and dynamic compression in BACs and BMSCs have been 
demonstrated.  While speculative, there are multiple potential regulatory mechanisms 
through which TGF-β1 signaling and mechanical stimulation interact.  Understanding the 
relationship between mechanical loading and TGF-β signaling may provide potential 
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targets for manipulating cell differentiation, as well as for treating diseased and injured 
cartilage.  To this end, this work is important for understanding in vitro development of 
3D scaffolds for cartilage regeneration.  It has been hypothesized that the loading 
environment in the knee is too harsh to allow an immature construct lacking mechanical 
integrity to survive and develop into a tissue capable of successful load bearing8.  
Facilitating a tissue-engineered construct capable of functioning successfully in vivo will 
involve matching mechanical and biochemical properties of native cartilage as closely as 
possible.   
While this work supports the importance of TGF-β signaling in articular 
chondrocytes and BMSCs, the TGF-β signaling pathway is only one of many growth 
factor mediated signaling pathways that regulate articular chondrocyte metabolism.  
These studies establish a paradigm for exploring interactions between mechanical 
stimulation and a specific growth factor mediated signaling pathway.  While in vitro 
mechanical stimulation may end up improving both the mechanical and biochemical 
properties of constructs, it may not prove to be practical or even feasible for purposes 
other than scientific investigation.  Understanding the pathways through which 
mechanotransduction occurs offers the possibility of regulating these mechanisms 





CHAPTER 2 BACKGROUND AND SIGNIFICANCE 
 
 
2.1 ARTICULAR CARTILAGE 
2.1.1 Structure and Function 
Articular cartilage is a hyaline cartilage found at the ends of diarthrodial joints 
and provides resistance to compressive, shear and tensile forces that occur during normal 
joint motion9.  This ability arises from the unique architecture of the matrix elements 
found in articular cartilage. The tissue consists of four major components: collagen, 
proteoglycans, water, and cells.  It is through the highly delicate and complex interactions 
of these constituents that articular cartilage maintains its resiliency and near frictionless 
properties10.  Because articular cartilage is mostly avascular, chondrocytes receive 
nourishment from the synovial fluid through diffusion9.  This avascularity also 
contributes to the limited healing properties of this tissue11. 
 
Collagen 
The extracellular matrix component most responsible for the resistance to tensile forces is 
collagen12.  Several types of collagen have been found in articular cartilage (II, V, VI, IX, 
X, XI, XII, XIV).  Collagen type II is 80-90% of the total collagen content, making it the 
most abundant collagen in articular cartilage12-14.  It is a homotrimer composed of three 
α1(II) chains that bind into a helical structure.  These helical molecules bind end to end to 
form microfibrils.  In combination with collagen types IX and XI, the microfibrils are 
arranged into fibrils ranging from 20-120nm in diameter in normal hyaline cartilage 
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(Figure 2.2).  Type IX collagen makes up approximately 2% of the collagen in articular 
cartilage; its proposed function is as a mechanical spacer within collagen fibrils, as well 
as to provide a location where the fibrils can interact with proteoglycans.    Collagen 
types V and XI are thought to regulate fiber size9,12.   
 
Proteoglycans 
The fibrillar collagen network is organized and stabilized through molecular 
cross-links that restrain the swelling pressure exerted by a high concentration of 
negatively charged sulfated glycosaminoglycans (sGAGs).  In articular cartilage, the 
GAGs are mainly chondroitin sulfate (CS) and keratan sulfate (KS), as well as a small 
proportion of dermatan sulfate (DS) chains15. Aggrecan is the predominant proteoglycan 
found in articular cartilage, constituting ~10% of the dry weight of articular cartilage16.  It 
consists of a protein core with attached CS chains containing predominately 4- or 6-
sulfated disaccharides17,18 and  a small amount of KS chains near the binding site for 
hyaluronan9.  These negatively charged GAGs attract the influx of water into the tissue, 
which makes up 60-90% of cartilage weight10.  The close interactions of aggrecan and 
collagen II prevent full swelling of the proteoglycan molecules, creating a swelling 
pressure that gives articular cartilage its compressive stiffness and maintains tensile stress 
in the type II collagen network19. While the collagen network is somewhat metabolically 
static20, aggrecan undergoes a distinct turnover process21,22 in which catabolic 
cleavage23,24 and removal of molecules from the extracellular matrix are in balance with 
synthesis and deposition of new molecules25,26.  
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 In addition to large, aggregating proteoglycans, human articular cartilage 
also contains smaller proteoglycans know as small leucine-rich repeat proteoglycans 
(SLRPs).  Human articular cartilage has been shown to contain 2 DS proteoglycans – 
biglycan and decorin – and one KS proteoglycan – fibromodulin27.  These SLRPs have 
been shown to interact with the fibrillar collagens of the extracellular matrix, though their 
sites and strengths of interaction may vary27. For example, decorin binds collagen type II 
and is thought to regulate collagen fibril size9. 
 
Chondrocytes  
The cells of articular cartilage are called articular chondrocytes and they are 
responsible for the balanced maintenance of the extracellular matrix proteins that affords 
this tissue its highly specialized properties28.  Chondrocytes make up 2-5% of total 
articular cartilage volume9,13,29, are mostly senescent, and slowly turn over their 
extracellular matrix30.  The interactions of chondrocytes with their extracellular matrix 
allow them to maintain tissue homeostasis as well as provide links to intracellular signal 
transduction pathways29.  Links to the extracellular matrix include, but are not limited to, 
the CD44 receptor which binds hyaluronan and annexin V (anchorin CII) and the α1β1 
and α2β2 integrins which bind type II collagen9,28,31.  Integrin interaction with the 
cytoskeleton provides cells with the ability to sense changes in their environment and 
also to change the affinity of specific integrins for extracellular matrix components31.  
Chondrocyte-matrix associations are crucial for cell survival31.  Blocking the ability of 
CD44 to bind hyaluronan causes chondrolysis of chondrocytes in articular cartilage slices 
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in vitro and cartilage degradation29,31.  Deprivation of collagen-derived signals has been 
shown to induce apoptosis31. 
 
Architecture  
The microstructure of articular cartilage varies from the joint surface to the 
subchondral bone (Figure 2.1).  The zonal distinctions include the degree of cellularity, 
the ratios of extracellular matrix components, growth factor concentrations, and 
hydrostatic pressures induced by loading9,13.  In the surface zone, the cells are flattened 
and run parallel to the surface.  The collagen in this zone is arranged in a “lamina 
splendens” layer of thin, tightly packed fibrils that also run parallel to the surface13.  The 
high fibrillar nature of this zone affords this zone with the highest tensile properties9,13.  
The proteoglycan content in this zone is the lowest and decorin and biglycan content is 
highest here.  Additionally, the cells in the superficial zone produce a specialized 
molecule unique to this region, lubricin, which is thought to contribute to lubrication9.  In 
the middle zone, cellularity decreases and the cells have a more rounded morphology9.  
Here, the predominant proteoglycan is aggrecan and the collagen fibrils are larger and 
more randomly organized as the load distribution within the tissues transitions from 
predominantly shear to predominantly compressive forces.  Below this zone, the deep 
zone contains the lowest cell density and aggrecan content.  The collagen fibrils in the 
deep zone are thickest and are oriented perpendicular to the surface of the joint9,13.  The 
calcified zone between below the deep zone provides transitional mechanical properties 
between the cartilage and the subchondral bone.  Cells here have the hypertrophic 
phenotype, specifically expression of collagen type X12.  Unlike, the growth plate this 
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region resists vascular invasion restricting nutritional flow into the cartilage from this 
surface.  Finally, the subchondral bone, which is much like cortical bone in structure, 
separates the articular cartilage from the underlying trabecular bone. 
In addition to the zonal variability in the extracellular matrix components and 
distribution, there are also variations on the cellular level as well.  The chondrocytes are 
surrounded by a pericellular or cell associated matrix that has a different composition 
from the further removed or interterritorial matrix9,31.  In general, the pericellular region 
is 2µm thick, fairly amorphous, and contains few collagen fibrils.  In this region, decorin 
and aggrecan are expressed and collagen Type VI is predominant, but types VI, IX, and 
XI have also been found28.  The collagen is arranged in a thin filamentous network that 
interacts with decorin and hyaluronan.  
Chondrocyte proliferation, differentiation, and homeostasis are not only governed 
by interactions with extracellular matrix, but also by soluble growth factors within the 
matrix.  Several growth factors are stored within the matrix of articular cartilage in active 
and inactive forms.  Bone morphogenetic proteins (BMPs) and transforming growth 
factor-β (TGF-β) are both stored in articular cartilage30,31.  Proteoglycans are known to 
indirectly influence chondrocyte activity, either through cell-matrix interactions or by 
binding specific growth factors in the extracellular matrix, thereby modifying their 
temporal and spatial effects15,32. For instance, the sequestering of TGF-β by 
proteoglycans within the extracellular matrix regulates the availability of this factor to 
chondrocytes31.  Similarly, insulin-like growth factor–I (IGF-I), fibroblastic growth 
factors (FGFs), and bone morphogenetic protein-2 (BMP-2) are also sequestered in 
articular cartilage31.  The roles of their interactions with various matrix proteins are still 
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being investigated.  There is, however, evidence that  the formation of focal adhesions 
due to integrin binding is necessary for chondrocytes to be responsive to some growth 
factors31.  This evidence demonstrates the important interplay between cells, extracellular 
























Figure 2.1: Articular cartilage constituents and hierarchy from the triple helix to the organ 

















2.1.2 Disease and Treatment Options 
Age, Injury and Disease 
 Articular cartilage undergoes several cellular and molecular changes with age.  
The surface becomes fibrillated, proteoglycan structure and composition are altered, and 
collagen matrices become increasingly cross-linked.  Cell proliferation, as well as matrix 
production, and response to growth factors all decrease9,33.  The loss of chondrocyte 
function with age is associated with telomere erosion and/or oxidative injury due to 
mitochondrial damage32. 
 The exact incidence of injury to articular cartilage is unclear, which is most likely 
due to the asymptomatic nature of many of these injuries14.  In a study by Shelbourne et 
al., patients with chondral lesions discovered at the time of ACL reconstructions resulted 
in a lower subjective healing score over a period of 8.7 years than those with patients 
with healthy cartilage34.  Radiographic evidence presented in recent studies demonstrates 
progression of cartilage degeneration of full-thickness defects treated by debridement.  
Advances in cartilage-specific MRI technology can determine location, size, and depth of 
cartilage lesions and, using contrast agents, biochemical and biomechanical changes can 
be diagnosed13,14.   
Martin et al.. defined mechanical damage to the articular surface by three 
classifications: damage to cells and extracellular matrix proteins with no visible 
disruption of the cartilage surface, chondral fissures involving only the articular cartilage 
(partial-thickness defects), and full-thickness defect that includes the entire thickness of 
the cartilage and the subchondral bone32.  It has been shown that impact loads greater 
than 25 MPa cause chondrocyte death and cartilage fissures.  Several investigators have 
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demonstrated that loads in the patellar femoral joint exceed 25MPa during normal joint 
loading showing the importance of rate of the applied load as well as its magnitude.  
Rapidly applied loads occur too fast for fluid movement out of the matrix, exposing 
matrix molecules and cells to damaging levels of mechanical stress.  Damage to cells can 
lead to decreased proteoglycan concentration, increased hydration, and disruption of 
collagen structure.  This, in turn, results in an uneven distribution of force transmission to 
the subchondral bone, leading to an increase in subchondral bone stiffness.  The greater 
stiffness of the subchondral bone transmits more load onto the damaged cartilage and this 
damaging spiral continues14.  Decrease in proteoglycan content or organization occurs 
before other signs of injury and may be due to increase degradation or decreased 
synthesis32,33,35.  Following injury, chondrocytes increase proliferation and matrix 
synthesis, but this healing response is insufficient to complete fill the defect and can lead 
to altered joint mechanics32. 
In full thickness injuries, blood enters the cavity resulting in hematoma formation 
and an inflammatory response.  Growth factors released from platelets and from the 
fractured bone matrix stimulate matrix production and attract stem cells to the site.  
Unfortunately, this repair response results in fibrocartilagenous tissue formation and the 
resultant tissue has inferior resilience, poor wear characteristics, and inferior 
stiffness11,14,32. 
 The ultimate goal of the early detection and treatment of traumatic articular 
cartilage injuries and the restoration of the normal joint mechanical environment is the 
prevention of cartilage degeneration and osteoarthritis (OA).  OA is the most common 
joint disease and it is characterized by joint pain and stiffness.  In later stages, muscle 
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atrophy and joint deformities may result2,36.  The disease is characterized by articular 
cartilage loss, osteophyte formation, and in some cases increased subchondral bone 
density.  Unfortunately, the pathophysiology is poorly understood and therefore reliable 
clinical preventive measures are difficult to design.  Primary OA frequently occurs with 
no known cause of degeneration and rarely occurs in younger patients2,36.  Secondary OA 
can develop in younger patients due to injury or a variety of hereditary, inflammatory, 
developmental, or metabolic disorders2,11,37.    
 Instability of the joint can contribute short-term abnormal loading, which may 
lead to degenerative diseases such as OA in the long-term38.  It has been shown that the 
results of cartilage repair techniques are lower if join instability is not corrected14.  For 
example, the meniscus reduces the very high contact stresses seen within the joint, 
thereby protecting articular cartilage from OA38.  It has been shown that loss of 20% of 
the meniscus can lead to 350% increase in contact forces in articular cartilage and, after 




Lavage and Debridement  
Lavage involves irrigation of the surface of joint arthroscopically39.  Debridement, 
popularized by Magnusson14, was the first arthroscopic treatment of chondral injuries to 
reduce mechanical symptoms and inflammation.  This procedure involves the 
arthroscopic removal of inflammatory tissue from the surface cartilage.  Both procedures 
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alleviate pain through the removal of debris, but are only beneficial for injuries due to 
minimal energy trauma in a highly stable joint14,39.   
 
Marrow stimulation  
The idea behind marrow stimulation is to stimulate the healing response of a full-
thickness cartilage defect, providing a stable filler containing progenitor cells and growth 
factors that will stimulate a natural healing response14,32,40.  Perforating the subchondral 
bone to repair articular cartilage lesions has been in practice since the concept was 
introduced by Pridie in 195614,32.  Abrasion arthroplasty is performed arthroscopically 
and involves removal of 1-2mm of bone down to the vasculature.  Unfortunately, this 
procedure is technique sensitive and involves uncontrolled destruction of the subchondral 
bone, leading to variable clinical outcomes.  Standardization of this technique, 
microfracture, was introduced by Steadman et al. in 199741.  It involves using 
arthroscopic picks to perforate the subchondral bone in a controlled pattern without 
drilling.  This allows for more controlled depth of penetration and placement.  This 
procedure achieves the best results in traumatic lesions surrounded by healthy tissue and 
is more successful in younger patients, presumably due to higher progenitor cell content 
of their bone marrow13,14.  In a 11 year follow-up study, Steadman et al. found that 80% 
of patients reported improvement after this procedure41.   
 
Osteochondral Transfer 
The transfer of cartilage autografts with intact subchondral bone was first 
published in 1985 with progression to arthroscopic methods in 199314,42.  In this 
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procedure, small subchondral bone plugs covered with healthy hyaline cartilage are 
removed from low-weight bearing areas and press fit into the recipient site.  Defects from 
1 to 4 cm can be filled depending on the availability of donor tissue.  The advantages of 
this technique are that tissue harvest and implantation can occur in one arthroscopic 
procedure, tissue availability and disease transmission is not an issue, and the procedure 
is relatively inexpensive14.  Overall, studies have demonstrated 80-90% good to excellent 
outcomes in follow-up studies14,43.  For larger defects, multiple plugs are transferred to 
the defects site in a procedure known as mosaicplasty.  In cases where insufficient tissue 
is available, allogenic sources for implantation are necessary11.   
 
Autologous Chondrocyte Implantation 
This treatment method of articular cartilage lesions was introduced by Grande et 
al. in 1989 and clinical application of this technique was pioneered by Brittberg et al. in 
199419. Implantation of chondrocytes is generally applied to shallow, partial-thickness 
lesions 2 to 10 cm2 in size and is indicated when the above treatments have failed.  
Cartilage tissue is removed arthroscopically from non-weight bearing surfaces of articular 
cartilage and the are cells released from the matrix and expanded in vitro.  After 
expansion, the patient undergoes a second procedure in which cells are injected 
underneath a autologous periosteal patch that is sutured to the surrounding intact 
cartilage14,39.  Recent studies comparing autologous chondrocyte implantation to 
osteochondral transfer noted significantly better subjective and histological outcomes 
with the implantation of chondrocytes13,14.  Optimization of the number of cells to be 
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implanted has not been studied; currently in the clinical setting, the aim is to implant 
30x106 cells/mL14,39.   
 
Limitations of Cartilage Defect Treatment Options 
Though the marrow stimulation techniques introduce growth factor and 
progenitor cells capable of adapting the chondrogenic phenotype into the cartilage lesion, 
the resultant tissue formed is mostly fibrocartilaginous39. The newly formed tissue is 
composed of predominantly collagen type I, has inferior mechanical properties to healthy 
articular cartilage, and rarely fills more than 75% of the defect area14. 
Growth factor delivery is an attractive an option to increase cell proliferation and 
matrix synthesis.  Through in vitro and in vivo studies,  the function of various growth 
factors has been discovered in recent years, but the clinical application of growth factors 
has not yet been implemented13.  New evidence that increased proliferation and matrix 
production by these cells may lead to degeneration due to enhanced senescence of 
chondrocytes may deter their application in the treatment of cartilage lesions without the 
introduction of a younger cell population into the area32.  
Osteochondral transfer has demonstrated good clinical results in follow-up 
studies. Unfortunately, there remain several limitations to the procedure, the most 
predominant of which is availability of healthy donor tissue14.  Significant research has 
been done to identify harvest locations for healthy tissue, but the harvesting of tissue for 
osteochondral transfer can lead to donor site morbidity, and the use of allogenic tissue 
increases the chances of infection transfer14,39.  Additionally, the fixation strength of 
osteochondral plugs has been shown to decrease after soaking of plugs in saline in vitro 
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over a period of 7 days, increasing the chances of graft failure.    Matching the original 
contours of the recipient type is also generally difficult, which may lead to localized 
regions of abnormal stresses and eventual cartilage degeneration14. 
 Autologous transfer of articular chondrocytes has yet to gain wide acceptance in 
the United States and it is estimated that only 10,000 procedures have been performed 
worldwide. Therefore little long-term data are available on this procedure.  Several 
follow-up studies have demonstrated good to excellent subjective improvements, but the 
variability in these results is site dependent.  Currently, this procedure is only 
recommended for shallow cartilage lesions not involving the subchondral bone14,39,44. 
Though great strides have been made in the clinical treatment of cartilage lesions, 
the limitations of these techniques do not completely inhibit formation of 
fibrocartilaginous tissue and do not fully address the poor integration of the replacement 
tissue 11.  Long-term studies are demonstrating the need for alternative strategies to treat 




2.2 ARTICULAR CHONDROCYTES 
2.2.1 Biomechanical Influences 
The biomechanical environment contributes to the regulation of cartilage 
development, maturation and maintenance.  Articular cartilage has been shown to be 
responsive to changes in mechanical loading across the joint.  Experimental studies have 
indicated that moderate exercise leads to increased proteoglycan content, while joint 
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immobilization leads to loss of proteoglycan content45,46.  In vitro studies have provided 
important information regarding how mechanical loading influences articular 
chondrocyte metabolism8,47.  Static compression of cartilage explants inhibits both 
protein and sGAG synthesis, while dynamic compression increases both protein and 
sGAG synthesis within given frequency and deformation ranges48.  Studies with isolated 
chondrocytes in hydrogels have demonstrated that the length of culture time preceding 
exposure to mechanical loading influences cellular response49.  The ability of a cell to 
sense mechanical stimulation after formation of a pericellular matrix, but before 
formation of an interconnected extracellular matrix, has been shown to be dramatically 
decreased.  For hydrogels subjected to loading after multiple weeks in culture, static 
compression was found to decrease both protein and sGAG synthesis, while dynamic 
loading increased synthesis50-52.   
 
2.2.2 Mechanotransduction  
The mechanisms by which chondrocytes sense changes in their local mechanical 
environment produced by these macroscopic stimuli are largely unknown.  Studies with 
articular chondrocytes in monolayer suggest that mechanosensitive ion channels may 
participate in chondrocyte mechanotransduction.  It has been demonstrated that fluid 
flow, which chondrocytes experience in vivo and which results in a variety of 
morphological and metabolic changes in cultured articular chondrocytes, can stimulate a 
rise in intracellular calcium concentration due to both G-protein modulation and the 
release of Ca2+ stores, possibly through an inositol 1,4,5-trisphosphate (IP3)-dependent 
mechanism53.  It has also been suggested that transient increases in intracellular Ca2+ 
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concentrations may be one of the earliest events involved in the response of chondrocytes 
to mechanical stress through deformation-induced Ca2+ waves initiated through 
mechanosensitive ion channels54.  Stretch-activated channels have been suggested to 
participate in the control of chondrocyte proliferation.  Also, blocking the Ca2+-senstitive 
K+ channels has been demonstrated to have an effect on both proliferation and mRNA 
level of certain proteins55.  However, important differences exist between chondrocyte 
behavior in monolayer and three dimensional cultures.  The extent to which these same 
ion channels are involved in the transduction of mechanical stimuli in three-dimensional 
culture is unclear. 
 
 
2.3 CARTILAGE TISSUE ENGINEERING 
In pathological states such as osteoarthritis, the complex metabolic balance of 
cartilage is disrupted, marked by increased catabolism and decreased synthesis of matrix 
proteins by chondrocytes.  This leads to a loss in the integrity and biomechanical function 
of cartilage1.  Tissue engineering offers a potential solution for the replacement of 
diseased and/or damaged cartilage3,4.  Unfortunately, plentiful donor cell populations are 
difficult to assemble, if not impossible.  It has been demonstrated that chondrocytes lack 
the ability to be expanded in monolayer culture without a parallel loss of phenotype5.  
Mesenchymal progenitor cells offer an alternative with a far greater expansion potential 




  The criteria for scaffold design in general is that the material must exhibit 
biocompatibility, provide mechanical support during the healing process, and support 
ingrowth of native cells and matrix.  When addressing biocompatibility, consideration 
must be given to not only how the recipient tissue will respond to the intact scaffold, but 
also to its degradation products as the tissue regenerates11,56.  For example, the build up 
of acidic products during the degradation of lactic acid based scaffolds has been shown to 
be detrimental to the surrounding tissue.  During the early stages of healing, the scaffold 
must be able to withstand the complex mechanical environment of articular cartilage, 
especially if cells and/or growth factors are to be delivered to the site56.  In articular 
cartilage, lack of integration with the surrounding cartilage has been the focus of much 
research.  Loosening of constructs due to the hypertrophic shear environments at the 
implant/cartilage interface may impede integration and implant stability is usually 
obtained by suturing or press fitting14.  Sites of uneven integration with the host tissue 
may later become the nucleation site of arthritic degeneration11.  Finally, ease of handling 
in the clinical setting is of critical importance for any tissue engineered application8. 
Several types of scaffolds are being investigated by articular cartilage tissue-
engineering researchers.  These include natural scaffolds (autologous or allogenic 
tissues), woven scaffolds like polyglycolic acid (PGA) and polylactic acid (PLA), and 
gels made from natural proteins like collagen, fibrin, chitosan, agarose, and alginate11,57.   
Materials derived from PLA and PGA are attractive because they have been 
USDA approved for in vivo applications for many years11,56,57.  They support cell 
attachment and matrix production of several different cell types involved in 
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osteochondral tissue engineering56.  They have been shown to support significant matrix 
accumulation by young bovine chondrocytes in rotating wall and perfusion bioreactors in 
vitro8.  Hydrogels are also attractive because their high hydration provides the construct 
with initial mechanical stability and allows diffusion of nutrients and waste products to 
and from the encapsulated cells.  The ability of these gels to be injected into a defect site 
and polymerized in situ make hydrogels ideal for easy delivery clinically.  A great deal of 
research has been performed to on the ability of alginate and agarose to recover and/or 
maintain the chondrocytic phenotype of cells derived from cartilaginous tissues8,58.   
 
2.3.2 Cell Source 
Though much has been learned from articular chondrocytes in vitro, the 
applicability in the clinical setting is limited by the fact that there are limited sites from 
which donor tissue can be harvested13.  Additionally, despite evidence that the 
chondrocytic phenotype lost by articular chondrocytes during expansion can be recovered 
by placing these cells in a 3D environment, poor expansion is still a characteristic of 
these cells.  MPCs can be easily isolated and offer high proliferation potential.  These 
undifferentiated MPCs are capable of differentiating into a distinct phenotype through a 
series of discrete steps, finishing with cells involved in the production of a distinct tissue 
type7,59.  The in vitro chondrogenesis of bone marrow derived MPCs has been described 
using the aggregate culture (i.e. pellet60) and gel culture (agarose61, alginate62) of  MPCs 
in media supplemented with transforming growth factor-beta 1 (TGF-β1)63.  Fibroblast 
growth factor 2 (FGF-2) has been found to maintain cells in a more proliferative state, 
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allowing in vitro expansion of BMSCs64.  BMSCs have been shown to retain some level 




2.4.1 Transforming Growth Factor β and Smad Signaling 
Both biochemical and biomechanical stimulation have been shown to influence 
the growth and differentiation of BMSCs.  Much effort investigating the effect of growth 
factor and cytokine supplementation on the chondrogenesis of BMSCs has focused 
around members of the transforming growth factor β (TGF-β) family66.  Multiple 
members of the TGF-β family, including TGF-β1, have been shown to induce in vitro 
chondrogenesis of BMSCs67,68.  The transforming growth factor β (TGF-β) superfamily is 
involved in the regulation of multiple cellular processes, including cell proliferation, 
differentiation and apoptosis69.  TGF-β transmits its signal from the cell surface via a 
transmembrane serine/threonine kinase receptor complex70,71.   Upon ligand binding, the 
type II receptor subunit engages and transphosphorylates a type I receptor subunit 
(TβRI), which in turn phosphorylates the receptor-activated Smad proteins (R-Smads) 
Smad2 and Smad3 (Figure 2.2).  A protein complex with Smad4 is formed with the 
activated R-Smads and translocated into the nucleus where they interact with additional 
transcription factors, binding to the promoters of responsive genes and regulate their 
expression by cooperating with other activators or repressors72.  In addition to the Smad 
pathway, TGF-β has been shown to activate other signaling pathways including p38 
mitogen-activated protein kinase (MAPK)73 and protein kinase C (PKC)74.  TGF-β 
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signaling has been demonstrated through the p38 MAPK pathway through activation of 
mitogen-activated protein kinase 1 (MEK1) and subsequent ERK/ELK signaling75,76.  It 
has also been shown that G-protein-dependent activation of PKC results from TGF-β 
stimulation of growth plate chondrocytes74.  It has been suggested that TGF-β 
responsiveness requires the activation of the R-Smad2/4 complexes as well as other 
signaling pathways.   
 
 
Figure 2.2: Proposed TGF-β signaling pathways in chondrocytes (TRE: TGF-β 
responsive element, VDR/RXR: vitamin D receptor/retinoic acid X receptor, AP-1: 
activation protein-1).  
(Adapted from Grimaud et al.77) 
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2.4.2 Biomechanical Influences 
Mechanical stimulation has been shown to be important in the development of 
certain tissues and may influence differentiation of BMSCs78.  It has been suggested that 
the combination of chondrogenic media and dynamic compressive loading may enhance 
chondrogenesis of BMSCs over the addition of exogenous factors alone79.  Dynamic 
compressive loading has been shown to increase the expression of chondrogenic markers, 
aggrecan and collagen II, in rabbit BMSCs in agarose culture79.  Dynamic compressive 
loading has also been shown to induce chondrogenesis in chick-bud mesenchymal 
cells80,81.  Human BMSCs cultured under conditions promoting chondrogenesis found 
that the application of cyclic hydrostatic pressure for multiple days increased 
proteoglycan and collagen content after 14 days in culture82.  Mechanical loading has 
been found to be critical in the differentiation of other tissue types, including bone.  
BMSCs cultured on partially demineralized bone subjected to four-point bending loading 
experienced elevated osteogenic differentiation, compared to unloaded controls83.  
Combined with the substantial knowledge base that mechanical stimulation can affect the 
maintenance of cartilage, these studies suggest that controlled mechanical stimulation 
may direct differentiation and subsequent matrix assembly in engineered cartilage 
derived from mesenchymal progenitor cells.   
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CHAPTER 3 INFLUENCE OF VARIOUS TISSUE-ENGINEERING SCAFFOLD 






The function of healthy cartilage resides in its ability to provide resistance to 
compressive, shear and tensile forces that occur during normal joint motion. This ability 
arises from the unique architecture of the matrix components found in articular cartilage. 
The fibrillar collagen network is organized and stabilized through molecular cross-links 
that restrain the swelling pressure exerted by a high concentration of negatively charged 
proteoglycans. Proteoglycans are known to indirectly influence chondrocyte activity, 
either through cell-matrix interactions or by binding specific growth factors in the 
extracellular matrix, thereby modifying their temporal and spatial effects15. Many of 
these biological interactions involve the highly negative glycosaminoglycan (GAG) 
chains, which are covalently attached to the protein cores of individual proteoglycan 
molecules15. In articular cartilage, the GAGs are mainly chondroitin sulfate (CS) and 
keratan sulfate chains found on the large, aggregating proteoglycan aggrecan, as well as a 
small proportion of dermatan sulfate (DS) chains15. Aggrecan monomers consist of a 
protein core to which are attached CS chains containing predominately 4- or 6-sulfated 
disaccharides84,85. These negatively charged GAGs produce a swelling pressure through 
interactions with the ionic interstitial fluid15, contributing to the compressive stiffness of 
the tissue and maintaining tensile stress in the type II collagen network. While the 
collagen network is somewhat metabolically static86, aggrecan undergoes a distinct 
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turnover process21,87 in which catabolic cleavage88,89 and removal of molecules from the 
extracellular matrix are in balance with synthesis and deposition of new molecules90,91. 
Maintenance of the appropriate structure and concentration of the proteoglycans is 
critical for maintaining healthy cartilage capable of resisting compressive loads.  
Alterations in glycosaminoglycan sulfation have been associated with aging and 
degeneration of articular cartilage. Changes include a decreased keratan sulfate to CS 
ratio and a decrease in overall glycosaminoglycan chain length15,92. The internal 
disaccharide (∆-disaccharide) composition of CS chains shifts with age, with an 
increased ratio of 6-sulfated (∆Di-6S) to 4-sulfated (∆Di-4S) disaccharides and a 
decrease in unsulfated (∆Di-0S) disaccharides15. The non-reducing termini of CS chains 
from aggrecan purified from fetal to elderly human cartilage contain distinctly different 
ratios of variably sulfated galNAc residues which are characteristic of the age of the 
patient93, with an age related increase in 4,6-disulfated residues and a corresponding 
decrease in 4-sulfated residues. Additionally, a decrease in CS terminal 4,6-disulfated 
residues and an increase in CS terminal 4-sulfated residues has been described for OA 
cartilage, perhaps due to a lower propensity to the specific 6-sulfotransferase involved in 
the terminal 4,6 reaction94-99.  
While distinct functional implications of CS sulfation patterns in cartilage have 
not yet been elucidated, recent work has suggested fundamental biological functions for 
chondroitin, chondroitin sulfate and dermatan sulfate in other systems.  These 
glycosaminoglycans have been implicated in growth factor and chemokine signaling, 
play critical roles in the development of the central nervous system, and function as 
receptors for various pathogens100-103.  Unsulfated chondroitin has been found to be 
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integral in the morphogenesis and cell division of C. elegans104. These functions are 
directly related to the sulfation patterns of the glycosaminoglycan chains.   
Understanding the degree and level of influence the CS fine structure plays in the 
biological activity of chondrocytes may provide a more in depth perspective on not only 
the state of native cartilage (i.e. osteoarthritic, injured, healthy) but also the development 
of engineered cartilages. A key component of most tissue engineering approaches to 
regenerating articular cartilage is the choice of a scaffold material. The 3D scaffold 
provides support for chondrocytes to proliferate and maintain their differentiated 
function58,105-107. In the case of undifferentiated cell populations (e.g., BMSCs, 
mesenchymal stem cells), the choice of scaffold may influence the differentiation and 
phenotypic stability of the cell populations. Scaffold materials commonly used for the 
tissue engineering of cartilage include degradable synthetic polymers (e.g., polyglycolic 
acid (PGA)108,109, polylactic acid110), fibrillar protein gels (e.g., collagen111, fibrin112,113), 
and polysaccharide gels (e.g., agarose114,115, alginate116,117). Matrix formation in these 
systems is typically quantified by measures of gross biochemical composition such as the 
total sulfated glycosaminoglycan (sGAG) content. While these gross measures are useful, 
more definitive molecular information is required to fully understand the biochemical 
characteristics of tissue engineered cartilage matrices.  
The study presented in this chapter examined the nature of the proteoglycan / 
GAG matrices synthesized by chondrocytes seeded in different scaffold materials. In 
addition to differences in total GAG content, fluorophore-assisted carbohydrate 
electrophoresis (FACE) revealed differences in CS/DS GAG fine structure among 
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different scaffold materials.  The results of this study were used to choose a scaffold 
material for use in subsequent studies. 
 
 
3.2 MATERIALS AND METHODS 
3.2.1 Construct assembly and cell culture 
Bovine articular chondrocytes were isolated from the stifle joints of two immature 
(<5 weeks) donor animals. Tissue was excised from the patellofemoral grooves, minced 
and digested in DMEM with 0.2% collagenase for 24 h in a 37°C, 5% CO2 incubator. 
After centrifugation at 160 x g, cells were washed twice with Ca2+, Mg2+ -free PBS and 
counted with a Coulter counter. Donor cells were kept separate and parallel duplicate 
experiments were run. Non-digested samples of cartilage were maintained as controls 
during the course of the experiment. Hydrogel constructs were created by seeding cells at 
a final density of 15x106 cells/mL in 1.5% low melting point (LMP) agarose, 0.75% 
sodium alginate, 2 mg/mL type I collagen (rat tail), and 50 mg/mL fibrin. Cells were also 
seeded on polyglycolic acid (PGA) felt at a target density of 15x106 cells/mL, but a low 
seeding efficiency resulted in an actual initial cell density of approximately 4x106 
cell/mL. It should be noted that seeding density may affect chondrocyte matrix synthesis 
and viability, perhaps due to diffusional limitations at high cell densities118,119. All 
constructs except PGA were cast in 12mm diameter x 3mm deep cylindrical wells in 
custom machined polycarbonate molds that were autoclave sterilized prior to gel casting. 
Agarose constructs were assembled by autoclaving 3% LMP agarose in 1X Ca2+, Mg2+ -
free PBS and then cooling the solution to 42°C. An equal volume of cells suspended at 30 
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x106 cells/mL in 2X DMEM and 20% FBS was added, and the solution was cooled in the 
molds. Alginate constructs were similarly assembled by autoclaving 1.5% alginic acid in 
1X Ca2+, Mg2+ -free PBS to solubilize and sterilize, cooling to 37°C, adding 30x106 
cells/mL in Ca2+, Mg2+ -free PBS and polymerizing the gels in the molds with 102 mM 
CaCl2. Collagen constructs were assembled by suspending 15x106 cell/mL in a solution 
containing 10% FBS, 0.5x DMEM and 2 mg/mL acid solubilized rat tail collagen type I 
and titrating the solution to neutral pH with 0.1M NaOH. Constructs were allowed to 
polymerize in a 37°C, 5% CO2 incubator for 30 minutes before transfer to 24 well plates 
with 2ml of media. Fibrin constructs were assembled by suspending cells in a solution of 
bovine fibrinogen, FBS, 6-aminocaproic acid, and DMEM. Bovine thrombin was 
dissolved in 40 mM CaCl2 , and 100 µl of the thrombin solution was placed into each 
well of a polycarbonate mold (12 mm diameter by 3 mm deep), followed by 200 µl of the 
cell/fibrinogen mixture. Final concentrations in the constructs were 50 mg/mL fibrinogen, 
50 U/mL thrombin, 10% FBS, 2 mg/mL 6-aminocaproic acid, and 15x106 cells/mL. 
Constructs were allowed to polymerize in a 37°C, 5% CO2 incubator for 30 min. PGA 
felts (45 mg/cm3 polymer density; 12-15 µm fiber thickness; 10 mm diameter by 2 mm 
thickness) were prewetted overnight in high-glucose DMEM containing 10% FBS. PGA 
felts were then seeded by repeatedly pipetting 1 mL of cell suspension (1.2x106 cells/mL) 
onto each felt and cultured on a shaker plate at 300 rpm for 24 hours. Additionally, native 
cartilage samples from the same joints were maintained in identical culture conditions for 
the comparison of ∆-disaccharide composition. 
Constructs and native cartilage samples (n=6 per group per endpoint) were 
cultured in 24 well plates with 2 mL of DMEM containing 10% FBS, 0.1mM NEAA, 
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4mM L-glutamine, 5 µg/mL gentamicin sulfate and 50 µg/mL ascorbic acid. For the 
PGA felts, the culture dish wells had been pre-coated with a thin layer of 1% agarose. As 
in previous studies on dorsal root ganglia120, smooth muscle cells121 and 
chondrocytes122,123, 6-aminocaproic acid (2 mg/mL) was added to the media of fibrin 
constructs to inhibit proteolytic degradation. Media were changed every two days, with 
samples retained for analysis of the sulfated glycosaminoglycans (sGAG) released from 
the constructs. After 20 and 40 days, constructs were weighed, lyophilized, reweighed, 
and digested in 1ml of 100mM ammonium acetate buffer with 250 µg/mL Proteinase K 
at 60°C for 24 hours. Portions of each digest were assayed for total DNA using the 
Hoechst 33258 assay with calf thymus DNA as a standard124 and sGAG using the 
DMMB assay125,126 with shark cartilage CS as a standard. 
 
3.2.2 Analytical Techniques 
Histological Sample Processing and Characterization 
Additional samples were rinsed in PBS, transferred to 10% neutral-buffered 
formalin for 48 hours, and then stored in 70% ethanol (n=2 per group per endpoint) to 
reduce the solubility of the GAG sidechains. Samples were subsequently embedded in 
paraffin and sectioned at five microns. Sections were stained with Safranin-O to visualize 
sulfated GAG distribution127.  
 
∆-Disaccharide Analysis  
The chondroitin sulfate and dermatan sulfate (CS/DS) ∆-disaccharide 
compositions of deposited GAGs were quantified for all 20 and 40 day constructs using 
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fluorophore assisted carbohydrate electrophoresis (FACE)128-132. GAGs were ethanol 
precipitated (final concentration of 75% v/v) from the Proteinase K digests and aliquots 
from each construct containing 5 µg of sGAG (as determined by the DMMB dye assay) 
were further enzymatically processed with 15 mU of chondroitinase ABC and 100 mU 
hyaluronidase in 100 µL of 50mM ammonium acetate buffer at 37°C for 16 hours. Buffer 
was evaporated and digestion products were fluorescently labeled for 16 hours at 37°C 
with 15 µL of 0.1M 2-aminoacridone and 1.0M sodium cyanoborohydride. After 
fluorescent labeling, 15 µL of glycerol was added to each sample. 5 µL portions of these 
samples were electrophoretically separated using monosaccharide FACE gels. 
Fluorescent bands were visualized at 300 nm illumination using a Kodak EDAS 120 gel 
imaging system. Band intensities were fit with a Gaussian model and converted to pmol 
amounts using a standard ladder containing a range of concentrations of purified ∆-
disaccharides (25-250 pmol) for product identification and quantification (50 pmol of 
∆Di-4,6S, 75 pmol hyaluronic acid, 100 pmol of ∆Di-6S, 150 pmol of ∆Di-4S, and 200 
pmol of ∆Di-0S). Relative ∆-disaccharide composition was expressed as a percent of 
total detected internal CS/DS ∆-disaccharides for ∆Di-0S (unsulfated), ∆Di-4S, ∆Di-6S 
and ∆Di-4,6S, and as the ratio of ∆Di-6S:∆Di-4S. For comparison, native articular 
cartilage samples that had been cultured for comparable periods were also analyzed via 
FACE.  For a detailed protocol, see appendix C. 
 
Statistical Analysis 
 For this chapter, as well as subsequent chapters, the details of the statistical 




 For a given construct type, no differences were noted in the organization of cells 
or sGAG matrix between histological samples from the 20 and 40 day time points. Cells 
in all scaffolds displayed predominantly a rounded morphology (Figure 3.1b-f) similar to 
chondrocytes in their native matrix (Figure 3.1a). Agarose constructs (Figure 3.1Error! 
Reference source not found.b) included isolated cells and multiple cell clusters 
surrounded by a pericellular matrix dense in sGAG, while the other constructs contained 
primarily isolated cells or small cell clusters. The intensity of pericellular matrix staining 
in the four other scaffold materials was either considerably less intense (alginate, 
collagen and PGA) or less extensive (fibrin) than that in agarose. Alginate constructs 
(Figure 3.1c) also displayed intense pericellular matrix staining, with a relatively high 
background level of staining due to the negatively charged alginate. Collagen constructs 
(Figure 3.1d) contained uniformly distributed cells and diffuse matrix staining. In 
contrast, fibrin constructs (Figure 3.1e) displayed a very immediate staining of sGAG 
surrounding either single cells or pairs of cells. PGA constructs (Figure 3.1f) contained 
islands with relatively intense matrix staining and numerous cells surrounded by regions 
apparently devoid of cells. Articular cartilage, alginate and fibrin constructs were 
surrounded by a layer with little sGAG staining and cells with a more flattened 
morphology (images not shown). 
 38
 
A. Articular Cartilage B. Agarose C. Alginate 
   
D. Collagen I E. Fibrin F. PGA 
   
 
Figure 3.1:  Representative interior sections stained with Safranin O from A) articular 




3.3.2 DNA Content 
 The relative changes in DNA content from initial seeding to day 20 or 40 
indicated differential increases in the cellular contents among scaffold types (Figure 3.2). 
The increases in DNA content of agarose and collagen constructs were not significantly 
different at either time point (p>0.8) and reached approximately 3.5 times the initial 
seeding density. Agarose constructs had significantly greater increases in DNA content 
than alginate, fibrin or PGA constructs at both day 20 (p≤0.0002) and day 40 (p≤0.028). 
Collagen constructs had significantly greater increases in DNA content than fibrin and 
PGA constructs at day 20 (p≤0.0016) and day 40 (p≤0.0001), and significantly greater 
increases than alginate constructs at day 40 (p<0.0001) but not day 20 (p=0.061). There 
were no significant changes in DNA content between 20 and 40 days for any constructs 
except for PGA (p<0.0001). PGA constructs exhibited a small (25%) increase in DNA 
content by day 20, followed by a substantial (109%, p<0.0001) increase in DNA content 
between days 20 and 40, resulting in a net increase comparable to that seen in the other 
construct types. At day 40, alginate, fibrin and PGA constructs had reached 
approximately 2.5 times the original seeding density, with no statistically significant 







































Agarose Alginate Collagen I Fibrin PGA  
 
Figure 3.2:  Construct DNA contents.   
A)  DNA contents at day 0.  PGA constructs had substantially fewer cells due to a low 
seeding density.  B)  DNA contents relative to day 0 levels for each scaffold type after 20 
and 40 days of culture.  Asterisks indicate p<0.05 versus all other scaffolds at the same 
time point, daggers indicate p<0.05 versus some other scaffolds at the same time point, 
and stars at day 20 indicate p<0.05 versus the day 40 value for the same scaffold.  
Individual differences are discussed in the text.  (mean±S.E.M., N=12). 
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3.3.3 sGAG Production 
The sGAG/DNA results indicated that constructs from all scaffold groups 
accumulated extracellular matrix over the 40 day culture period (Figure 3.3). Between 
days 20 and 40, agarose constructs exhibited a continued increase in sGAG/DNA 
(p<0.0001) while alginate, collagen, and fibrin constructs exhibited no significant change 
in sGAG/DNA. PGA constructs had significantly lower sGAG/DNA at day 40 as 
compared to day 20 (p<0.0001), which can be attributed to the dramatic increase in DNA 
content over that period. The patterns of matrix accumulation and cell content changes 
resulted in differences in sGAG/DNA among scaffolds at each time point. At day 20, 
PGA constructs had significantly higher sGAG/DNA than all other groups (p<0.0001), 
while alginate constructs had significantly lower sGAG/DNA than all groups (p≤0.0023) 
except collagen constructs (p=0.45). At day 40, agarose constructs had significantly 
higher sGAG/DNA than all other groups (p<0.0001), while collagen and alginate 
constructs had significantly lower sGAG/DNA (p≤0.0003 and p<0.0001 respectively) 
than all other groups.  
The sGAG detected in the media indicated that sGAG was released from all 
constructs through the 40 day culture period (Figure 3.4).  Overall, the average sGAG 
release rate was lowest for alginate constructs and comparable for agarose, collagen and 
PGA constructs.  The kinetics of sGAG release were similar for agarose, alginate, 
collagen and fibrin, with increasing release rates through day 30 followed by a significant 
(except for agarose) drop in sGAG release on days 31-40.  In contrast, the sGAG release 































Agarose Alginate Collagen I Fibrin PGA  
 
Figure 3.3:  Construct sGAG content normalized to DNA content after 20 and 40 days of 
culture.   
Asterisks indicate p<0.05 versus all other scaffolds at the same time point, daggers 
indicate p<0.05 versus some other scaffolds at the same time point, and stars at day 20 
indicate p<0.05 versus the day 40 value for the same scaffold.  Individual differences are 
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3.3.4 ∆-Disaccharide Composition 
As in native articular cartilage, ∆Di-4S and ∆Di-6S comprised the majority (~ 
80%) of CS/DS-derived ∆-disaccharides (Table 3-1), although the fraction of each ∆-
disaccharide varied somewhat. Overall, the fraction of ∆Di-4S was lower at day 20 than 
at day 40 (p=0.0025), although the pairwise comparisons did not indicate a significant 
increase for any individual scaffold. The fraction of ∆Di-4S was higher for agarose than 
for all other scaffolds (p≤0.0002). This pairwise difference was significant at day 20 
versus all scaffolds (p<0.0001) except collagen (p=0.053) and was significant at day 40 
versus fibrin (p=0.031) and PGA (p=0.034) but not collagen (p=0.055) or alginate 
(p=0.25). Other than a higher fraction for collagen compared to PGA at day 20 
(p=0.014), there were no other significant differences in ∆Di-4S among scaffolds at either 
time point. The fraction of ∆Di-6S was not significantly different between day 20 and 
day 40 (p>0.19), but did vary among scaffolds (p<0.0001). Among the construct groups, 
the fraction of ∆Di-6S was smaller for agarose than for all other scaffolds (p≤0.032) and 
was smaller for collagen than for alginate (p=0.0017) and PGA (p=0.021). The ratio of 
∆Di-6S: ∆Di-4S in the constructs was generally somewhat higher than that in native 
tissue explants (Figure 2.5). The ratio of ∆Di-6S:  ∆Di-4S was slightly higher at day 20 
than at day 40 (p=0.009), was lower for agarose than for all other scaffolds (p≤0.0019), 
and was lower for collagen than for alginate (p=0.007) and PGA (p=0.0075). 
Overall, the fraction of ∆Di-4,6S was significantly higher at day 20 than at day 40 
(p=0.0017), but other than a slightly higher level for fibrin constructs at day 40 (p=0.078) 
there were no significant differences in the fraction of ∆Di-0S between days 20 and 40. 
There were significant differences among scaffold types in the fractions of both 
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unsulfated ∆Di-0S and disulfated ∆Di-4,6S. Alginate constructs had a lower fraction of 
∆Di-0S than all other scaffold groups (p<0.0001) and a higher fraction of ∆Di-4,6S than 
all other scaffold groups (p<0.0001). In contrast, collagen constructs had a higher fraction 
of ∆Di-0S than all other scaffold groups (p≤0.023) and a lower fraction of ∆Di-4,6S than 
alginate, fibrin or PGA (p≤0.0001) constructs. Other than a significantly higher level of 
∆Di-0S for agarose than for fibrin at day 20 (p=0.0084), there were no other significant 





























Figure 3.5:  Construct ∆Di-6S/∆Di-4S ratios after 20 and 40 days of culture.   
Levels for articular cartilage (AC) cultured for comparable periods are included for visual 
comparison.  Asterisks indicate p<0.05 versus all other scaffolds at the same time point 
and daggers indicate p<0.05 versus some other scaffolds at the same time point.  
Individual differences are discussed in the text.  (mean±S.E.M., N=12). 
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Table 3-1: GAG ∆-disaccharide contents derived from CS and DS after 20 and 40 days of 
culture.   
Levels for articular cartilage cultured for comparable periods are included for 
comparison.  Values are expressed as percentages of total ∆-disaccharide measured.  
Asterisks indicate p < 0.05 versus all other scaffolds at the same time point and daggers 








 While a wide variety of biomaterials have been proposed for use in cartilage 
tissue engineering, few studies have quantitatively compared details of chondrocyte 
activity and extracellular matrix production in different scaffold materials. This study 
found significant differences in cell proliferation and extracellular matrix accumulation 
among five scaffolds commonly used for chondrocyte in vitro culture studies and 
cartilage tissue engineering. Over the first 20 days, PGA constructs had the lowest 
increase in cell content but the greatest accumulation of sGAG per cell and the greatest 
rate of sGAG release to the media. Between day 20 and day 40, the sGAG/DNA of the 
other constructs was fairly stable while that of PGA constructs decreased substantially 
due to the substantial increase in cell proliferation in PGA scaffolds. Chondrocytes in 
agarose synthesized the most sGAG throughout the study, resulting in a substantially 
higher sGAG/DNA than all other scaffolds at day 40. Distinct differences between 
scaffolds were also noted in the distributions of cells and matrix. The differences in the 
distribution of the chondrocytes in the various scaffolds may be due to inherent 
differences in the preparation required for the various scaffolds or in how the cells 
interact with particular scaffolds after seeding. Other possible reasons for the cell 
clustering include the migration of cells into colonies or localized cell death. 
Furthermore, this study revealed substantial quantitative differences in the ∆-
disaccharide composition of the proteoglycans accumulated in the different scaffolds. 
Overall, the internal ∆-disaccharide profiles of glycosaminoglycans in alginate constructs 
least resembled that of native articular cartilage, whereas the profile of agarose constructs 
most closely resembled that of articular cartilage. The primary notable difference in the 
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levels of the monosulfated ∆Di-4S and ∆Di-6S was for agarose constructs, which had a 
higher fraction of ∆Di-4S, lower fraction of ∆Di-6S, and lower ∆Di-6S:  ∆Di-4S than all 
other scaffold groups. More striking differences were seen in the levels of unsulfated 
∆Di-0S and disulfated ∆Di-4,6S. Alginate constructs had a lower fraction of unsulfated 
residues and a higher fraction of disulfated residues than other groups. Conversely, 
collagen constructs had the highest fraction of unsulfated residues and the lowest fraction 
of disulfated residues. These patterns suggest that some aspects of the construct 
environment influence a tradeoff between incorporation of unsulfated ∆Di-0S and 
disulfated ∆Di-4,6S into newly synthesized proteoglycans. Further studies would be 
necessary to identify the causes of the observed differences in sulfation patterns (e.g., 
altered sulfotransferase activity, altered ratios of proteoglycan species, etc.). Interestingly, 
the influence of mechanical stimulation on GAG disaccharide composition also appears 
to depend on the cellular environment.  Cyclic compression of cartilage tissue explants 
had no effect on the internal disaccharide composition of newly synthesized GAGs133, 
while cyclic compression of chondrocytes in fibrin constructs significantly decreased the 
proportion of unsulfated ∆Di-0S134.  Further exploration of variations between scaffolds 
in the response to mechanical stimulation will be important in the development of 
mechanically functional engineered cartilage constructs. 
The similarities and differences among scaffolds in proteoglycan accumulation 
and glycosaminoglycan composition were consistent for both donor animals at both time 
points, suggesting that the scaffold material directly or indirectly influences chondrocyte 
proteoglycan metabolism. Prior to the deposition of any extracellular matrix, chondrocyte 
interactions with the scaffold would vary substantially depending on the type of scaffold. 
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Direct chondrocyte binding to protein scaffolds such as collagen or fibrin via integrins or 
other cell surface receptors may influence a variety of cellular functions135-137. In contrast, 
chondrocytes would initially be isolated from interactions with the scaffold material 
when suspended in the agarose and alginate hydrogels. In PGA scaffolds, chondrocytes 
initially adhere to and spread on serum proteins absorbed onto the polymer mesh, 
resulting in an initial state somewhat similar to monolayer culture138,139.  
In each of these systems, chondrocytes would eventually interact primarily with 
the new extracellular matrix produced by the cells, but the accumulation of that matrix 
could be influenced by the physical properties of the scaffold140. For example, the highly 
permeable, macroscopically porous PGA scaffolds initially provide little resistance to 
diffusion of secreted proteins and proteoglycans, allowing much of the newly synthesized 
material to escape the construct141,142. Conversely, scaffolds such as alginate and agarose 
provide substantial resistance to diffusion of large molecules, resulting in more 
concentrated pericellular accumulation of secreted matrix components143. Additionally, 
the biophysical environment of the cell may vary between scaffolds. For example, the 
agarose gel provides an electrochemically neutral environment, while the negatively 
charged alginate may affect both the ionic environment and the interstitial pH, potentially 
influencing cell behavior and the ability of the local environment to sequester important 
growth factors, cytokines and chemokines.  
While the functional implications of altered ∆-disaccharide sulfation patterns in 
native or engineered cartilage are unknown, there is evidence of structure-function 
relationships in other tissues and with other sulfated GAGs. Oversulfation of CS/DS 
chains containing GlcAβ1-3GalNAc(4,6-O-disulfate) or IdoAα1-3GalNAc(4,6-O-
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disulfate) in the large aggregating proteoglycan versican affects its ability to bind to L- 
and P-selectin and chemokines144. Additionally, any amount of sulfation has been shown 
to inhibit the ability of versican to interact with CD44145. It has been shown that 
oversulfated CS chains play a role in the development of the brain. Specifically, CS 
chains with oversulfated structures are involved in neuronal adhesion, migration and 
neuritogenesis 146. Thus, the possibility exists that variations in the sulfation of the CS 
chains in cartilage may alter the binding of nutrients, chemokines and growth factors, 
thereby influencing chondrocyte migration, differentiation, and matrix production.  
With advances in tissue engineering, it has become apparent that more 
sophisticated methods of evaluating engineered cartilage constructs need to be employed. 
In this study, articular chondrocytes seeded into different scaffolds exhibited differences 
in proliferation, the quantity of matrix accumulated and the fine structure of the newly 
synthesized glycosaminoglycans. It should be noted that many evolving approaches to 
cartilage tissue engineering rely on either passage expanded chondrocytes or chemically 
manipulated progenitor cells, either of which would be expected to continue 
differentiating towards a chondrocytic phenotype within the construct environment. In 
such cases where relatively rapid changes in phenotype are expected, the influence of the 
scaffold environment on cell behavior and matrix composition may be more pronounced. 
An appreciation of the details of the extracellular matrix structure in engineered tissues 
may be important in understanding the relative maturity and health of the engineered 
tissue and the degree to which engineered implants may differ from and integrate with the 




CHAPTER 4  INFLUENCE OF VARIOUS ION-CHANNEL 
MECHANOTRANSDUCTION PATHWAYS ON THE BIOSYNTHESIS OF 







The biomechanical environment contributes to the regulation of cartilage 
development, maturation and maintenance147.  Experimental studies have indicated that 
moderate exercise leads to increased proteoglycan content, while joint immobilization 
leads to loss of proteoglycan content45,46.  In vitro studies have provided important 
information regarding how mechanical loading influences articular chondrocyte 
metabolism8,148.  In previous in vitro investigations using cartilage tissue explants or 
chondrocytes in hydrogel culture, static compression decreased both aggrecan and type II 
collagen gene expression and synthesis, whereas dynamic compression at appropriate 
frequencies increased anabolic activity52,149-152.  While tissue culture experiments have 
demonstrated the sensitivity of articular chondrocytes to mechanical stimuli, the cellular-
level physical signals that chondrocytes sense, and to which they respond in their 
biophysical environment, remain unclear. 
In vivo compression of cartilage results in a variety of physical effects at the tissue 
and cell levels, including electrokinetic effects, hydrostatic fluid pressurization, direct 
cellular deformation and interstitial fluid flow153.  Any or all of these effects may be 
important mechanical stimuli.  In cartilage, chondrocytes are completely surrounded by 
extracellular matrix networks, thus receiving physical signals from a 3D environment.  In 
 53
contrast, most studies of the mechanisms involved in chondrocyte mechanotransduction 
have been performed in the absence of a 3D matrix via monolayer experiments.   
Studies with articular chondrocytes in monolayer suggest that mechanosensitive 
ion-channels may participate in chondrocyte mechanotransduction.  Fluid flow-induced 
shear, which chondrocytes may experience in vivo due to load-induced convective flow, 
results in a variety of morphological and metabolic changes in cultured articular 
chondrocytes.  Flow-induced shear can stimulate a rise in intracellular calcium 
concentration due to both G-protein modulation and the release of Ca2+ stores, possibly 
through an inositol 1,4,5-trisphosphate (IP3)-dependent mechanism154.  It has also been 
suggested that transient increases in intracellular Ca2+ concentrations may be one of the 
earliest events involved in the response of chondrocytes to mechanical stress through 
deformation-induced Ca2+ waves initiated via mechanosensitive ion-channels54.  Stretch-
activated channels have been suggested to participate in the control of chondrocyte 
proliferation.  Also, blocking the Ca2+-senstitive K+ have been demonstrated to have an 
effect on both proliferation and mRNA levels of certain proteins55.   
However, important differences exist between chondrocyte behavior in monolayer 
and 3D cultures, and the extent to which these same ion-channels are involved in the 
transduction of mechanical stimuli in 3D culture is unclear.  In one of the few studies to 
examine similar issues in 3D culture, the upregulation of aggrecan gene expression in 
bovine articular cartilage explants subjected to a compressive stress of 0.1MPa for 1 hour 
was reversed in the presence of thapsigargin, which depletes Ca2+ stores, with no 
significant effect on the aggrecan expression in the tare-loaded explants155.   
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The objectives of the studies presented in this chapter were to investigate the 
dose-dependent inhibition of protein and sGAG synthesis by inhibitors of four ion-
channel inhibitors in articular cartilage explants, to investigate the recovery of protein 
and sGAG synthesis by the four ion-channel inhibitors in articular cartilage explants and 
to investigate the response of chondrocytes seeded in agarose to dynamic compression 
when cultured with each of these inhibitors.  Four ion-channel inhibitors that have been 
implicated in chondrocyte mechanotransduction in monolayer studies were examined:  4-
Aminopyridine (4AP), a voltage-dependent K+ channel blocker, Nifedipine (Nf), an L-
type voltage sensitive calcium channel blocker, Gadolinium (Gd), an inhibitor of cation-
selective stretch-activated ion-channels, and  Thapsigargin (Tg), a natural plant product 
which depletes the Ca2+ store in the sarcoplasmic and endoplasmic reticula by inhibiting  
ATP-dependent Ca2+ pumps.   
 
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Explant and construct culture 
In a preliminary experiment examining effects of the inhibitors on  proteoglycan 
and protein synthesis as well as gross viability, cartilage explants 3 days post-
explantation and chondrocytes seeded into agarose gels and cultured for 5 weeks 
responded similarly to varying doses of the inhibitors (data not shown).  Due to the short 
duration of preculture required for the explants, they were used to examine the dose-
response of chondrocytes to the inhibitors, as well as the recovery after exposure to the 
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inhibitors.  To eliminate zonal variations in cartilage explant stiffnesses which might be 
influential when loading, chondrocytes were enzymatically released from the cartilage 
and cast into agarose gels to examine the response of chondrocytes to static and dynamic 
compression.   
Full thickness cartilage explants were excised with a 4mm biopsy punch from 
immature bovine femoral condyles and femoropatellar grooves.  After removing the 
superficial and deep zone layers, the cartilage was sliced into multiple 3mm thick disks 
using a custom cutting block.  Explants from different locations were randomly dispersed 
across groups.  Prior to any exposure to inhibitors, explants were precultured for 3 days 
in basal media consisting of DMEM plus 10% FBS, non-essential amino acids, 
Antibiotic-Antimycotic, 50µg/mL ascorbate and 0.4mM proline.   
To enzymatically isolate chondrocytes, tissue was excised from the femoral-
patellar grooves, minced and digested in DMEM with 0.2% collagenase for 24 hours in a 
37°C, 5% CO2 incubator. After centrifugation at 160 x g, cells were washed twice with 
Ca2+, Mg2+ -free PBS and counted with a Coulter counter.   Cells were seeded at a final 
density of 10x106 cells/mL in 2% LMP agarose.  Constructs were cast in 4mm diameter x 
3mm deep cylindrical wells in custom machined polycarbonate molds that were 
autoclave sterilized prior to gel casting. Agarose constructs were assembled by 
autoclaving 4% LMP agarose in 1X Ca2+, Mg2+ -free PBS and then cooling the solution 
to 42°C. An equal volume of cells suspended at 20x106 cells/mL in 2X DMEM and 20% 
FBS was added, and the solution was cooled in the molds at room temperature for 10 
minutes. Gels were removed from molds and precultured for 4 weeks in basal medium 
prior to the addition of any ion-channel inhibitors.  Medium was changed every two days.   
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Ion-channel inhibitors 
Four ion-channel inhibitors that have been implicated in chondrocyte 
mechanotransduction in monolayer studies were examined.  4-Aminopyridine (4AP), a 
voltage-dependent K+ channel blocker, has been shown to temporally affect chondrocyte 
proliferation156,157.  Nifedipine (Nf), an L-type voltage sensitive calcium channel blocker, 
has been shown to inhibit dynamic mechanical strain induced upregulation of 
parathyroid-hormone-related protein expression158, as well as prostaglandin E2 
upregulation of insulin-like growth factor binding protein-3 expression and synthesis in 
chondrocytes.159.  Gadolinium (Gd), an inhibitor of cation-selective stretch-activated ion-
channels, has been shown to increase sGAG synthesis at 4mM and inhibit proliferation in 
a dose-dependent manner160.  Thapsigargin (Tg), a natural plant product which depletes 
the Ca2+ store in the sarcoplasmic and endoplasmic reticula by inhibiting  ATP-
dependent Ca2+ pumps, has been shown to inhibit protein production and secretion, as 
well as sGAG synthesis (but not GAG synthesis)161.  4AP was solubilized in water, Nf in 
DMSO, Gd in 1M HCl, and Tg in DMSO.  The range of doses examined for the 
inhibitors is shown in Table 4-1, as well as the dose chosen for the recovery and 
compression experiments. 
 
4.2.2 Experimental Design 
As the effects of sustained exposure to the toxins and appropriate doses for 3D 
culture were unknown, dose-response and recovery experiments were first performed for 
each of the inhibitors.  For the dose-response experiment, tissue explants (n=4-
6/condition) were cultured for 24 hours in basal medium alone or supplemented with 
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various levels of the four ion-channel inhibitors (Table 4-1), followed by 20 hours in 
media containing both inhibitors and radiolabeled precursors.  For the recovery 
experiment, tissue explants (n=8/condition) were cultured for 24 hours in basal medium 
alone or supplemented with one level of the four ion-channel inhibitors.  After exposure 
to the inhibitors, explants were rinsed three times for 10 minutes each time in PBS and 
then transferred into basal medium without inhibitors.  Explants were cultured for 20 
hours in radiolabeled precursors beginning 4, 24 or 48 hours after return to basal medium 
to evaluate their ability to recover both protein and sGAG synthesis rates. 
For the static and dynamic compression studies, gels (n=8-10/condition) were 
cultured in basal medium with or without a single level of each ion-channel inhibitor for 
24 hours prior to loading.  Gels were cultured for an additional 20 hours in the same 
media supplemented with radiolabeled precursors under the following conditions: static 
compression (10%), 1Hz oscillatory compression (10%±3%) and free swelling (FS).  
Control samples were also cultured at 0%, providing similar nutrient diffusion limitations 
due to the platens.  Dynamic compression was applied using a custom designed 
mechanical loading system (see appendix D).   
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Table 4-1: Ion-channel inhibitors and levels used in dose-response, recovery and 
compression experiments.   
Dose-response levels spanned five orders of magnitude.  4-Aminopyridine (4AP) is a 
voltage-dependent potassium channel blocker.  Nifedipine (Nf) is an L-type voltage 
sensitive calcium channel blocker.  Gadolinium (Gd) blocks cation-selective stretch-
activated ion-channels.  Thapsigargin (Tg) is a natural plant product which depletes the 
Ca2+ store in the sarcoplasmic and endoplasmic reticula by inhibiting ATP-dependent 
Ca2+ pumps.   
 
Recovery &
Toxin Low – High Compression Values
4AP (4-Aminopyridine ) 10mM – 100mM 10mM
Gd (Gadolinium ) 1mM – 10mM 1mM
Nf (Nifedipine ) 1mM – 10mM 1mM





4.2.3 Analytical Techniques 
Radiolabel incorporation 
Media were supplemented with 20µCi/mL L-5-3H-proline and 10µCi/mL 35S-
sodium sulfate for the final 20 hours of each culture period to measure protein and sGAG 
synthesis, respectively.  At the end of the specified period, the samples were removed 
from the radiolabeled media and washed four times for 30 minutes each time in PBS 
supplemented with 0.8 mM sodium sulfate and 1 mM L-proline at 4°C to allow 
unincorporated radiolabeled precursors to diffuse out of the samples.  Samples were then 
weighed, lyophilized, reweighed, digested in 1ml of 100mM ammonium acetate buffer 
with 250 µg/mL Proteinase K at 60°C for 24 hours and assayed for radiolabel content 
with an LS5000TD liquid scintillation counter (Beckman Coulter, Fullerton, CA).  
Portions of each digest were assayed for total DNA using the Hoechst 33258 assay with 
calf thymus DNA as a standard162 and sGAG using the 1,9-dimethyl-methylene blue 
assay125,163 with shark cartilage chondroitin sulfate as a standard. 
 
Viability Staining 
 Gel constructs were imaged for cell viability using the Molecular Probes 
Live/Dead kit (n=3/group/timepoint).  Constructs were imaged directly after 24 hours in 
the inhibitors (levels as indicated for the recovery portion of the experiment), and then 
24, 48, and 60 hours after being returned to basal media.  After rinsing samples in three 
10-minute PBS washes with gentle agitation, they were incubated for 1 hour in 4µM 
calcein and 4µM ethidium in PBS.  To remove any unincorporated calcein and ethidium, 
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samples were rinsed in three 10-minute PBS washes.    Samples were then imaged with a 





4.3.1 Dose Response  
Each inhibitor induced a dose-dependent inhibition of sGAG synthesis, but 
inhibition of protein synthesis was less consistent.  The voltage-dependent K+ channel 
inhibitor 4AP inhibited both protein and sGAG synthesis at levels equal to or above 
10mM (p≤0.01) (Figure 4.1A).  The cation-selective stretch-activated channel inhibitor 
Gd had no significant effect on protein synthesis, but inhibited sGAG synthesis at 10mM 
(p=0.0001) (Figure 4.1B).  The L-type voltage sensitive calcium channel inhibitor Nf had 
no significant effect on protein synthesis, and only the highest level (10mM) inhibited 
sGAG synthesis (p=0.0011) (Figure 4.1C).  The ATP-dependent Ca2+ pumps inhibitor 
Tg inhibited sGAG synthesis at 100nM (p<0.0001), 1µM (p<0.0001) and 10µM 
(p<0.0001); protein synthesis was significantly inhibited at 100nM (p=0.0094) and 1µM 
(p=0.034) (Figure 4.1D). 
Inhibitor levels for subsequent studies were determined based on the dose-
response results and practical concerns including the precipitation of high concentrations 
of certain inhibitors out of solution.  Table 4-1 shows the values chosen for the 




Figure 4.1: Dose-dependent inhibition of cartilage explant protein (L-5-3H-proline 
incorporation) and sGAG (35S-sodium sulfate incorporation) synthesis rates for each of 




































































 There were no qualitative differences in explant cell viability either immediately 
after exposure to the inhibitors (Figure 4.2) or 24, 48 or 60 hours after being returned to 
basal medium.  Both the protein and sGAG synthesis rates of the explants exposed to 
each of the inhibitors fully recovered by three days after removal of the inhibitors (Figure 
4.3Error! Reference source not found.).  After one recovery day, protein synthesis of 
the explants exposed to 4AP was not statistically different from that of the control 
explants (p=0.086), with increasing recovery by day 2 (p=0.94) (Figure 4.3A).  SGAG 
synthesis of samples exposed to 4AP had recovered by day 2 (p=0.89).  Protein synthesis 
by samples exposed to Gd and Nf had recovered after one day (p=1.0 and p=0.97 
respectively) (Figure 4.3B, C).  sGAG synthesis by samples exposed to Gd and Nf had 
recovered after one day (p=1.0 and p=0.99 respectively).  Protein and sGAG synthesis 





Figure 4.2: Representative Live/Dead images of cartilage explants exposed to the ion-
channel inhibitors for 24 hours.   
Viability was similar to controls for all inhibitors, and no decrease in viability was 
observed for up to three days after removal from the inhibitors (not shown). 











































































Figure 4.3: Protein and sGAG synthesis rates of cartilage explants during recovery from 
24 hours of exposure to the ion-channel inhibitors.   
Data are normalized by synthesis rates of untreated control explants cultured for 
comparable periods.  indicates P < 0.05 vs. control for protein synthesis and   




4.3.3 Gel Response 
 For the static and dynamic compression experiments, free-swelling gels in all 
media conditions were run in parallel to account for baseline effects of the inhibitors 
(Figure 4.4).  The addition of 4AP, Nf, and Tg significantly inhibited both protein and 
sGAG synthesis rates (p<0.0001).  The addition of Gd inhibited sGAG synthesis, but not 





















Figure 4.4:  Protein and sGAG synthesis rates of free-swelling gels after 44 hours of 
exposure to the ion-channel inhibitors.   
Data are normalized by synthesis rates of untreated controls.   indicates P < 0.05 vs. 
control for protein synthesis and  indicates P < 0.05 vs. control for sGAG synthesis.  




4.3.4 Static Compression 
 While static compression significantly inhibited protein synthesis in all treatment 
groups, the effects on sGAG synthesis were more variable (Figure 4.5).  For the control 
and 4AP groups, 50% static compression inhibited protein synthesis over the 0% and 
10% groups (p≤0.0067), with no significant effect on sGAG synthesis.  For the Gd 
groups, all levels of static compression significantly affected protein synthesis 
(0%>10%>50%) (p≤0.0056); 10% static compression inhibited sGAG synthesis over the 
0% group (p=0.0077).  For the Nf groups, 50% static compression inhibited both protein 
and sGAG synthesis over the 0% and 10% groups (p≤0.017).  For the Tg groups, all 
levels of static compression significantly affected protein synthesis (0%>10%>50%) 

















































0% Static 10% Static 50% Static
 
 
Figure 4.5: Protein (A) and sGAG (B) synthesis rates for gels subjected to varying grades 
of static compression for 20 hours in the presence of ion-channel inhibitors.   
Data are normalized by respective free-swelling synthesis rates.  * indicates P < 0.05 vs. 
respective 0% static group.  (mean ± S.E.M., N = 8-10) 
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4.3.5 Dynamic Compression 
As with the static compression, the effects of dynamic compression on protein 
synthesis were more consistent than the effects on sGAG synthesis (Figure 4.6).  For all 
groups except 4AP, dynamic compression significantly stimulated protein synthesis over 
static controls (p≤0.001).  For only the control and Gd groups, dynamic compression 
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Figure 4.6: Protein (A) and sGAG (B) synthesis rates for gels subjected to static and 
dynamic compression for 20 hours in the presence of ion-channel inhibitors.   
Data are normalized by respective free-swelling synthesis rates.  * indicates P < 0.05 vs. 





While chondrocytes respond to mechanical stimuli in both 3D culture and 
monolayer, the mechanisms linking these alterations in the cellular environment to 
specific changes in cell behavior are not well understood.  This study examined whether 
blocking specific ion-channels, a technique demonstrated with cells in monolayer, 
modifies the cellular response to compression in 3D culture. 
          As appropriate doses for 3D culture were unknown, the treatment levels in this 
study included inhibitor levels above and below those typically used in previous 
monolayer studies.  Compression-independent changes in matrix synthesis were observed 
for at least one level of all inhibitors, with a generally greater impact on sGAG synthesis 
than on protein synthesis.  Although cytotoxicity could explain some of these effects, 
Live/Dead staining of tissue samples incubated with each of the inhibitors revealed no 
substantial changes in cell viability.  Additionally, the results of the recovery experiment 
indicated that samples exposed to all inhibitors recovered both protein and sGAG 
synthesis rates.  Sustained protein synthesis at levels down-regulating sGAG synthesis 
suggests a selective inhibition of cellular functions.  Chondrocytes in agarose generally 
retained the capacity to increase protein synthesis rates in response to oscillatory 
compression, suggesting that inhibition of the specific channels did not block any non-
redundant pathways or that the inhibition produced was transient and found to be similar 
to that of controls.  
Overall, treatment with the inhibitors more significantly affected sGAG synthesis 
suggesting that these ion-channels influence proteoglycan production or processing.  
Inhibition of Ca2+ channels by Nf affected protein synthesis, with little effect on sGAG 
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synthesis, a unique response of the four inhibitors examined.  In contrast to the 
compression independent selective inhibition of protein synthesis by Nf, the upregulation 
of protein synthesis due to dynamic stimulation was unaffected, while the upregulation of 
sGAG synthesis was blocked.  A potential reason for the inhibition of mechanically-
stimulated upregulation of sGAG synthesis may be due to a critical role in the 
mechanoregulation of proteoglycan production by Ca2+ channel signaling.  There was no 
significant stimulation of either protein or sGAG synthesis rates by dynamic compression 
in the presence of 4AP, the voltage-dependent Ca2+ channel inhibitor, which could 
suggest a role for K+ signaling in mechanotransduction.  Alternatively K+ channels may 
play such a dominant role in overall matrix synthesis such that any upregulation of matrix 
components may be overwhelmed.  Treatment with Tg significantly impaired both 
overall protein and sGAG synthesis rates, with a substantial decrease in sGAG synthesis.  
There was a significant upregulation of protein synthesis by dynamic compression with 
Tg treatment, but there was no effect on sGAG synthesis.  With the overall levels of 
sGAG synthesis being so low, it is difficult to discern whether this trend is valid, 
although the effect on sGAG synthesis is consistent with previous reports155. 
Very little is known about how mechanical signals are transduced from 
extracellular matrix to inside of the cell to activate biosynthesis and cellular activity.  One 
group of the membrane molecules that can potentially transmit matrix deformation 
signals to inside of the cell are cation-channels164.  Some of these channels that transmit 
Ca2+ have been shown to play an important role in regulating chondrocyte proliferation 
and maturation in monolayer55,165.  Sensing the dynamic polarization of the cell 
membrane may be required to mechanotransduce the differential forces involved in static 
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and dynamic compression, portions of which are affected by the addition of the voltage-
dependent channel inhibitors, 4AP and Nf.    
Recent evidence from C. elegans suggests that mechanosensitive ion-channels are 
part of the mechanotransducing complex that connects the extracellular matrix to the 
cytoskeleton.  It has been postulated that the deformation of the collagen matrix may 
mechanically affect the opening and closing of ion-channels, which are linked to the 
matrix by direct binding of the collagenous molecules166-168.  The results of this study 
found that interruption of Ca2+ signaling pathways abolished the upregulation of sGAG 
synthesis by dynamic mechanical compression.  It remains to be determined whether 
direct binding of the matrix is the mechanism that is responsible for the involvement of 
ion-channels in mechanotransduction of chondrocytes.  Future directions to investigate 
this possibility might include disrupting the collagenous extracellular matrix prior to 
loading with enzymatic digestion or mechanically loading freshly seeded gels, where 
there is no matrix for the cells to interact with.  Overall, this study suggests that different 
ion-channels play distinct, yet cooperative, roles to convert the same mechanical signals 
into different cellular responses, but that the roles of these ion channels in 3D are less 
distinct than in 2D culture experiments.  
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CHAPTER 5 INFLUENCE OF THE TGF-β SIGNALING PATHWAY ON THE 







 In addition to using mechanical stimulation to control chondrocyte behavior, 
biochemical factors have been found to influence chondrocyte proliferation and 
metabolism.  Different biochemical factors have been used to expand chondrocyte cell 
populations, to increase cartilage-specific ECM production and to influence chondrocyte 
differentiation state.  Members of the TGF-β superfamily, as well as Insulin Growth 
Factor I (IGF-I), have been found to positively influence gene expression and matrix 
synthesis.  Specifically, TGF-β has been found to maintain chondrocyte phenotype in 
vitro.  Isoforms of TGF-β, including, but not limited to, TGF-β1 and TGF-β3, have been 
found to promote chondrogenesis in undifferentiated cell populations such as BMSCs, 
periosteally-derived cells and adipose-derived cells.   
The overall objective of the studies presented in this chapter was to investigate the 
role of the TGF-β signaling pathway in the BACs under dynamic compressive loading.  
Specifically the effects of dynamic and static compressive loading on BAC gene 
expression and matrix synthesis in the presence of the TGF-β signaling inhibitor 
SB431542 were examined.  Investigation of the influence of transforming growth factor 
β1 (TGF-β1) signaling in the response of chondrocytes to dynamic compressive loading 
may provide clues to the mechanisms involved in chondrocyte maintenance through 
mechanical stimulation.  The mechanisms through which mechanotransduction occurs in 
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chondrocytes remain largely elusive.  This work addresses a potential mechanism for 
mechanotransduction in BAC cells. 
 
 
5.2 MATERIALS AND METHODS 
5.2.1 Construct culture 
To enzymatically isolate chondrocytes, tissue was excised from the femoral-
patellar grooves, minced and digested in DMEM with 0.2% collagenase for 24 hours in a 
37°C, 5% CO2 incubator.  After centrifugation at 160 x g, cells were washed twice with 
Ca2+, Mg2+ -free PBS and counted with a Vi-Cell Cell Viability Analyzer.   Cells were 
seeded at a final density of 20x106 cells/mL in 3% LMP agarose.  Constructs were cast in 
4mm diameter x 3mm deep cylindrical wells in custom machined polycarbonate molds 
that were autoclave sterilized prior to gel casting.  Agarose constructs were assembled by 
autoclaving 3% LMP agarose in 1X Ca2+, Mg2+ -free PBS and then cooling the solution 
to 42°C.  Cells were centrifugally pelleted and resuspended in the agarose to yield a final 
concentration of 20x106 cells/mL, and the solution was cooled in the molds at room 
temperature for 10 minutes. Gels were removed from molds and precultured for 24 hours 
in basal medium prior to the addition of the inhibitor.  Medium was changed every two 
days.   
 
5.2.2 TGF-β Inhibitor 
SB431542 is a small molecule ATP-mimetic inhibitor of the kinase activity 
associated with members of the activin receptor-like kinase (ALK) family, specifically 
 74
ALK5 (TGF-β type I receptor, TGF-βRI), ALK4 (activin type I receptor) and ALK7 
(nodal type I receptor)169-171.  The hypothesized mechanism for TGF-β signaling 
inhibition due to SB431542 is competition for the ATP-binding site on the type I 
receptor169-171.  Upon phosphorylation by the type II receptor and ATP binding, the type I 
receptor (ALK5) phosphorylates Smad 2 and Smad 3 proteins172,173.  Without ATP 
binding, the kinase activity of ALK5 is inhibited172,173.  Therefore, the phosphorylation of 
the target substrates, Smad 2 and Smad 3 (Smad2/3), is inhibited169-171.   
 
5.2.3 Experimental Design 
Dose and Recovery Responses 
 As the effects of sustained exposure to the inhibitor and appropriate doses for 3D 
culture were unknown, dose-response and recovery experiments were first performed.  
The dose response of SB431542 on protein and sGAG synthesis rates was investigated.  
BAC constructs (n=6-8/condition) were cultured for two hours in basal media alone or 
supplemented with 0.1, 1, 10 or 100 µM of the inhibitor, followed by 20 hours in media 
containing both inhibitors and radiolabeled precursors.  The concentration of the inhibitor 
to be used in both the recovery and mechanical stimulation studies was determined by the 
first dose exhibiting a repression of either proteoglycan or protein synthesis rates.    
To investigate the recovery from the inhibitor, BAC constructs (n=8/condition) 
were cultured for 24 hours in basal medium alone or supplemented with 1 µM of the 
inhibitor.  The 1 µM concentration of SB431542 was the first dose level to display 
inhibition of protein synthesis.  1 µM of SB431542 has also been used in previous 
monolayer experiments investigating the inhibitory effects of the molecule169,170.  After 
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exposure to the inhibitor, constructs were rinsed three times for 10 minutes each time in 
PBS and then transferred into basal medium without inhibitors.  Constructs were cultured 
for 20 hours in radiolabeled precursors beginning 4, 24 or 48 hours after return to basal 
medium to evaluate their ability to recover both protein and sGAG synthesis rates.  The 
recovery study was used to evaluate whether there were any sustained effects of BAC 
matrix synthesis rates by exposure to SB431542. 
 
Mechanical Stimulation 
Dynamic compression was applied using a custom designed mechanical loading 
system (see appendix D).  For the static and dynamic compression studies, constructs 
were cultured in basal medium with or without 1 µM of SB431542 for 2 hours prior to 
loading (BASAL and BASAL+SB respectively).  One subset of the constructs 
(n=6/condition) were cultured for an additional 20 hours in the same media supplemented 
with radiolabeled precursors under the following conditions: static compression (10%), 
1Hz oscillatory compression (10%±3%) and free swelling (FS).  The other subset of 
constructs (n=8/condition) were cultured for an additional 20 hours under the following 
conditions: static compression (10%), 1Hz oscillatory compression (10%±3%) and free 
swelling (FS) before being analyzed for mRNA expressions.  
 
5.2.4 Analytical techniques 
Radiolabel incorporation 
Media were supplemented with 20µCi/mL L-5-3H-proline and 10µCi/mL 35S-
sodium sulfate for the final 20 hours of each culture period to measure protein and sGAG 
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synthesis rates, respectively.  At the end of the specified period, the samples were 
removed from the radiolabeled media and washed four times for 30 minutes each time in 
PBS supplemented with 0.8 mM sodium sulfate and 1 mM L-proline at 4°C to allow 
unincorporated radiolabeled precursors to diffuse out of the samples.  Samples were then 
weighed, lyophilized, reweighed, digested in 1ml of 100mM ammonium acetate buffer 
with 250 µg/mL Proteinase K at 60°C for 24 hours and assayed for radiolabel content 
with an LS5000TD liquid scintillation counter (Beckman Coulter, Fullerton, CA).  
Portions of each digest were assayed for total DNA using the Hoechst 33258 assay with 
calf thymus DNA as a standard162. 
 
Real-Time RT-PCR 
Agarose gels were immediately dissociated in Qiagen Lysis Buffer with 1% beta-
mercaptoethanol.  The RNeasy Total RNA Kit (Qiagen, Chatsworth, CA) was then used 
according to manufacturer’s protocol to purify RNA from the samples.  The yield of the 
purified isolate was read at 260 nm and 280 nm on a UV-1601 Spectrophotometer 
(Shimadzu, Columbia, MD). 
1µg of mRNA was transcribed to cDNA using the Promega RT System (Promega, 
Madison, WI) and manufacturer’s protocol.  The SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA) was mixed with primers and cDNA for real time detection 
of amplification.  Real time, quantitative RT-PCR was performed with an ABI PRISM 
7700 Sequence Detector System (PE Biosystems, Foster City, CA).  
For primer information, see Table 5-1. 
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Table 5-1: Primer sequences for real-time RT-PCR for bovine β-actin, aggrecan, 
biglycan, collagen type I, collagen type II, collagen type X, decorin, GAPDH, TGF- β1 
and TGF- β receptor type I (TβRI). 
 
Bovine Gene Forward Primer 5’-3’ Reverse Primer 5’-3’ 
β-actin CGA GCA TTC CCA AAG TTC TAC TTC CTG TAA CAA TGC ATT TCG 
aggrecan CCT CAG GGT TTC CTG ACA TTA TAA GCT CAG TCA CGC CAG ATA 
biglycan GGT CCT CGT GAA CAA CAA GAT 
 
GGA TCT CAC ACA GGT GGT TCT 
 
collagen type I AAG AAC CCA GCT CGC ACA TG 
 
GGT TAG GGT CAA TCC AGT AGT AAC CA 
 
collagen type II GCA TTG CCT ACC TGG ACG AA 
 
CGT TGG AGC CCT GGA TGA 
 
collagen type X TCT CCA AAG CTT ACC CAG CTA CAG GTG AAG ATT CCA GTT CTT G 
decorin ACT GAA GGA ATT GCC AGA GAA 
 
CTA CGA CGA TCA TCT GGT TCA 
 
GAPDH CCT TCA TTG ACC TTC CTA CAT GGT CTA TGG AAG ATG GTG ATG GCC TTT CCA TTG 
TGF- β1 GGC AAC AAA ATC TAT GAC CTT CAA GTG GAC ATT AAC GG 
TβRI TCG AAA GCA TGA AGG ACA AC CCA GCA CTC AGT CAA CGT CT 
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5.3 RESULTS 
5.3.1 Dose Response  
 Protein synthesis was inhibited in a dose-dependent manner by SB431542, while 
significant inhibition of sGAG synthesis only occurred at the highest dose (Figure 5.1).  
At 0.1 µM of the inhibitor, neither protein nor sGAG synthesis rates were inhibited.  At 1 
and 10 µM, only protein synthesis was inhibited (68% of control, p<0.001 and 46% of 
control, p<0.001).  At 100 µM, both protein and sGAG synthesis rates were inhibited to 
approximately 20% of control synthesis rates (p<0.001).  Consistent with previous work 
using the TGF-β inhibitor SB431542171, 1 µM of the inhibitor was chosen to investigate 
the recovery of matrix synthesis after inhibitor exposure and the response to mechanical 


















Figure 5.1: Dose-dependent inhibition of BAC construct protein (L-5-3H-proline 
incorporation) and sGAG (35S-sodium sulfate incorporation) synthesis rates for the 
inhibitor SB431542.   
Data are normalized by synthesis rates of untreated control constructs (dashed line 
indicates 100% of control).   indicates P < 0.05 vs. control for protein synthesis and 
 indicates P < 0.05 vs. control for sGAG synthesis.  (mean ± S.E.M., N = 6)  
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5.3.2 Recovery Response 
 There was no inhibition of sGAG synthesis during or after exposure to 1 µM 
SB431542 (Figure 5.2).  SGAG synthesis was not significantly different from unexposed 
samples during the first 48 hours after inhibitor exposure.  After 3 days post-exposure to 
the inhibitor, sGAG synthesis was stimulated in the samples previously exposed to the 
inhibitor compared to unexposed samples (121% of control, p=0.027). 
 Protein synthesis was still inhibited during the 24 hour period after exposure to 
SB431542 (p=0.008).  By the second day post-exposure, protein synthesis was stimulated 
in the samples previously exposed to the inhibitor compared to unexposed samples 
(p=0.005).  By the third day post-exposure, protein synthesis was not significantly 

















Figure 5.2: Recovery response of BAC construct protein (L-5-3H-proline incorporation) 
and sGAG (35S-sodium sulfate incorporation) synthesis rates for the inhibitor SB431542.   
Day indicates days post-exposure to inhibitor.  Data are normalized by synthesis rates of 
untreated control constructs cultured in parallel (dashed line indicates 100% of control).  
 indicates P < 0.05 vs. control for protein synthesis and  indicates P < 0.05 vs. 




5.3.3 Mechanical Stimulation: Gene Expression 
 There was no significant regulation of aggrecan or the housekeeping gene 
GAPDH by either dynamic compression or the inhibitor SB431542. (Figure 5.3E,F)   
 In the absence of the inhibitor, collagen II gene expression was stimulated 1.6-
fold and collagen I gene expression was stimulated 2.2-fold by dynamic compression 
(p=0.031 and p=0.037 respectively) (Figure 5.3A,B).  While there was no significant 
stimulation by dynamic compression of TGF-β1 gene expression, there was a stimulation 
of TGF-β Receptor I (ALK5) gene expression in the absence of the inhibitor (p=0.042) 
(Figure 5.3C,D).  Exposure to the inhibitor SB431542 inhibited the regulation of collagen 
II, collagen I, and TGF-β Receptor I gene expressions, without significantly affecting the 
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Figure 5.3: Gene expression for BAC constructs dynamically compressed for 20 hours in 
the absence (BASAL) or presence of the inhibitor SB431542 (BASAL+SB).   
Data are normalized by respective static group (dashed line indicates 100% of static for 
that condition).  No significant differences were found in gene expression between static 






5.3.4 Mechanical Stimulation: Matrix Synthesis Rates 
 For the unexposed samples, dynamic compression stimulated protein synthesis 
1.3-fold and slightly stimulated sGAG synthesis 1.1-fold over static compression in 
BASAL samples (p<0.001 and p=0.005 respectively) (Figure 5.4).  There was no 
stimulation of either protein or sGAG synthesis rates by dynamic compression in the 
samples exposed to 1µM SB431542.  For the statically compressed samples, there were 

















Figure 5.4:  Matrix synthesis rates for BAC constructs dynamically compressed for 20 
hours in the absence or presence of the inhibitor SB431542.   
Data are normalized by respective static group (dashed line indicates 100% of static for 
that condition).   indicates P < 0.05 vs. control for protein synthesis and  indicates 






 Both biomechanical and biochemical stimuli have been shown to influence 
cartilage maintenance and metabolism.  Dynamic compression and exogenous TGF-β 
have been found to maintain chondrocyte phenotypic expression in vitro.  Buschmann et 
al. have hypothesized that there is a synergistic relationship between the growth factor 
and compressive loading of chondrocytes174.  In rabbit BMSCs cultured in agarose, 
Huang et al. found that sustained dynamic compression stimulated TGF-β1 gene 
expression, as well as TGF-β receptors I and II gene and protein expressions175,176.  
Huang et al. also found was that dynamic compression stimulated the expression of 
chondrocytic genes and proteins such as aggrecan and collagen II at a similar level as 
treatment with TGF-β1 only, although the overall level of chondrogenesis in any group 
was fairly modest.  The combination of TGF-β1 and dynamic compression had no greater 
effect than treatment with TGF-β1 alone.  While the signaling pathway through which 
TGF-β acts has been thoroughly explored, the mechanisms through which cells respond 
to mechanical stimulation are far less clear.  This objective of this study was to explore 
the possible interaction between TGF-β signaling and mechanical regulation of BAC 
biosynthesis.  The effects of dynamic and static compressive loading on BAC gene 
expression and matrix synthesis in the presence of the TGF-β signaling inhibitor 
SB431542 were examined.   
 TGF-β signaling has been shown to be dependent on both ALK5 and the TGF-β 
type II receptor.  Signaling is mediated via phosphorylation of the cytoplasmic proteins 
Smad 2 and Smad 3 (Smad2/3).  Upon phosphorylation by ALK5, Smad2/3 are released 
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from the receptor.  The auto-inhibitory 3D folding is relieved.  Smad4 is bound and the 
complex translocates to the nucleus where transcriptional regulation occurs72,177.    
 The small molecule SB431542 was chosen to inhibit TGF-β signaling due to its 
nanomolar inhibition of ALK5 kinase abilities with greater than 100-fold selectivity 
against p38 MAPK and 25 other kinases171.  Inman et al. found SB431542 preferentially 
inhibited ALK5 kinase activity in cells transfected with constitutively active type I 
receptors (ALK2 through ALK7)170.  SB431542 is a small molecule ATP-mimetic 
inhibitor of the kinase activity.  The hypothesized mechanism for TGF-β signaling 
inhibition due to SB431542 is competition for the ATP-binding site on the type I 
receptor169,171.  Upon phosphorylation by the type II receptor and ATP binding, the type I 
receptor (ALK5) phosphorylates Smad2/3 proteins.  Without ATP binding to ALK5, the 
kinase activity of ALK5 in inhibited.  Therefore the phosphorylation of the target 
substrates, Smad2/3, is inhibited. 
 The present study found that SB431542 selectively inhibited protein synthesis 
over sGAG synthesis in BAC agarose constructs.  Protein synthesis was inhibited linearly 
in a dose dependent manner.  Inhibition was found to be recoverable after removal from 
the inhibitor.  The inhibition of protein synthesis by 22 hours of exposure to 1 µM of 
SB431542 had recovered to 87% of basal levels by 24 hour after removal from the 
inhibitor.  By 2 days post-exposure, protein synthesis had recovered to 112% of basal 
synthesis rates.  SGAG synthesis was only significantly affected at the highest inhibitor 
level of 100 µM. 
 Exposure to 1 µM of SB431542 had no significant effect on either gene 
expression or matrix synthesis rates for BAC samples statically compressed compared to 
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statically compressed BASAL samples.  In addition, the addition of the inhibitor also 
abrogated the stimulation of protein and sGAG synthesis by dynamic compression seen 
in the BASAL samples.   
 With no effect on aggrecan gene expression and a low level of stimulation of 
sGAG synthesis by dynamic compression in the basal samples, the effect, if any, of 
inhibiting the TGF-β signaling pathway on proteoglycan gene expression is unclear.  
Conversely, there was a substantial and significant upregulation of collagen I and II gene 
expressions, as well as protein synthesis, in basal samples by dynamic stimulation.  The 
effect of inhibiting TGF-β signaling seems to occur at the transcriptional level, with no 
stimulation occurring due to dynamic stimulation in the presence of the inhibitor.  These 
results demonstrate that the TGF-β signaling pathway potentially plays a profound role in 
the mechanotransduction of BACs subjected to dynamic compression. 
 Tschumperlin et al. postulate that mechanotransduction in epithelial cells 
potentially occurs via growth factor shedding from the extracellular matrix, inducing 
autocrine binding of epidermal growth factor ligands to the epidermal growth factor 
receptor, requiring no direct conformational alteration by any protein by mechanical 
stress178.    Since there is little to no extracellular matrix in these 1-day old BAC agarose 
constructs, a mechanism involving growth factor shedding is unlikely.  Most likely, the 
majority of TGF-β accessible to the BACs is in solution in the medium, either produced 
by the BACS or introduced with the FBS.   
While speculative, there are multiple potential regulatory mechanisms through 
which TGF-β1 signaling and mechanical stimulation interact.  The mechanisms fall into 
one of two categories, either TGF-β1 signaling influencing mechanotransduction or 
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mechanotransduction influencing TGF-β1 signaling.  One potential mechanism for 
mechanical stimulation modulation of TGF-β1 signaling involves the production and 
activation of endogenous TGF-β, as well as the activation of latent TGF-β introduced into 
the system by the FBS.  Increased proteolytic cleavage of the latent complex could result 
from either an upregulation in plasmin or stromelysin-1 concentrations in the pericellular 
and extracellular matrix179,180.  In either system, stimulation of TβR1 is one potential 
mechanism for the modulation of dynamic loading via TGF-β signaling.  An increase in 
the available supply of TβR1 could potentially lead to a greater level of Smad2/3 
activation, amplifying the signaling occurring as a result of TGF-β1 exogenous 
stimulation.  Another possible mechanism for regulation of chondrogenesis by 
mechanical stimulation is an increase in the phosphorylation of the Smad2/3 proteins 
and/or its translocation to the nucleus.   
Another Smad-related possibility involves an increase in Smad activation of 
mechanosensitive proteins by TGF-β signaling, such as focal adhesion kinase (FAK) and 
paxillin thus increasing the mechanosensitivity of the cells181-183.  There are other 
potential regulatory mechanisms through which TGF-β1 signaling and mechanical 
stimulation may interact including regulation by mechanical stimulation of proteolytic 
moieties such as plasmin, leading to the activation of latent TGF-β1, either endogenously 
produced (both BACs and BMSCs) or introduced into the culture system by the FBS 
(BACs only).  Both chondrocytes and BMSCs have been found to be affected by TGF-β 
concentrations in the media77,184,185.   
 In differentiating cells, TGF-β1 and TGF-β3 have been shown to upregulate Sox9 
gene expression.  This upregulation of Sox9 expression is indicative of chondrogenesis in 
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MPC populations.  Sox9 has been shown to bind to the promoter region of type II 
collagen, enhancing transcription and collagen II mRNA expression.  Smad3 has been 
found to enhance the transcriptional activity of Sox9 and the expression of the α1 (II) 
collagen (COL2A1) gene by forming a transcriptional complex with Sox9 and binding to 
the promoter region of COL2A1186.  While Sox9 levels parallel COL2A1 in 
differentiating cells, Aigner et al. found no positive correlation between Sox9 and 
COL2A1 expression levels in adult articular chondrocytes187.  For this reason, Sox9 
expression was not analyzed in the current study.  Possibly, dynamic compression may 
upregulate chondrocytic gene expression and production through mechanisms similar to 
those utilized in cells undergoing chondrogenic differentiation including upregulation of 
Sox9 levels.  If this was the case, inhibiting TGF-β signaling during mechanical 
stimulation would be analogous to depriving a differentiating cell of the growth factor. 
 Future studies are needed to investigate the interactions between TGF-β signaling 
and mechanical stimulation.  The efficacy and efficiency of the inhibition of Smad2/3 
phosphorylation by incubation with SB431542 should be determined.  Both western 
blotting and IHC could be used to determine the levels of total Smad and phosphorylated 
Smad, as well as localization in the presence and absence of both the inhibitor and 
mechanical stimulation.  A more thorough analysis of protein expression is needed to 
complement the gene expression data presented in this study, including looking at TβRI 
protein expression.   Overall this study established an interaction between TGF-β 
signaling and dynamic compression in BACs in agarose culture.  TGF-β signaling was 
found to be critical in the upregulation of chondrocyte gene and protein expressions by 
dynamic compression. 
 91
CHAPTER 6 INFLUENCE OF PASSAGING, MEDIA SUPPLEMENTS AND 







Osteogenesis and chondrogenesis have been demonstrated in BMSCs from 
multiple species including human188,189, bovine190-192, canine193 and rat194. The in vitro 
chondrogenesis of bone marrow derived MPCs has been described using the aggregate 
culture (i.e. pellet195) and gel culture (agarose196, alginate197) of  MPCs in media 
supplemented with transforming growth factor-beta 1 (TGF-β1)63.  Fibroblast growth 
factor 2 (FGF-2) has been found to maintain cells in a more proliferative state, allowing 
in vitro expansion of BMSCs64.  BMSCs have been shown to retain some level of 
chondrogenic potential through 20 or more passages198.   
While numerous studies have investigated chondrogenesis in a variety of animal 
models and culture systems, the conditions of culture have varied including passage 
number, cell seeding density in hydrogels, and media conditions.  The studies presented 
in this chapter investigate whether these factors can significantly impact BMSC 
differentiation and should be considered when developing cell-based therapies for 




6.2 MATERIAL AND METHODS 
6.2.1 Cell Isolation 
BMSCs were isolated from both the femoral and tibial diaphyses of 2-4 week old 
calves within 24 hours of slaughter.  After removal of all fascia and muscle, the bones 
were cut at the mid-diaphysis with a sterile bone saw.  Marrow was removed from the 
medullary canal and transferred to a 50mL conical with sterile PBS plus 1% 
antibiotic/antimycotic (A/A: 100U/mL penicillin, 100ug/mL streptomycin, 250 ng/mL 
Amphotericin).  Marrow was sequentially passed through large bore (25mL) and small 
bore (5mL) pipets to disrupt large pieces.  Marrow was then sequentially passed through 
16- and 18-gauge needles.  Marrow suspension was centrifuged at 300 x g for 15 
minutes.  The separated fatty layer was removed and discarded.  The cell pellet was 
resuspended in PBS and passed through a 20-gauge needle.    Mononuclear cells were 
counted with a Vi-Cell Cell Viability Analyzer using the Trypan Blue exclusion method. 
Cells were plated in T-flasks at 5 x 103 mononuclear cells per cm2 in passaging 
medium (consisting of low glucose DMEM, 10% FBS, 1% antibiotic/antimycotic, ± 
1ng/mL bFGF).  Nonadherent cells were removed during media change three days later.  
Cells were cultured until confluent (~ 2 weeks, P1), detached with 0.05% trypsin/1mM 
EDTA, and replated at 5 x 103 cells per cm2.  Cells were passaged up to a total of four 
times and seeded into either 2% alginate or 3% agarose gels.   
Gels were cultured in basal media consisting of high glucose DMEM plus 
antibiotic/antimycotic, non-essential amino acids, 1% ITS+ and 50µg/mL ascorbate 
(BASAL), basal media plus 10ng/mL TGF-β1 (TGF-β1), or basal media plus 10ng/mL 
TGF-β1 and 100nM dexamethasone (TGF-β1+DEX).  Dexamethasone only was ran in a 
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preliminary study and found to not be statistically different from BASAL media (data not 
shown).  Media were changed every two days for 16 days.     
 
6.2.2 Experimental Design 
Passaging Study 
Bovine BMSCs were plated at 1x106 cells per T-150 flask and expanded to 
confluence (3 doublings) in monolayer for 2, 3 or 4 passages (P2, P3, P4 respectively).  
After each passage, BMSCs were seeded at 25x106 cells/mL in 2% LVG Pronova 
alginate and cultured as stated above.  Samples were after 7 days in culture (n=4-
6/group).   
 
Seeding Density Study 
Passage 3 BMSCs were seeded at 12.5x106 (LOW), 25x106 (MID) and 50x106 
(HIGH) cells/mL in 2% LVG Pronova alginate and cultured as stated above.  Samples 
were after 7 days in culture (n=4-6/group).   
 
Alginate Time Course 
Passage 3 BMSCs were seeded at 25x106 cells/mL and cultured in 2% LVG 
Pronova alginate and cultured as stated above for 2, 4, 7 or 14 days (n=6/group).   
 
Agarose Time Course  
Passage 3 BMSCs were seeded at 20x106 cells/mL and cultured in 3% agarose 
and cultured in basal media consisting of high glucose DMEM plus 
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antibiotic/antimycotic, non-essential amino acids, 1% ITS+, 50µg/mL ascorbate and 
0.4mM proline (BASAL), basal media plus 10ng/mL TGF-β1 (TGF-β1), or basal media 
plus 10ng/mL TGF-β1 and 100nM dexamethasone (TGF-β1+DEX) for 8 or 16 days.  
Media were changed every two days (n=6/group).    
 
6.2.3 Analytical techniques 
Quantitative RT-PCR 
Alginate gels were dissociated in 100mM EDTA and the cells were pelleted down 
and resuspended in Qiagen Lysis Buffer with 1% beta-mercaptoethanol. Agarose gels 
were immediately dissociated in Qiagen Lysis Buffer with 1% beta-mercaptoethanol.  
The RNeasy Total RNA Kit (Qiagen, Chatsworth, CA) was then used according to 
manufacturer’s protocol to purify RNA from the samples.  The yield of the purified 
isolate was read at 260 nm and 280 nm on a UV-1601 Spectrophotometer (Shimadzu, 
Columbia, MD). 
1µg of mRNA was transcribed to cDNA using the Promega RT System (Promega, 
Madison, WI) and the manufacturer’s protocol.  The SYBR Green PCR Master Mix 
(Applied Biosystems, Foster City, CA) was mixed with primers and cDNA for real time 
detection of amplification.  Real time, quantitative RT-PCR was performed with an ABI 
PRISM 7700 Sequence Detector System (PE Biosystems, Foster City, CA).  
 
Radiolabel Incorporation 
Media were supplemented with 20µCi/mL L-5-3H-proline and 10µCi/mL 35S-
sodium sulfate for the final 20 hours of each culture period to measure protein and sGAG 
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syntheses, respectively.  At the end of the specified period, the samples were removed 
from the radiolabeled media and washed four times for 30 minutes each time in PBS 
supplemented with 0.8 mM sodium sulfate and 1 mM L-proline at 4°C to allow 
unincorporated radiolabeled precursors to diffuse out of the samples.  Samples were then 
weighed, lyophilized, reweighed, digested in 1ml of 100mM ammonium acetate buffer 
with 250 µg/mL Proteinase K at 60°C for 24 hours and assayed for radiolabel content 
with a Perkin Elmer Tri-Carb 2900TR liquid scintillation counter.  Portions of each digest 
were assayed for total DNA using the Hoechst 33258 assay with calf thymus DNA as a 
standard162 and sGAG using the 1,9-dimethyl-methylene blue assay125,199 with shark 
cartilage chondroitin sulfate as a standard. 
 
Viability Staining 
 Gel constructs were imaged for cell viability using the Molecular Probes 
Live/Dead kit (n=3/group/timepoint).  Constructs were imaged directly after 24 hours in 
the inhibitors (levels as indicated for the recovery portion of the experiment), and then 
24, 48, and 60 hours after being returned to basal media.  Samples were rinsed in three 
10-minute PBS washes with gentle agitation, followed by incubation for 1 hour in 4µM 
calcein and 4µM ethidium in PBS.  To remove any unincorporated calcein and ethidium, 
samples were rinsed in three 10-minute PBS washes.    Samples were then imaged with a 




For histology, additional samples were rinsed in PBS, transferred to 10% neutral-
buffered formalin for 48 hours, and then stored in 70% ethanol (n=2 per group per 
endpoint) to reduce the solubility of the GAG sidechains. Samples were subsequently 
embedded in paraffin and sectioned at five microns. Sections were stained with safranin-




6.3.1 Passaging Study 
Gene Expression 
 Collagen II expression varied with both passage and media supplementation.  
Overall, collagen II expression was highest in the samples treated with both TGF-β1 and 
dexamethasone (TGF+DEX) (p≤0.016) (Figure 6.1).  Collagen II expression was highest 
in the passage 3 (P3) samples treated with both TGF-β1 and dexamethasone (TGF+DEX) 
and decreased with passage number for all groups except for the group treated with both 
TGF-β1 and dexamethasone (TGF+DEX) (p<0.001) (Figure 6.1A).   
Aggrecan expression varied with passage number.  Expression was higher in the 
passage 2 samples compared to either passage 3 or 4 (p≤0.012) (Figure 6.1B).  There 




































































































Figure 6.1: Gene expression results for BMSCs passaged 2, 3 and 4 times and seeded in 
2% alginate.   






sGAG per DNA 
 sGAG accumulation varied with both passage number and media 
supplementation.  Overall, sGAG per DNA accumulation was highest in the samples 
treated with both TGF-β1 and dexamethasone (TGF+DEX) (p≤0.044) and lowest in the 
samples not supplemented with TGF-β1 (BASAL) (p≤0.013) (Figure 6.2).  sGAG per 
DNA accumulation was dropped off at the 4th passage for the samples treated with both 
TGF-β1 and dexamethasone (TGF+DEX) with no significant changes in the samples not 
supplemented with TGF-β1 (BASAL) (p≤0.003).  Due to the upregulation of both 
collagen II expression and sGAG/DNA accumulation, subsequent studies were performed 





















































Figure 6.2: sGAG per DNA accumulation for BMSCs passaged 2, 3 and 4 times and 
seeded in 2% alginate.   




6.3.2 Seeding Density Study 
Gene Expression 
Aggrecan expression was lowest in the samples not treated with TGF-β1 
(BASAL) (p≤0.001) (Figure 6.3A).  For the groups treated with both TGF-β1 and 
dexamethasone (TGF+DEX), expression was higher in the samples seeded at 25x106 
cells/mL (MID) compared to those seeded at 12.5x106 cells/mL (LOW) (p<0.001).   
Collagen II expression varied with both seeding density and media 
supplementation.  Expression was highest in the samples treated with both TGF-β1 and 
dexamethasone (TGF+DEX) (p≤0.010) and lowest in the samples not supplemented with 
TGF-β1 (BASAL) (p≤0.002) (Figure 6.3B).  Collagen II expression was lower in the 
samples seeded at 12x106 cells/mL (LOW) compared to the samples seeded at 25x106 
cells/mL (MID) (p=0.010).  For the groups treated with TGF-β1 only (TGF) and both 
TGF-β1 and dexamethasone (TGF+DEX), collagen II expression was highest in the 
samples seeded at 25x106 cells/mL (MID) (p≤0.001) (Figure 6.3B).   
Collagen I expression varied with media supplementation, but not significantly 
with seeding density (Figure 6.3C).  Expression was highest in the samples treated with 
only TGF-β1 (TGF) (p≤0.003) and lowest in the samples not treated with TGF-β1 
(BASAL) (p≤0.001).   
Collagen X gene expression was the highest in the samples seeded at 12.5x106 
cells/mL (LOW) (p≤0.004) (Figure 6.3D).   
Sox9 expression was lowest in the samples not treated with TGF-β1 (BASAL) 
(p≤0.026) (Figure 6.3E).  Expression was higher in the samples treated with 50x106 
cells/mL (HIGH) compared to those seeded at 12.5x106 cells/mL (LOW) (p=0.002).  For 
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the samples treated with TGF-β1 only (TGF), Sox9 expression was the highest in the 
samples seeded at 50x106 cells/mL (HIGH) (p<0.006) (Figure 6.3E).   For the groups 
treated with both TGF-β1 and dexamethasone (TGF+DEX), Sox9 expression was the 
highest in the samples seeded at 50x106 cells/mL (HIGH) (p<0.021) and the lowest in the 

































































































































































































Figure 6.3: Gene expression for BMSCs seeded at three different cellular densities in 2% 
alginate (LOW=12.5x106, MID=25x106 and HIGH=50x106 cells/mL).   








sGAG per DNA 
 Overall, samples treated with both TGF-β1 and dexamethasone (TGF+DEX) had 
the highest amount of sGAG per DNA (p<0.001) and samples not treated with TGF-β1 
(BASAL) had the lowest amount (p<0.001) (Figure 6.4).  Groups seeded at 25x106 
cells/mL (MID) had a greater amount of sGAG per DNA compared to those seeded at 
12.5x106 cells/mL (LOW) (p=0.003).  Compared to the other groups treated with TGF-β1 
only (TGF), samples seeded at 25x106 cells/mL had a greater amount of sGAG per DNA 
accumulation compared to the other two seeding densities (p≤0.016).Overall, the group 
seeded at 25x106 cells/mL (MID) and supplemented with both TGF-β1 and 
dexamethasone (TGF+DEX) had the highest sGAG per DNA compared to all other 
groups (p<0.001).  Due to the upregulation of sGAG/DNA accumulation, subsequent 






























Figure 6.4: sGAG per DNA accumulated for BMSCs seeded at three different cellular 
densities in 2% alginate. 
 LOW=12.5x106, MID=25x106 and HIGH=50x106 cells/mL.   indicates p<0.05 vs. 






6.3.3 Alginate Time Course 
Gene Expression 
 Only two media conditions were evaluated for the time course: no TGF-β1 added 
(BASAL) and both TGF-β1 and dexamethasone added (TGF+DEX).  Overall, aggrecan 
and collagen II gene expressions were higher in the samples treated with both TGF-β1 
and dexamethasone (TGF+DEX) (p<0.042) (Figure 6.5A,B).  Aggrecan and Sox9 gene 
expressions were highest in the day 4 samples treated with both TGF-β1 and 
dexamethasone (TGF+DEX) (p<0.001 and p<0.001 respectively) (Figure 6.5A,C).  
Collagen II expression was the highest in the day 14 samples treated with both TGF-β1 
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Figure 6.5: Gene expression time course for passage 3 BMSCs seeded 25x106 cells/mL in 
2% alginate. 






sGAG per DNA 
 Overall, sGAG per DNA values were higher in the samples treated with both 
TGF-β1 and dexamethasone (TGF+DEX) (p=0.003) (Figure 6.6).  The day 14 sGAG per 
DNA levels in the samples treated with both TGF-β1 and dexamethasone (TGF+DEX) 
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Figure 6.6: sGAG per DNA time course for passage 3 BMSCs seeded 25x106 cells/mL in 
2% alginate.   




6.3.4 Agarose Time Course 
Viability 
 There were no overall differences in cellular viability between the gels imaged on 
day 8 and on day 16, therefore only images from day 8 samples are shown (Figure 6.7).  
Qualitatively, there was a dramatic difference in viability between the samples treated 
with basal media and those treated with TGF-β1, with a much higher proportion of dead 
cells found in the samples treated with basal media only.  Samples treated with basal 
media had substantially more dead cells.  There were no drastic differences between the 
two groups treated with TGF-β1.  Viability was also less in the interior of the constructs 








































    
Figure 6.7: Viability staining for BMSCs in agarose cultured for 16 days.  Green 





 Overall, aggrecan, collagen II and collagen I gene expressions were higher in the 
samples treated with TGF-β1+DEX and lower in BASAL samples (p<0.001) (Figure 
6.8).    
Aggrecan, collagen II and collagen I expressions were upregulated over day 0 
levels at both timepoints for BASAL samples (p<0.001).  There was an upregulation 
from day 8 to 16 for both collagen II and I expressions (p<0.005) (Figure 6.8B,C).  There 
was a downregulation in expression from day 8 to 16 for aggrecan (p=0.008) (Figure 
6.8A). 
Aggrecan, collagen II and collagen I expressions were upregulated over day 0 
levels at both timepoints for TGF samples (p<0.001).  There was a upregulation from day 
8 to 16 for collagen II expression (p=0.004) (Figure 6.8B,C).  There was a 
downregulation in expression from day 8 to 16 for both aggrecan and collagen I 
expressions (p=0.008) (Figure 6.8B,C). 
Aggrecan, collagen II and collagen I expressions were upregulated over day 0 
levels at both timepoints for TGF+DEX samples (p<0.005).  There was a upregulation 
from day 8 to 16 for both aggrecan and collagen II expressions (p<0.008) (Figure 
6.8A,B).  There was a downregulation in expression from day 8 to 16 for collagen I 


















































BASAL TGF TGF+DEX  
Figure 6.8: Gene expression for BMSCs in agarose cultured for 8 and 16 days.  
 indicates P < 0.05 vs. day 0 levels and † indicates P < 0.05 vs. all other in the 







Matrix Synthesis Rates 
 Consistent with the gene expression results, both protein and sGAG synthesis 
rates increased with the addition of TGF-β1 and furthermore with the addition of 
dexamethasone (p<0.001) (Figure 6.9).  Both protein and sGAG synthesis rates increased 





































BASAL TGF TGF+DEX  
Figure 6.9: Matrix synthesis rates for BMSCs in agarose cultured for 8 and 16 days.  
* indicates P < 0.05 vs. day 0 levels and  indicates P < 0.05 vs. respective group’s day 







 Consistent with both the gene expression and matrix synthesis rates, at both days 
8 and 16, sGAG accumulation was the highest in the gels treated with TGF-β1+DEX and 
lowest in the gels treated with basal medium (p<0.001 for all) (Figure 6.10).  There were 
no changes in sGAG content for the gels treated with basal media over time.  sGAG 
content increased over time for the samples treated with TGF-β1 only (p≤0.0085) and for 















BASAL TGF TGF+DEX  
Figure 6.10: sGAG accumulation for BMSCs in agarose cultured for 8 and 16 days.  
* indicates P < 0.05 vs. day 0 levels and  indicates P < 0.05 for day 16 vs. respective 




 There were drastic differences in sGAG deposition between the three media 
groups and two timepoints (Figures 6.11, 6.12).  Samples treated with basal media 
showed no observable sGAG staining after 16 days of culture.  TGF-β1 samples had 
limited sGAG staining in the interiors of the scaffolds even after 16 days, with a marked 
increase in sGAG deposition between days 8 and 16 near the edges of the constructs.  
sGAG deposition was limited to the pericellular area of individual cells.  Samples treated 
with TGF-β1 and dexamethasone showed no significant sGAG deposition in the interior 
of the construct after 8 days of culture, with more deposition seen near the edges (Figure 
6.Error! Reference source not found.12).  After 16 days of culture, samples treated 
with TGF-β1 and dexamethasone showed significantly more sGAG deposition both 
internally and in the edge regions compared to other timepoints and media conditions.  
There was diffuse staining with an increased intensity pericellularly. 
 Overall, the addition of TGF-β1 and furthermore dexamethasone increased both 
chondrogenic gene expression and sGAG per DNA accumulation compared to BASAL 
supplementation.  There was a marked increased in sGAG accumulation from days 8 to 
16 for both the samples treated with TGF-β1 only and both TGF-β1 and dexamethasone.  
Samples treated with both TGF-β1 and dexamethasone accumulated a substantially 
greater amount of sGAG after 16 days of culture.  
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Figure 6.12: Representative Safranin O stained sections for BMSCs in agarose cultured 




 It has been well established that the parameters of culturing progenitor cell 
populations affect the differentiation capacity of these cells201,202.  For human MPCs, the 
constituents of the basal medium including the quality of FBS, glucose concentration, and 
stable glutamine, as well as culture conditions such as passaging and seeding densities 
affect the final outcome201.  For this reason, it was important to characterize the bovine 
BMSC culture variables. 
 Of the critical genes of interest, Sox9, aggrecan and collagen II, results were not 
always self-consistent within a given perturbed parameter.  Differences between 
parameters in aggrecan results, in particular, were often unclear and insignificant.  In 
general, collagen II gene expression was consistent with the sGAG accumulation for the 
TGF-β1 groups for all parameters investigated.  While gene expression provided useful 
information on the effects of varying culture parameters, sGAG accumulation data were 
generally the easiest to understand and interpret, therefore more emphasis was placed on 
that variable in putting various parameters into perspective.   
While there were no discernable differences in either the BASAL or TGF-β1 
groups between passage numbers, passage 3 had the most positive response in the TGF-
β1+DEX group.  Collagen II expression was significantly higher in the P3 TGF-β1+DEX 
group compared to all other groups.  sGAG per DNA accumulation was significantly 
higher in the P3 TGF-β1+DEX group compared to the other P3 groups.  While not 
significant, the P3 levels of sGAG accumulation were qualitatively higher than the other 
two passages for the P3 TGF-β1+DEX group.   
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 While there were no discernable differences in either the BASAL group by 
seeding density, the MID density (25x106 cells/mL) had the most positive response in the 
TGF-β1and TGF-β1+DEX groups for both collagen II gene expression and sGAG per 
DNA accumulation.  When compared within themselves, the gene expression results 
were not entirely consistent.  There were little observable differences in aggrecan and 
collagen I expressions between seeding densities, or between the two media conditions 
containing TGF-β1.  Collagen X expression, an indicator of chondrocyte hypertrophy, 
was highest in the LOW density (12.5x106 cells/mL) samples and Sox9 expression was 
highest in the HIGH density (50x106 cells/mL) samples. 
 For both the passaging and seeding density comparisons, the TGF-β1+DEX 
samples stimulated both chondrogenic gene expression and matrix synthesis, compared to 
the BASAL and TGF-β1 groups.  In the chondrogenesis of the bovine BMSCs, the 
addition of dexamethasone had an overwhelmingly positive effect on the parameters 
examined, including upregulating sGAG accumulation, aggrecan and collagen II 
expressions, while downregulating collagen X expression.  The response to the addition 
of dexamethasone in different culture systems is varied.  Awad et al. found that the 
addition of dexamethasone appeared to amplify protein synthesis but had suppressive 
effects on sGAG synthesis and accumulation on human adipose-derived stromal cells 
supplemented with TGF-β1203.  Dexamethasone has been found to suppress proliferation 
and chondrogenesis in the chondrogenic ATDC5 cells204,205.  Conversely, scrapie-
responsive protein 1 precursor (SCRG-1) expression has been found to be 
dexamethasone-dependent during chondrogenesis.  SCRG1 in human MPCs suppressed 
their proliferation, and stimulated chondrogenesis in C3H10T1/2 cells, confirmed by 
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reduced collagen type I and elevated collagen type IIB expression.  While the mechanism 
(or mechanisms) though which dexamethasone works in the culture system presented in 
this dissertation is not known, the addition of dexamethasone to TGF-β1 supplementation 
had a positive effect on the gene expressions and matrix syntheses outcomes measured.  
 The overall level of chondrogenesis was higher in the agarose hydrogel culture 
compared to the alginate hydrogel culture for the samples treated with TGF-β1+DEX.  
After 2 weeks of culture, collagen II gene expression was 3 orders of magnitude higher in 
the agarose samples treated with TGF-β1 and dexamethasone, compared to the alginate 
samples treated with both TGF-β1 and dexamethasome, with no differences between the 
untreated samples for either scaffold.  There was also a 2-fold difference in sGAG per 
DNA accumulation between agarose and alginate after two weeks, approximately 3.4 µg 
sGAG per µg DNA in alginate at day 14 compared to 8.5 µg sGAG per µg DNA at day 
16 (data not shown).  In each system, the cellular content was similar both initially and 
after two weeks.  Differences in the chondrogenic response of BMSCs between the 
scaffold types may be due to differences in the material properties including charge and 
diffusional restrictions.  While agarose is relatively inert, alginate carries a negative 
charge.  Also, as the study presented in chapter 3 demonstrated, chondrocytes produce a 
matrix more similar to articular cartilage in agarose compared to alginate.  In addition to 
preserving the phenotype of BACs, agarose may also support chondrogenesis in BMSCs 
preferentially than in alginate.   
Numerous studies have investigated chondrogenesis in a variety of animal models 
and culture systems using different passages, cell densities, and media conditions.  The 
present study demonstrates that these factors can significantly impact BMSC 
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differentiation and should be considered when developing cell-based therapies for 
cartilage repair.  Passage 3 cells were chosen to be utilized for future studies due to the 
increase in collagen II expression and sGAG accumulation in the samples treated with 
TGF+DEX.  Practical concerns, such as expanding the BMSC population adequately for 
3D culture also made passage 3 an attractive option.  The mid-range seeding density of 
25x106 cells/mL was chosen to be utilized for future studies due to the increased collagen 
II expression and sGAG accumulation in the samples treated with TGF and TGF+DEX.  
Due to the increase in chondrogenic markers in agarose compared to alginate, agarose 
was chosen for downstream studies.  Another potential benefit in using agarose as a 3D 
hydrogel is that it is relatively easy to get a series of uniform samples with a set 
geometry.  Casting of alginate makes it somewhat more labor intensive to achieve similar 
results in uniformity.  For the purpose of this dissertation, further studies utilized passage 




CHAPTER 7  INTERACTION BETWEEN THE TGF-β SIGNALING PATHWAY 
AND DYNAMIC COMPRESSIVE LOADING IN THE CHONDROGENESIS OF 





Both biochemical and biomechanical stimulation have been shown to influence 
the growth and differentiation of BMSCs.  Much effort investigating the effect of growth 
factor and cytokine supplementation on the chondrogenesis of BMSCs has focused 
around members of the transforming growth factor β (TGF-β) superfamily (TGF-βs, 
BMPs, activins) which have been found to play roles in chondrocyte growth, 
differentiation and commitment66.  TGF-β family members have also been shown to 
participate in the control of proliferation, extracellular matrix synthesis, migration and 
apoptosis in many different cell types, including chondrocytes and chondrogenic 
progenitor cells19,66,77,206.  Multiple members of the TGF-β family, including TGF-β1, 
have been shown to induce in vitro chondrogenesis of BMSCs68,207.   
The transforming growth factor β (TGFβ) superfamily is involved in the 
regulation of multiple cellular processes, including cell proliferation, differentiation and 
apoptosis208.  TGF-β transmits its signal from the cell surface via a transmembrane 
serine/threonine kinase receptor complex209,210.   Upon ligand binding, the type II 
receptor subunit engages and transphosphorylates a type I receptor subunit (TβRI), which 
in turn phosphorylates the receptor-activated Smad proteins (R-Smads) Smad2 and 
Smad3 (Figure 1).  A protein complex with Smad4 is formed with the activated R-Smads 
and translocated into the nucleus where they interact with additional transcription factors, 
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binding to the promoters of responsive genes and regulate their expression by cooperating 
with other activators or repressors72.  In addition to the Smad pathway, TGF-β has been 
shown to activate other signaling pathways including p38 MAPK73 and protein kinase C 
(PKC)74.  TGF-β signaling has been demonstrated through the p38 MAPK pathway 
through activation of mitogen-activated protein kinase 1 (MEK1) and subsequent 
ERK/ELK signaling75,211.  It has also been shown that G-protein-dependent activation of 
PKC results from TGF-β stimulation of growth plate chondrocytes74.  It has been 
suggested that TGF-β responsiveness requires the activation of the R-Smad2/4 complexes 
as well as other signaling pathways.   
Mechanical stimulation has been shown to be important in the development of 
certain tissues and may influence differentiation of BMSCs78.  It has been suggested that 
the combination of chondrogenic media and dynamic compressive loading may enhance 
chondrogenesis of BMSCs over the addition of exogenous factors alone79.  Dynamic 
compressive loading has been shown to increase the expression of chondrogenic markers, 
aggrecan and collagen II, in rabbit BMSCs in agarose culture79.  Dynamic compressive 
loading has also been shown to induce chondrogenesis in chick-bud mesenchymal 
cells212,213.  Studies on human BMSCs cultured under conditions promoting 
chondrogenesis found that the application of cyclic hydrostatic pressure for multiple days 
increased proteoglycan and collagen contents after 14 days in culture82.  Mechanical 
loading has been found to be critical in the differentiation of other tissue types, including 
bone.  BMSCs cultured on partially demineralized bone subjected to four-point bending 
loading experienced elevated osteogenic differentiation, compared to unloaded controls83.  
Combined with the substantial knowledge base that mechanical stimulation can affect the 
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maintenance of cartilage, these studies suggest that controlled mechanical stimulation 
may direct differentiation and subsequent matrix assembly in engineered cartilage 
derived from mesenchymal progenitor cells. 
The overall objective of the studies presented in this chapter was to investigate the 
mechanotransduction of BMSCs through the interactions between TGF-β1, 
dexamethasone and dynamic compressive loading.  Specifically, the effects of dynamic 
and static compressive loading on BMSC gene expression, matrix synthesis and TGF-β 
signaling though Smad effector molecules were examined.  Investigation of the influence 
of transforming growth factor β1 (TGF-β1) signaling on the response of chondrocytes 
and BMSCs to dynamic compressive loading may provide clues to the mechanisms 
involved in chondrocyte differentiation and define other potential targets to regulate this 
process.  The mechanisms through which mechanotransduction occurs in chondrocytes 
and chondroprogenitor cells remain largely elusive.  This work addresses a potential 
mechanism for mechanotransduction in these cells. 
 
 
7.2 MATERIALS AND METHODS 
7.2.1 Cell Isolation 
BMSCs were isolated from both the femoral and tibial diaphyses of 2-4 week old 
calves within 24 hours of slaughter.  After removal of all fascia and muscle from the 
bones, the bones were cut at the mid-diaphysis with a sterile bone saw.  Marrow was 
removed from the medullary canal and transferred to a 50ml conical with sterile PBS plus 
1% antibiotic/antimycotic (A/A: 100U/mL penicillin, 100ug/mL streptomycin, 250 
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ng/mL Amphotericin).  Marrow was sequentially passed through large bore (25mL) and 
small bore (5mL) pipets to disrupt large pieces.  Marrow was then sequentially passed 
through 16- and 18-gauge needles.  Marrow suspension was centrifuged at 300 x g for 15 
minutes.  The separated fatty layer was removed and discarded.  The cell pellet was 
resuspended in PBS, passed through a 20-gauge needle and filtered through a 100µm 
nylon filter.    Mononuclear cells were counted with a Vi-Cell Cell Viability Analyzer 
using the Trypan Blue exclusion method. 
Cells were plated in T-flasks at 5 x 103 mononuclear cells per cm2 in passaging 
medium (consisting of low glucose DMEM, 10% FBS, 1% antibiotic/antimycotic, ± 
1ng/mLbFGF).  Nonadherent cells were removed during the first media change three 
days later.  Cells were cultured until confluent (~ 2 weeks, P1), detached with 0.05% 
trypsin/1mM EDTA, and replated at 5 x 103 cells per cm2.  Cells were again cultured 
until confluence and seeded into 3% agarose gels.  Agarose gels were assembled by 
autoclaving 6% LMP agarose in 1X Ca2+, Mg2+ -free PBS and then cooling the solution 
to 42°C.  An equal volume of cells suspended at 40 x106 cells/mL  in 1X Ca2+, Mg2+ -free 
PBS was combined with the agarose for a final concentration of 20 x106 cells/mL in 3% 
agarose.  The agarose was cast in 3mm sheets between two electrophoresis plates and 
cooled until polymerized (approximately 10 minutes).  Biopsy punches were used to 
extract gels 4mm in diameter.   
Gels were cultured in basal medium consisting of high glucose DMEM plus 
antibiotic/antimycotic, non-essential amino acids, 1% ITS+, 50µg/mL ascorbate and 
0.4mM proline (BASAL), basal medium plus 10ng/mL TGF-β1 (TGF-β1), or basal 
medium plus 10ng/mL TGF-β1 and 100nM dexamethasone (TGF-β1+DEX).  In a 
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preliminary study, dexamethasone alone did not significantly increase sGAG 
accumulation over 8 days relative to BASAL media (data not shown).  As the focus of 
these studies was on the interactions between TGF-β and compression, the non-
chondrogenic dexamethasone-alone condition was excluded from further studies.  Media 
were changed every two days.   
 
7.2.2 Experimental Design 
Short Term Loading 
Dynamic compression was applied using a custom designed mechanical loading 
system (see appendix D).  Samples were cultured in either BASAL, TGF-β1 or TGF-
β1+DEX media for either 8 or 16 days before the application of loading.  Mechanical 
stimulation groups included static compression (10%), 1Hz dynamic compression (10% ± 
3%) and free swelling (FS).  Samples were mechanically stimulated for 3 hours to 
evaluate gene expression and 20 hours to evaluate matrix synthesis rates.  For 
immunohistochemistry and Western blotting, cells were mechanical stimulated for 1 
hour.  See appendix E for the Western blotting protocol. 
 
Long Term Loading 
Dynamic compression was applied using a custom designed mechanical loading system 
(see appendix D).  Samples were cultured in either BASAL, TGF-β1 or TGF-β1+DEX 
media for either 8 days before the application of loading.  Samples were mechanically 
stimulated for 12 hours each day for 8 days.  In the 12 hours of the day, constructs were 
maintained at the 10% static offset.  Mechanical stimulation groups included static 
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compression (10%), 1Hz dynamic compression (10% ± 3%) and free swelling (FS).  
Samples were either analyzed using immunohistochemistry for collagen I and collagen II 
localization (see appendix D) or general biochemistry methods. 
 
7.2.3 Analytical Techniques 
Quantitative RT-PCR 
Agarose gels were immediately dissociated in Qiagen Lysis Buffer with 1% beta-
mercaptoethanol.  The RNeasy Total RNA Kit (Qiagen, Chatsworth, CA) was then used 
according to manufacturer’s protocol to purify RNA from the samples.  The yield of the 
purified isolate was read at 260 nm and 280 nm on a UV-1601 Spectrophotometer 
(Shimadzu, Columbia, MD). 
1µg of total RNA was transcribed to cDNA using the Promega RT System 
(Promega, Madison, WI) and manufacturer’s protocol.  The SYBR Green PCR Master 
Mix (Applied Biosystems, Foster City, CA) was mixed with primers and cDNA for real 
time detection of amplification.  Real time, quantitative RT-PCR was performed with an 




7.3.1 Day 8 Short Term Loading 
Gene Expression 
 The effects of dynamic compression varied greatly between media conditions and 
genes for the samples cultured for 8 days prior to loading (Figure 7.1).    Dynamic 
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compression downregulated aggrecan gene expression for the samples treated with TGF-
β1 (5-fold, p=0.0053) and TGF-β1 and dexamethasone (3-fold, p=0.035), with no effect 
on the BASAL samples (Figure 7.1A).  Dynamic compression upregulated collagen II 
expression in BASAL samples (3-fold, p=0.0006) and samples treated with TGF-β1 and 
dexamethasone (2-fold, p=0.021), with no effect on TGF-β1 samples (Figure 7.1B).  
Dynamic compression upregulated collagen I expression for BASAL samples (3-fold, 
p=0.0012), with no effect on the samples treated with TGF-β1 or TGF-β1 and 


















































Figure 7.1: Gene expression for BMSCs seeded in agarose and subjected to 3 hours of 
mechanical stimulation on day 8.   







 There were no differences in the pairwise comparisons for any of the media 
conditions for either protein or sGAG synthesis rates for the samples cultured for 8 days 
prior to loading (Figure 7.2).  Overall, basal samples had the lowest sGAG synthesis rates 
(p<0.001) and samples treated with TGF-β1 and dexamethasone had the highest 




























Figure 7.2: Matrix synthesis rates for BMSCs seeded in agarose and subjected to 20 
hours of mechanical stimulation on day 8.   






7.3.2 Day 16 Short Term Loading 
Gene Expression 
The effects of dynamic compression varied greatly between media conditions and 
genes for the samples cultured for 16 days prior to loading but were strikingly different 
from effects of loading on day 8 (Figure 7.3).    Dynamic compression upregulated 
aggrecan gene expression for both basal samples (2-fold, p=0.017) and samples treated 
with TGF-β1 and dexamethasone (3-fold, p<0.001), with no effect on the TGF-β1 
samples (Figure 7.3A).  Dynamic compression upregulated collagen II expression for 
samples treated with TGF-β1 (5-fold, p=0.002) or TGF-β1 and dexamethasone (60-fold, 
p=0.000), with no effect on the basal samples (Figure 7.3B).  Dynamic compression 
upregulated collagen I expression for samples treated with TGF-β1 (30-fold, p<0.001) or 
TGF-β1 and dexamethasone (100-fold, p<0.001), with no effect on the basal samples 






















































Figure 7.3: Day 16 gene expression for BMSCs seeded in agarose and subjected to 3 
hours of mechanical stimulation.   






 Matrix synthesis rates were fairly consistent with the gene expression results for 
16 days prior to loading.  Overall, both protein and sGAG synthesis rates were lowest in 
the basal samples (p<0.001) and highest in the samples treated with TGF-β1 and 
dexamethasone (p<0.001) (Figure 7.4).  Dynamic compression had no significant effect 
on either protein or sGAG synthesis rates for basal samples.  Dynamic compression 
stimulated protein synthesis rates for TGF-β1 samples (2-fold, p<0.001), but not sGAG 
synthesis rates.  Dynamic compression stimulated both protein (2-fold, p<0.001) and 
proteoglycan (2-fold, p<0.001) synthesis rates for samples treated with TGF-β1 and 


























Figure 7.4: Day 16 matrix synthesis rates for BMSCs seeded in agarose and subjected to 
20 hours of mechanical stimulation.   






Total Smad 2/3 
 The results of IHC indicated qualitative differences not elucidated via Western 
blotting.  In all media and mechanical stimulation conditions, there was diffuse Smad2/3 
cytoplasmic staining for total Smad2/3 throughout the cells, with no noticeable 
differences in the level of staining or the numbers of cells stained (Figure 7.6, 7.6).  In 
constructs treated with BASAL media, nuclear localization of Smad2/3 was low, with no 
qualitative differences between the different modes of mechanical stimulation.   
In the constructs treated with TGF-β1, there was a marked increase in Smad2/3 
nuclear localization compared to BASAL conditions, with both a greater number of cells 
displaying localization and more intense staining.  There was also a qualitative increase 
in the number of cells with pronounced Smad2/3 nuclear localization in the dynamically 
compressed samples compared to the statically compressed samples.  In constructs 
treated with TGF-β1+dexamethasone, there were more cells with pronounced nuclear 
localization of Smad2/3 than in either the BASAL or TGF-β1 samples, regardless of 
mechanical stimulation.  A greater number of cells in the samples dynamically stimulated 
seemed to have pronounced nuclear localization than in either the statically compressed 
or unloaded samples.  While preliminary, these observations suggest that dynamic 
compression increases the percentage of total Smad2/3 localized to the nucleus. 
Between media conditions, there were no significant differences in the levels of 
Smad2/3 detected by Western blotting (Figure 7.7).  In a pair-wise comparison, dynamic 
compression increased Smad2/3 protein levels over static compression for the samples 
treated with TGF-β1+dexamethasone (p<0.001).  There were no differences detected in 
either the BASAL or TGF-β1 groups with dynamic compression. 
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Figure 7.5: Total Smad2/3 immunohistochemical staining after 1 hour of mechanical 
stimulation.   
Constructs were cultured for 16 days prior to mechanical stimulation.  Representative 





Figure 7.6: Total Smad 2/3 (Smad 2/3) immunohistochemical staining.   
Smad 2/3 localization was both cytoplasmic as well as nuclear.  Constructs were cultured 
for 16 days prior to mechanical stimulation.    Unloaded construct stimulated with TGF-
β1 shown and representative of positive pSmad 2/3 staining.  Image taken at 100X 
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Figure 7.7:  Smad 2/3 levels.   
Smad 2/3 levels were measured by Western blotting and normalized by gel background 
and a standard on each gel.  Constructs were cultured for 16 days prior to mechanical 
stimulation.  (A) Representative blot for the TGF samples with the normalizing standard 
in the lane 1 (discussed in appendix E), static samples in lanes 3-7, and dynamic samples 
in lanes 8-12.  (B) Dashed line indicates 100% of gel standard.   indicates P < 0.05 vs. 






 In all media and mechanical stimulation conditions, diffuse Phospho-Smad2/3 
(pSmad2/3) cytoplasmic staining throughout the cells was comparable to background 
staining using fluorescent microscopy (Figure 7.8).  When imaged using confocal 
microscopy, all pSmad2/3 localization was nuclear with no diffuse cytoplasmic staining 
apparent (Figure 7.9Error! Reference source not found.). 
 In the BASAL samples, there were qualitatively no differences in the number of 
cells with pSmad2/3 nuclear localization or the level of localization between samples 
dynamically compressed or unloaded.  There were qualitatively fewer cells with 
pSmad2/3 nuclear localization in the statically compressed samples compared to those 
either dynamically compressed or unloaded.     
The constructs treated with TGF-β1, there was a marked increase in pSmad2/3 
nuclear localization compared to BASAL conditions, with both a greater number of cells 
displaying localization and a brighter level of staining.  There was also a qualitative 
increase in the number of cells with pronounced pSmad2/3 nuclear localization in the 
dynamically compressed samples compared to the statically compressed samples. 
In constructs treated with TGF-β1+dexamethasone, there were no observable 
differences in either the number of cells with nuclear localization or the intensity of 
staining of pSmad 2/3 compared to the TGF-β1 samples, regardless of mechanical 
stimulation.   
 Between media conditions, there were significant differences in the levels of 
pSmad2/3 detected by Western blotting (Figure 7.10).  Samples treated with BASAL 
media had significantly less pSmad2/3 protein compared to the other media groups 
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(p<0.001).  In a pairwise comparison, dynamic compression increased pSmad2/3 protein 
levels over static compression slightly for the samples treated with both BASAL (1.9-
fold) and TGF-β1 (1.4-fold) media (p=0.011 and p=0.005 respectively).  There were no 
in pSmad2/3 differences detected between static and dynamic compression in the TGF-
β1+dexamethasone groups.  
 In general, the IHC complemented the Western blotting results, with the 
exception of the modulation of Smad2/3 phosphorylation by dynamic compression.  IHC 
showed no differences between the response to dynamic compression of samples treated 
with TGF-β1 only and those treated with both TGF-β1 and dexamethasone.  In both 
media conditions, dynamic compression upregulated pSmad2/3 localization to the 
nucleus demonstrated by in increase in the number of pSmad2/3 cells as well as in 
intensity of staining.  Western blotting did not correspond clearly with the IHC findings 
for the samples treated with both TGF-β1 and dexamethasone, showing no significant 
regulation of Smad phosphorylation by dynamic compression. 
 Overall, both the IHC and Western blotting demonstrated that dynamic 
compression increased TGF-β signaling through the Smad2/3 pathway.  While 
preliminary, dynamic compression increased Smad2/3 phosphorylation and nuclear 
localization, as well as increase the number of cells responding with TGF-β1 signaling. 
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Figure 7.8: Phosphorylated Smad2/3 immunohistochemical staining after 1 hour of 
mechanical stimulation.   
Constructs were cultured for 16 days prior to mechanical stimulation.  Representative 
sections shown.  Negative control replaces primary antibody with non-immune rabbit 




Figure 7.9:  Phosphorylated Smad 2/3 (pSmad 2/3) immunohistochemical staining.   
pSmad 2/3 localization was primarily nuclear for all conditions.  Constructs were 
cultured for 16 days prior to mechanical stimulation.    Unloaded construct stimulated 
with TGF-β1+ DEX shown and representative of positive pSmad 2/3 staining.  Image 



















Figure 7.10:  Phosphorylated Smad 2/3 (pSmad 2/3) levels.   
pSmad 2/3 levels were measured by Western blotting and normalized by gel background 
and a standard on each gel.  Constructs were cultured for 16 days prior to mechanical 
stimulation.  (A) Representative blot for the TGF samples with the normalizing standard 
in the lane 1 (discussed in appendix E), molecular weight marker in lane 2, static samples 
in lanes 3-7, and dynamic samples in lanes 8-12.  (B) Dashed line indicates 100% of gel 
standard.   indicates P < 0.05 vs. respective static group for relative pSmad 2/3 levels.  
† indicates P < 0.05 vs. other media groups.  (mean±S.E.M, n=5) 
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B 
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TGF-β Receptor Type I 
Between media conditions, there were significant differences in the levels of TβRI 
detected by Western blotting (Figure 7.11).  Samples treated with TGF-β1 media had 
significantly more TβRI protein compared to the other media groups (p<0.001).  
Dynamic compression increased TβRI protein levels over static compression slightly for 
the samples treated with both BASAL (1.7-fold) and TGF-β1 (1.2-fold) media (p=0.006 
and p=0.038 respectively).  There were no differences between static and dynamic 
compression detected in the TGF-β1+dexamethasone groups. 
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Figure 7.11: TGF-β Receptor I (TGF-β RI) levels.   
TGF-β RI levels were measured by Western blotting and normalized by gel background 
and a standard on each gel.  Constructs were cultured for 16 days prior to mechanical 
stimulation.  (A) Representative blot for the TGF samples with the normalizing standard 
in the left lane (discussed in appendix E).  (B) Dashed line indicates 100% of gel 
standard.   indicates P < 0.05 vs. respective static group for relative pSmad 2/3 levels.  
† indicates P < 0.05 vs. other media groups.  (mean±S.E.M, n=5) 
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7.3.3 Long Term Loading 
DNA 






















10% Static Dynamic  
 
Figure 7.12: DNA content after loading from day 8 to day 16.   
Samples were loaded 12 hours per day.  (mean±S.E.M, n=4-8) 
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sGAG per DNA 
 Between media conditions, there were significant differences in the levels of 
sGAG accumulated per cell (Figure 7.13).  Samples treated with BASAL media had 
significantly less sGAG accumulated per cell than samples treated with either TGF-β1 or 
TGF-β1+dexamethasone (p<0.001).  Samples treated with TGF-β1+dexamethasone had 
significantly more sGAG accumulated per cell than samples treated with either BASAL 
media or TGF-β1 (p<0.001). 
 Analyzed with a pairwise comparison, dynamic compression inhibited 
sGAG accumulation per cell over static compression for the samples treated with TGF-β1 
(0.5-fold, p<0.001).  There were no differences detected in either the BASAL or TGF-























Figure 7.13: sGAG per DNA accumulation after loading from day 8 to day 16.   
Samples were loaded 12 hours per day.   indicates P < 0.05 vs. respective static group.  
† indicates P < 0.05 vs. other BASAL groups.  (mean±S.E.M, n=4-8) 
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Collagen I / II Content 
 There was considerably less collagen I and collagen II in the samples treated with 
BASAL media compared to the other media conditions (Figure 7.14).  There were no 
observable differences between the TGF-β1 or TGF-β1+DEX samples in the amount of 
collagen accumulated.  Between mechanical stimulation groups, there were no observable 
differences in the amounts or types of collagen accumulated in the samples treated with 
TGF-β1.  There were no observable differences in the amounts or types of collagen 
accumulated in the unloaded and statically loaded samples treated with TGF-
β1+dexamethasone, there was observably less collagen I and more collagen II in the 
dynamically loaded samples. 
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Figure 7.14: Collagen I / II co-localization after loading from day 8 to day 16.   
Samples were loaded 12 hours per day.  Collagen I shown in RED, Collagen II in 
GREEN and DNA in BLUE.  Images taken at 20X magnification via fluorescence 






 Overall, the addition of TGF-β1 increased cell viability, gene expression, matrix 
synthesis and sGAG content over basal media.  The addition of dexamethasone further 
enhanced all three.  There was little stimulation of gene expression or matrix synthesis at 
day 8 with mechanical loading in chondrogenic media, although there was significant 
upregulation of gene expression in BASAL medium.  On day 16, there was significant 
stimulation by dynamic loading compared to static loading for chondrogenic groups.  The 
level of stimulation was also dependent on media condition, with the samples treated with 
basal media being the least responsive and the samples treated with TGF-β1 and 
dexamethasone being the most responsive.  Overall, both collagens I and II gene 
expressions were more responsive to dynamic loading than aggrecan expression. 
Differences between the responsiveness to mechanical stimulation of samples 
cultured 8 days before loading compared to those cultured 16 days before loading could 
be the result of multiple factors.  One potential reason in the differing response to loading 
could be that the differentiation states of the cells in the various media formulations may 
alter their response to mechanical loading.  The greater the level of chondrogenic 
differentiation the more similar in response the cells might be to that of a terminally 
differentiation chondrocyte.  Also, the different levels of matrix accumulation could have 
affected both the biochemical signaling from the extracellular matrix involved in 
dynamic loading, as well as the local mechanical stimuli resulting from the macroscopic 
loading.  The accumulation and structure of the pericellular and further removed 
extracellular matrix has been shown to affect the deformation of chondrocytes in 
hydrogel cuture49.  Chondrocytes have been shown to be deformable before a pericellular 
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matrix has been developed (i.e. in freshly seeded cultures) and after an interconnected 
ECM has been established, with little to no deformation occurring with the formation of a 
just pericellular matrix due to stress shielding of the surrounding matrix49,214.  This has 
been proposed as an explanation for the observed loss and subsequent redevelopment of 
mechanoregulation of chondrocytes in agarose. 
 Overall, total Smad2/3 levels seemed to be largely unaffected by media condition 
or mechanical stimulation, with only the TGF-β1+DEX samples responding significantly 
to dynamic compression.  While the levels seemed largely stable, the localization of the 
Smad2/3 proteins was dependent on both media condition and mechanical stimulation.  
The addition of TGF-β1, and furthermore dexamethasone, increased nuclear localization 
of Smad2/3, as well as the application of dynamic compression.  Due to the interference 
of agarose and potentially extracellular matrix components, the levels of cytoplasmic 
localization versus nuclear localization were not able to be analyzed via Western blotting. 
 Compared to total Smad2/3 localization, pSmad2/3 was primarily localized to the 
nucleus as evidenced by both IHC and Western blotting.  There was an increase Smad2/3 
phosphorylation in the samples treated with TGF-β1 and TGF-β1+DEX compared to 
BASAL samples.  Phosphorylation of Smad2/3 increased in both BASAL and TGF-β1 
samples, with no significant effect on the TGF-β1+DEX samples.  One possible 
explanation for the discrepancy between the IHC and Western blotting results could be 
that the amount of ECM in the TGF-β1+DEX samples interfered with isolating the 
intracellular proteins from the agarose/ECM material.  The lack of enhanced 
phosphorylation of Smad2/3 in the TGF-β1+DEX samples could be due to saturation of 
the TGF-β signaling pathway.  There may be a functional limit to the amount of TGF-β 
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signaling in the BMSCs.  Alternatively, the timing of the activation of the Smad proteins 
by mechanical stimulation may not be similar in all media conditions.  Kim et al. found 
that TGF-β1 increased phosphorylation of Smad2 by 15 minutes, with peaked activation 
occurring between 15 and 60 minutes215.  The singular timepoint of 60 minutes evaluated 
in the current study does not address the temporal variations in Smad activation in the 
different media conditions.  Overall, the IHC and Western blotting results were 
consistent.   
 The pSmad2/3 localization to the nucleus is consistent with the generally accepted 
paradigm for TGF-β signaling173.  There was also an increase in TβRI protein expression 
in the TGF-β1 samples, as well as an upregulation by dynamic compression in both 
BASAL and TGF-β1 samples.  The results of this study demonstrate that dynamic 
loading can alter gene expression, matrix synthesis rates and intracellular 
phosphorylation for bovine BMSCs.  However the response of the cells to dynamic 








The study presented in Chapter 3 investigated the differences in the response of 
BACs to various commonly used tissue engineering scaffolds: agarose, alginate, type I 
collagen, fibrin and PGA.  The study examined the nature of the proteoglycan / GAG 
matrices synthesized by chondrocytes seeded in these different scaffold materials. In 
addition to differences in total GAG content and distribution, FACE analysis revealed 
differences in CS/DS GAG fine structure among different scaffold materials.  Overall, the 
internal ∆-disaccharide profile of GAGs in alginate constructs least resembled that of 
native articular cartilage, whereas the profile in agarose constructs most closely 
resembled that of articular cartilage.  Striking differences were seen in the levels of 
unsulfated ∆Di-0S and disulfated ∆Di-4,6S between scaffold types, revealing a tradeoff 
between incorporation of unsulfated ∆Di-0S and disulfated ∆Di-4,6S into newly 
synthesized proteoglycans.  While differences were detected between scaffold 
environments, further investigation would be necessary to identify the causes of the 
observed differences in sulfation patterns (e.g., altered sulfotransferase activity, altered 
ratios of proteoglycan species, etc.).  This study illustrated the dependency of the 
metabolic behavior of BACs on scaffold environment.  Articular chondrocytes seeded 
into different scaffolds exhibited differences in proliferation, the quantity of matrix 
accumulated and the fine structure of the newly synthesized glycosaminoglycans.  
Specifically, BACs in agarose synthesized a disaccharide matrix most similar to that of 
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native articular cartilage, as well as accumulating a greater amount of sGAG compared to 
other scaffold types. 
The studies in Chapter 4 explored the influences of various ion-channel pathways 
on the response of BACs to dynamic and static compression.  The objectives of the 
studies were to investigate the dose-dependent inhibition of protein and sGAG synthesis 
by inhibitors of four different ion-channel signaling pathways in articular cartilage 
explants, the recovery of protein and sGAG synthesis by the four ion-channel inhibitors 
in articular cartilage explants and the response of chondrocytes seeded in agarose to 
dynamic compression when cultured with each of these inhibitors.  The ion-channel 
inhibitors examined were 4-Aminopyridine (4AP), a voltage-dependent K+ channel 
blocker, Nifedipine (Nf), an L-type voltage sensitive calcium channel blocker, 
Gadolinium (Gd), an inhibitor of cation-selective stretch-activated ion-channels, and 
Thapsigargin (Tg), a natural plant product which depletes the Ca2+ store in the 
sarcoplasmic and endoplasmic reticula by inhibiting  ATP-dependent Ca2+ pumps.  
Overall, treatment with the inhibitors more significantly affected sGAG synthesis 
suggesting that these ion-channels influence proteoglycan production or processing.  
Inhibition of Ca2+ channels by Nf affected protein synthesis, with little effect on sGAG 
synthesis, a unique response of the four inhibitors examined.  In contrast to the 
compression independent selective inhibition of protein synthesis by Nf, the upregulation 
of protein synthesis due to dynamic stimulation was unaffected, while the upregulation of 
sGAG synthesis was blocked.  A potential reason for the inhibition of mechanically-
stimulated upregulation of sGAG synthesis may be due to a critical role in the 
mechanoregulation of proteoglycan production by Ca2+ channel signaling.  Overall, the 
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studies presented in Chapter 4 suggest that different ion-channels play distinct, yet 
cooperative, roles to convert the same mechanical signals into different cellular 
responses, but that the roles of these ion channels in 3D are less distinct than in 2D 
culture experiments.  These studies led us to examine a more specific pathway, the TGF-
β signaling pathway. 
 The studies in Chapter 5 explored the influence of the TGF-β signaling pathway 
on the response of BACs to dynamic and static compression.  The effects of dynamic and 
static compressive loading on BAC gene expression and matrix synthesis in the presence 
of the TGF-β signaling inhibitor SB431542 were examined, as well as the dose and 
recovery response to the inhibitor.  SB431542 selectively inhibited protein synthesis over 
sGAG synthesis in BAC agarose constructs.  Synthesis returned to BASAL levels 2 days 
after removal from the inhibitor.  Dynamic compression has been documented to 
upregulate chondrocyte gene and matrix expression in 3D culture216-218.  The addition 
SB431542 abrogated stimulation of all genes and matrix syntheses stimulated by 
dynamic compression in the BASAL samples, with no significant effect on the statically 
compressed samples.  These findings suggest that TGF-β signaling may be integral in the 
mechanotransduction involved in the dynamic compression of BACs in 3D culture.     
 The studies in Chapter 6 investigated the influences of various culture parameters 
on the chondrogenic differentiation of bovine BMSCs.  It has been well established that 
the parameters of culturing progenitor cell populations affects the differentiation capacity 
of these cells201,202.  The studies investigated whether these factors such as passaging, 
seeding density, growth factor supplementation and scaffold can significantly impact 
BMSC differentiation.  In all studies, chondrogenesis was highest in the TGF-β1+DEX 
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groups.  While a dependency on passage number was not clear for all media conditions, 
passage 3 cells provided the highest level of chondrogenesis in the TGF-β1+DEX 
samples.  For the TGF-β1 groups (with and without dexamethasone), constructs seeded at 
25x106 cells/mL had the highest chondrogenic response.  Also, in general, the 
chondrogenic response of BMSCs was higher in agarose than in alginate.  These studies 
illustrated that these culturing factors can significantly impact BMSC differentiation and 
should be considered when developing cell-based therapies for cartilage repair, and led us 
to define specific conditions for use in subsequent studies involving the mechanical 
stimulation of BMSCs.   
 The studies in Chapter 7 explored the interaction between TGF-β supplementation 
and mechanical loading on the chondrogenic differentiation of bovine BMSCs.  It has 
been suggested that the combination of chondrogenic media and dynamic compressive 
loading may enhance chondrogenesis of BMSCs over the addition of exogenous factors 
alone79.  Similar to the previous chapter, TGF-β1 enhanced chondrogenesis over BASAL 
conditions, with the addition of dexamethasone further enhancing chondrogenesis.  There 
was a marked difference in the response of constructs to loading depending on the 
preculture duration.  After 8 days of preculture, there was no significant regulation of 
matrix synthesis rates and an inhibition of aggrecan gene expression with dynamic 
compression in the TGF-β1 and TGF-β1+DEX groups, but a stimulation in BASAL.  
After 16 days of preculture, dynamic compression upregulated both collagen I and 
collagen II gene expression in both TGF-β1 groups, with aggrecan expression only being 
upregulated in the TGF-β1+DEX group and no regulation of the BASAL groups.  
Complementing the gene expression data, protein synthesis was upregulated by dynamic 
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compression in both TGF-β1 groups, while proteoglycan expression was only 
upregulated in the TGF-β1+DEX group.  Interestingly, dynamic loading stimulated 
pSmad2/3 and TβR1 levels for both the BASAL and TGF-β1 groups, but not for the 
TGF-β1+DEX group, perhaps due to a saturation in TGF-β signaling with this media 
supplementation.  Long term dynamic loading between days 8 and 16 yielded an 
inhibition in sGAG accumulation in the TGF-β1 samples, compared to static controls.  
These results suggest that the response of BMSCs in agarose culture to dynamic loading 
is dependent on either cell differentiation state, matrix accumulation or a combination of 




 The work presented in this dissertation demonstrates that there are marked 
differences between the responses of BACs and bovine BMSCs to mechanical 
stimulation in 3D culture.  In theory, the BACs are a committed cell source, already 
expressing chondrogenic genes and proteins upon being released from their native 
environment and seeded into 3D agarose culture.  Upon seeding into agarose, the 
signaling pathways necessary for maintenance of the chondrocyte phenotype are 
functional in the presence of the FBS media.  Sox9, aggrecan and collagen II gene 
expression levels are high upon introduction into 3D culture187,219.  Conversely, the 
BMSCs are a progenitor cell source, with the ability to differentiate into multiple cells 
types (multilineage potential was not examined within the scope of this work)220.  Upon 
seeding into 3D culture and introduction of TGF-β1, the cells experience a shift in 
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cellular activity, moving from a proliferative state to a differentiating state185,221.  TGF-β1 
upregulates Sox9, considered the first master chondrogenic factor.  Upon Sox9 
upregulation, a complex series of largely unknown downstream events work in concert to 
shift the progenitor cell phenotype towards that of a differentiated chondrocte220.   
Distinct differences between BACs and BMSCs in their gene and phenotypic 
expression over time were found.  Mauck et al. found that the amount of sGAG and the 
equilibrium modulus of BMSCs seeded into agarose and cultured for 10 weeks were 
lower than those of BACs from the same animal donor190.  In the BMSC samples, both 
sGAG content and equilibrium modulus were found to plateau with time in the BMSC 
constructs, suggesting that diminished capacity is not the result of delayed differentiation.  
While this dissertation did not focus on a direct comparison between the matrices 
produced by both cells types, it is possible that there are structural differences in the 
matrices as well as overall accumulation amounts.   
The extent of an ECM has been shown to influence chondrocyte deformation in 
3D agarose culture.  Knight et al. have demonstrated that the stiffness of isolated 
chondrons (chondrocytes with attached pericellular matrix intact) seeded into agarose is 
higher than that of the surrounding extracellular agarose environment, leading to stress 
shielding of the chondrocytes during loading214.  The possibility exists that the level of 
cellular deformation between the two cell types, and even within the BMSC population 
cultured in different media formulations, is different at a given time and a given 
differentiation state.  Safranin O staining of BMSCs in agarose showed the beginning of a 
more interconnected endogenously produced ECM only after 16 days of culture in the 
TGF-β1+DEX group (Figure 6.13).  At day 16, the constructs treated with TGF-β1 only 
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resembled more similarly the TGF-β1+DEX day 8 samples.  Irrespective of 
differentiation state, the degree of mechanostimulation will be affected by these varying 
amounts of accumulated matrix49,214,222.  Interpretation of the effects of dynamic 
compression between the different media conditions must be kept in perspective realizing 
that the local mechanical environments may be different. 
 The addition of dexamethasone to the chondrogenic media greatly influenced both 
the gene expression and matrix synthesis of the differentiating BMSCs.  Glucocorticoids, 
including dexamethasone, affect gene expression by transcriptional and 
posttranscriptional mechanisms by binding to specific receptors that belong to the 
superfamily of nuclear receptors (classical mechanism).  The glucocorticoid/receptor 
complex acts as a ligand-dependent transcriptional factor to either activate or repress the 
transcription of certain genes223,224.   Dexamethasone is a glucocorticoid that is typically 
added to both chondrogenic and osteogenic cultures to stimulate the osteochondral 
phenotype225,226.  Dexamethasone has been found to upregulate cFOS mRNA expression 
in osteoblasts through a mechanism involving binding to a soluble glucocorticoid 
receptor intracellularly and interacting with cFOS mRNA227.  Locker et al. found that 
dexamethasone induced Sox9 upregulation in the pluripotent mesoblastic C1 line228.  
While the mechanisms of dexamethasone in the chondrogenic studies presented in this 
dissertation are unknown, positive regulation though Smad2/3 or Sox9, as well as 
negative regulation of the inhibitory Smads and SMURFs, are possibilities.   
Complimentary to our findings, Huang et al. found that cyclic compressive 
loading promoted gene expressions of Sox9, c-Jun, and both TGF-beta receptors and 
productions of their corresponding proteins in rabbit BMSCs in 3D agarose culture176.  
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TβRI has been shown to cause receptor-activated Smad2/3 phosphorylation at the C-
terminal SSXS motif, causing dissociation from the receptor and association with the 
common mediator Smad4172,229,230.  Upon heteromeric complex formation, translocation 
to the nucleus occurs leading to interaction with various DNA-binding co-factors and co-
modulators to activate transcription.  The study presented in Chapter 5 demonstrated that 
there is an interaction, or a series of interactions, between TGF-β signaling and dynamic 
compression in BACs cultured in agarose.  The study presented in Chapter 7 illustrated 
an increase in TβRI protein expression in BMSCs treated with TGF-β1, as well as an 
upregulation by dynamic compression in both BASAL and TGF-β1 samples.  The 
suggestion of an interaction in both cell systems has been substantiated.  While 
speculative, there are multiple potential regulatory mechanisms through which TGF-β1 
signaling and mechanical stimulation interact.  The mechanisms fall into one of two 
categories:  the influence on mechanotransduction by the TGF-β signaling pathway or the 
influence on TGF-β signaling by mechanical stimulation. 
 The first category of potential mechanisms involves the potential modulation of 
mechanotransduction by the TGF-β signaling pathway, either directly or indirectly.  
TGF-β and its signaling pathway may be increasing the sensitivity of the BACs and 
BMSCs to loading.  TGF-β signaling may lead to pSmad activation of mechanosensitive 
proteins, such as focal adhesion kinase (FAK) and paxillin, which might therefore 
increase the mechanosensitivity of the cells181-183.  Another potential mechanism involves 
the interaction of Smad2/3, in combination with Smad4, with Sox9.  In differentiating 
cells, TGF-β1 and TGF-β3 have been shown to upregulate Sox9 gene expression.  This 
upregulation of Sox9 expression is indicative of chondrogenesis in MPC populations.  
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Sox9 has been shown to bind to the promoter region of type II collagen, enhancing 
transcription and collagen II mRNA expression.  Smad3 has been found to enhance the 
transcriptional activity of Sox9 and the expression of the α1 (II) collagen (COL2A1) gene 
by forming a transcriptional complex with Sox9 and binding to the promoter region of 
COL2A1186.  While Sox9 levels parallel COL2A1 in differentiating cells, Aigner et al. 
found no positive correlation between Sox9 and COL2A1 expression levels in adult 
articular chondrocytes187.  Possibly, dynamic compression may upregulate chondrocytic 
gene expression and production through mechanisms similar to those utilized in cells 
undergoing chondrogenic differentiation including upregulation of Sox9 levels.  If this 
was the case, inhibiting TGF-β signaling during mechanical stimulation would be 
analogous to depriving a differentiating cell of the growth factor. 
The second category of potential mechanisms involves the modulation of the 
TGF-β signaling pathway by mechanical stimulation.  One direct mechanism may 
involve the stimulation of TGF-β production by mechanical stimulation.  Also, 
mechanical stimulation may upregulate the production of proteolytic moieties such as 
plasmin and stromelysin-1, leading to the activation of latent TGF-β1, either 
endogenously produced (both BACs and BMSCs) or introduced into the culture system in 
the FBS (BACs only)179,180,231.  Both chondrocytes and BMSCs have been found to 
affected by TGF-β concentrations in the media77,184,185.  Also, in either cell system, 
stimulation of TβR1 is one potential mechanism for the modulation of dynamic loading 
via TGF-β signaling.  An increase in the available supply of TβR1 could potentially lead 
to a greater level of Smad2/3 activation, amplifying the signaling occurring as a result of 
TGF-β1 exogenous stimulation.  Another possible mechanism for regulation of 
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chondrogenesis by mechanical stimulation is an increase in the phosphorylation of the 
Smad2/3 proteins and/or its translocation to the nucleus via alterations in the intracellular 
space, either separating or bringing together certain proteins and molecules.   
The studies in chapters 4, 5 and 7 demonstrated that the upregulation of protein 
expression and proteoglycan expression by dynamic compression in chondrocytes and 
chondroprogenitors do not necessarily parallel one another.  The study presented in 
chapter 4 showed that there were differences in the effects of perturbing various ion-
channels on protein and proteoglycan expression in BACs.  Specifically, inhibiting L-
type voltage Ca2+ signaling (with Nf) differentially inhibited protein synthesis over 
proteoglycan synthesis; conversely, inhibition of voltage-dependent K+ signaling (with 
4AP) inhibited sGAG synthesis over protein synthesis.  In chapter 5, collagen II gene 
expression in BACs was found to be modulated by 3 hours of dynamic compression, 
whereas aggrecan gene expression was not.  Both protein and  sGAG syntheses were 
upregulated with 20 hours of dynamic compression, with both upregulations being 
abrogated by the addition of the TGF-β signaling antagonist, SB431542.  The study 
presented in chapter 7 demonstrated that the BMSCs response to dynamic compression 
was dependent on preculture duration and media supplementation.  Dynamic 
compression of BMSCs cultured with both TGF-β1 and dexamethasone upregulated only 
collagen II gene expression and protein synthesis after 8 days of preculture.  After 16 
days of preculture, both protein and proteoglycan expressions were upregulated by 
dynamic compression in BMSCs cultured in the same media.  Taken together, these data 
suggest that the upregulation of protein and proteoglycan synthesis is independent, with 
some overlap. 
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The upregulation of TβRI gene expression in BACs with dynamic compression 
and TβRI protein expression in BMSCs by dynamic compression suggests that the 
intersection of TGF-β signaling and dynamic compression may occur at the TGF-β 
receptor level.  This is consistent with observations in the literature that dynamic 
compression increases expression of (both receptors?) by rabbit BMSCs.(cite recent 
Huang paper—in press?)  If dynamic compression increases TβRI protein expression 
independent of the TGF-β signaling pathway, this could lead to an increase in TGF-β 
ligand binding and thus upregulation of subsequent TGF-β signaling through Smad 
phosphorylation.  However, other results are inconsistent with this model.  Specifically, 
introduction of the TGF-β signaling inhibitor SB431542 not only blocked the increases in 
matrix genes by dynamic compression but also blocked the increase in TβRI gene 
expression, indicating that receptor regulation is not independent of TGF-β signaling.  
Therefore, it appears likely that the upregulation of TβRI gene expression in 
chondrocytes and TβRI protein expression in BMSCs depended on an increase in TGF-β 
signaling.  Simply put, an upregulation of TβRI availability is not what is being initially 
modulated by dynamic compression.  An alternative hypothesis that has not yet been 
explored is that the mechanism of regulation occurs intracellularly, through an 
upregulation of the accessory TGF-β receptor, betaglycan (TGF-β receptor III). 
Betaglycan is a transmembrane glycoprotein with large extracellular regions that 
bind TGF-β and very similar cytoplasmic regions without any identifiable signaling 
motif232.  The extracellular portion of betaglycan contains both heparin sulfate and 
chondroitin sulfate chains and binds to TGF-β via its core protein233.  One of the known 
functional roles of betaglycan is as a positive regulator of TGF-β signaling.  Betaglycan 
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increases the affinity of the binding of TGF-β ligands to the TGF-β type II receptor 
(TβRII), enhancing the cell’s responsiveness to TGF-β234.  Lopez-Casillas et al. found 
that this effect appears to be mediated by a “presentation complex” formed by 
betaglycan, TGF-β and TβRII232,234.  In contrast to the membrane bound form of 
betaglycan, soluble betaglycan has been shown to have a negative regulatory effect on 
TGF-β ligand binding to TβRII through competitive inhibition, thus downregulating 
TGF-β signaling235.  Betaglycan has been found to be transcriptionally upregulated 
during skeletal muscle differentiation236, as well being involved in the deregulation of 
activin signaling during cancer metastasis237.     
Mechanical loading could thus increase chondrocyte and chondroprogenitor 
sensitivity to TGF-β by upregulating betaglycan transmembrane expression and 
downregulating soluble betaglycan, possibly through the p38-MAPK pathways which 
have been shown to regulate proteoglycan expression77.  Through an increase in the 
availability of betaglycan on the cell surface and a decrease in the soluble betaglycan 
competing for the TGF-β ligand, there would be an increase in TGF-β ligand binding to 
TβRII and subsequent TβRI – TβRII - ligand complex formation.  The increase in TβRI – 
TβRII - ligand complex would lead to an upregulation of Smad2 and Smad3 
phosphorylation, Smad2/3-Smad4 complex formation and localization to the nucleus, and 
ultimately enhanced gene transcription. 
These studies have illustrated a potential connection between dynamic 
compression and TGF-β signaling in both chondrocytes and chondroprogenitors.  
Understanding the relationship between mechanical loading and TGF-β signaling may 
provide potential targets for manipulating cell differentiation, as well as for treating 
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diseased and injured cartilage.  To this end, these findings are important for 
understanding in vitro development of 3D scaffolds for cartilage regeneration.  It has 
been hypothesized that the loading environment in the knee is too harsh to allow an 
immature construct lacking mechanical integrity to survive and develop into a tissue 
capable of successful load bearing8.  Facilitating a tissue-engineered construct capable of 
functioning successfully in vivo will involve matching mechanical and biochemical 
properties of native cartilage as closely as possible.   
Clearly TGF-β is important for articular chondrocytes and BMSCs, but only one 
of many growth factor mediated signaling pathway that regulate articular chondrocyte 
metabolism.  These studies establish a paradigm for exploring interactions between 
mechanical stimulation and a specific growth factor mediated signaling pathway.  While 
in vitro mechanical stimulation may end up improving both the mechanical and 
biochemical properties of constructs, it may not prove to be practical or even feasible for 
purposes other than scientific investigation.  Understanding the pathways through which 
mechanotransduction occurs offers the possibility of regulating these mechanisms 
biochemically, as opposed to biomechanically.    
 
 
8.3 RECOMMENDATIONS AND FUTURE WORK 
 The work presented in this dissertation has added to the current body of 
knowledge on articular chondrocytes, progenitor cells, growth factor supplementation 
and mechanical stimulation.  Coupled with extensive literature on articular cartilage and 
mechanical stimulation, these studies begin to aid in creating a foundation for 
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understanding the transduction of mechanical stimuli.  These studies establish another 
potential mechanism for mechanotransduction in 3D culture, signaling through 
interaction with the TGF-β pathway.    
 The study presented in chapter 3 investigating the differences in the ECM 
produced by chondrocytes in different tissue engineering scaffold demonstrated that there 
were differences in both the total amount of sGAG accumulated, as well as in the 
composition of the GAG matrix.  While the functional implications of altered ∆-
disaccharide sulfation patterns in native or engineered cartilage are unknown, there is 
evidence of structure-function relationships in other tissues and with other sulfated 
GAGs.   Variations in the sulfation of GAGs has been shown to alter the binding of 
nutrients, chemokines and growth factors, thereby influencing cell migration, 
differentiation, and matrix production144-146.   
While the use of the inhibitor SB431542 proved useful in determining whether 
there may be an interaction between TGF-β signaling and dynamic compression, in 
general, the use of chemical inhibitors is best utilized in concert with other means of 
discerning signaling through a particular pathway.  External ligand agonists, 
constitutively active and dominant negative forms of proteins are commonly employed to 
investigate particular signaling pathways.  When you perturb a system to attempt to 
understand it, you run the risk of biasing the system.  For this reason it is important to 
address a question from multiple directions.  Using the already well established paradigm 
for TGF-β signaling through Smad phosphorylation and translocation, different point in 
this signaling path need to be perturbed to yield a better understanding the interaction (or 
interactions) between mechanotransduction and TGF-β signaling.  The use of external 
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ligand agonists and constitutively active TβRI would help elucidate the influences from 
growth factor shedding, growth factor activation and upregulation and activation of TβRI.  
Protein zymography could also be used to look at the regulation of matrix enzymes by 
either loading or TGF-β supplementation, addressing the role of TGF-β activation in the 
interaction between mechanotransduction and TGF-β signaling.  Use of both dominant 
negative mutations of Smad2/Smad3, as well as constitutively phosphorylated 
Smad2/Smad3, in the presence of mechanical stimulation may help understand the role of 
these proteins in mechanical stimulation.  Blocking TGF-β signaling external to the cell 
through the use of ligand agonists would address whether mechanical stimulation affects 
TGF-β signaling by modulating the activation of latent forms of TGF-β though an 
upregulation of proteolytic factors.   
 Without the use of additional sophisticated biochemical techniques, a more 
thorough examination of target protein expression would be useful in investigating at 
which aspects of TGF-β signaling are regulated by mechanical stimulation in both BACs 
and BMSCs.  In the study presented in the dissertation, mechanical loading influenced 
total Smad2/3, pSmad2/3 and TβRI protein and gene expression levels.  A more 
exhaustive study looking at these signaling moieties in combination with better 
characterizing the structural properties of the ECM would provide better insight into the 
interaction between TGF-β1 signaling and mechanical loading.  As previously discussed, 
the level of ECM directly affects the deformation of cells encapsulated by hydrogel 
scaffolding. 
While somewhat speculative, the potential role of betaglycan in the anabolic 
stimulation of dynamic compression would be interesting to explore.  Either an increase 
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in betaglycan at the cell membrane or a decrease in soluble betaglycan could lead to 
increased TGF-β signaling, and preliminary studies to examine both aspects would be 
fairly straightforward.  Levels of soluble betaglycan could be examined through Western 
blotting for the protein, as well as its fragments, in the media from BAC agarose gels 
subjected to either dynamic compression, static compression or unloaded in the presence 
and absence of TGF-β inhibition with SB431542.  A downregulation in soluble 
betaglycan and betaglycan fragments with dynamic compression in both the presence and 
absence of the inhibitor would support the hypothesis that TGF-β signaling is modulated 
by a downregulation in soluble, competitive betaglycan.  Additionally, the betaglycan 
(glycosylated protein ~250kDa, core protein ~120kDa) associated with the BAC agarose 
constructs should be Western blotted after rinsing the excess soluble betaglycan out of 
the construct.  To more sensitively address the rate of betaglycan synthesis, the culture 
media could be supplemented with 35S-sulfate (which would be incorporated into newly 
synthesized betaglycan).  The newly synthesized betalycan could then be 
immunoprecipitated from conditioned culture media, and the IPed protein could be 
assessed via scintillation counting to determine the 35S-sulfate incorporation.  To 
complement the protein expression data, the betaglycan mRNA expression could be 
analyzed with real-time RT PCR to determine the effect of loading on betaglycan gene 
expression.  If transmembrane betaglycan expression is upregulated by dynamic 
compression in both the presence and absence of the TGF-β inhibitor, it is likely that the 
regulation of the transmembrane proteoglycan is occurring independent of the Smad 
signaling pathway.  While these assaying techniques are fairly simple, they would be 
largely indicative of whether betaglycan is participating in the interaction between TGF-β 
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signaling and dynamic compression in BACs.  If such a role were substantiated, further 
studies would need to be performed to elucidate the connection between dynamic 
compression and betaglycan upregulation. 
These current findings also have broader implications for the targeting of 
therapeutics.  Stimulation of matrix synthesis by either biomechanical or biochemical 
stimulus has been shown to depend on the matrix environment as well as the cell type.  
Future intervention suggested by the seemingly inherent susceptibility of articular 
cartilage to osteoarthritic degradation may focus on early treatment of the cartilage to 
delay the onset of degradation.  However, it is important to recognize the need for a 
thorough investigation of the potential effects of biochemical or biomechanical 
treatments.  The current studies have shown differential effects of physiologically 
relevant stimuli on cells from different tissues, with differential effects.  Therefore, 
consideration of the effects of a specific treatment on the target tissue as well as 
neighboring tissues will be necessary to ensure net positive effects on the overall health 




APPENDIX A MATERIALS AND REAGENTS 
 
 
Product  Vendor  Location  
Collagen I Antibody  Abcam  Cambridge, MA  
Collagen II Antibody  Abcam  Cambridge, MA  
PGA felts Albany International Mansfield, MA 
e-aminocaproic acid  Acros Organics Fairlawn, NJ  
L-5-
3
H-proline  American Radiolabeled 
Chemicals  
St. Louis, MO  
SYBR Green Master Mix  Applied Biosystems  Foster City, CA  
Glass Electrophoresis Plates  Bio-Rad  Hercules, CA  
Dissacharide standards Calbiochem La Jolla, CA 
Chondroitinase ABC Calbiochem La Jolla, CA 
Chondroitinase AC Calbiochem La Jolla, CA 
Hyaluronidase Calbiochem La Jolla, CA 
4-Aminopyridine Calbiochem La Jolla, CA 
Nifedipine Calbiochem La Jolla, CA 
Thapsigargin Calbiochem La Jolla, CA 
Protease Inhibitor Cocktail Set I Calbiochem La Jolla, CA 
Rat-tail collagen I Collaborative Biomed Bedford, MA 
T-75 Flasks  Corning  Corning, NY  
0.22 mm Polyethersulfone Filter  Corning  Corning, NY  
EDAS 120 Imaging System Eastman Kodak New Haven, CT 
Proteinase K  EMD Chemicals  Gibbstown, NJ  
b-Mercaptoethanol  EMD Chemicals  Gibbstown, NJ  
24-well Plates  Falcon  Franklin Lakes, 
CA  
48-well Plates  Falcon  Franklin Lakes, 
CA  
Triton X-100  Fisher Scientific  Pittsburg, PA  
Sodium Dodecyl Sulfate  Fisher Scientific  Pittsburg, PA  
   
Mono gels and running buffer Glyko Novato, CA 
Fetal Bovine Serum  Hyclone  Logan, UT  
Bovine Fibrinogen  ICN Biomedical  Irvine, CA  
Thrombin  ICN Biomedical  Irvine, CA  
Ecolume  ICN Biomedical  Irvine, CA  
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High Glucose Dulbecco's Modified 
Eagle's Medium  
Invitrogen  Carlsbad, CA  
HEPES Buffer  Invitrogen  Carlsbad, CA  
AP-conj anti-Biotin Invitrogen  Carlsbad, CA  
Non-essential Amino Acids  Invitrogen  Carlsbad, CA  
Gentamicin  Invitrogen  Carlsbad, CA  
Fungizone (Amphotericin B)  Invitrogen  Carlsbad, CA  
Phosphate Buffered Saline  Invitrogen  Carlsbad, CA  
Collagenase Type II  Invitrogen  Carlsbad, CA  
Trypsin  Invitrogen  Carlsbad, CA  
Antibiotic/Antimycotic Invitrogen  Carlsbad, CA  
Forward and Reverse Primers  Invitrogen  Carlsbad, CA  
Biotin SP-conj anti-Rb IgG Jackson Immuno  
Polysulfone  JM Machining  Lawrenceville, 
GA  
p-DAB  JT Baker  Phillipsburg, NJ  
Chloramine T  Mallinckrodt  Paris, KY  
Red FDA Rubber  McMaster Carr  Atlanta, GA  
Microcon YM-30 Millipore  
4 mm Biopsy Punch  Miltex  York, PA  
6 mm Biopsy Punch  Miltex  York, PA  
LIVE/DEAD® Assay Kit Molecular Probes  Eugene, OR  
Labeled Goat a-Rabbit IgG Antibody  Molecular Probes  Eugene, OR  
Labeled Goat a-Mouse IgG Antibody  Molecular Probes  Eugene, OR  
Phalloidin  Molecular Probes  Eugene, OR  
2-Aminoacridone HCl Molecular Probes  Eugene, OR  
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S-sodium sulfate  MP Biomedicals  Irvine, CA  
rh bFGF  PeproTech  Rocky Hill, NJ  
rh IGF-I  PeproTech  Rocky Hill, NJ  
rh PDGF-AB  PeproTech  Rocky Hill, NJ  
rh TGF-b1  PeproTech  Rocky Hill, NJ  
Promega Reverse Transcription Kit  Promega  Madison, WI  
Alginic acid Pronova Oslo, Norway 
Qiagen Rneasy Mini Kit  Qiagen  Valencia, CA  
Qiagen Qiashredders  Qiagen  Valencia, CA  
Calf Stifle Joints  Research 87  Marlborough, 
MA  
TWEEN-20 Sigma  St. Louis, MO  
Gadolinium Sigma  St. Louis, MO  
L-proline  Sigma  St. Louis, MO  
L-ascorbic acid  Sigma  St. Louis, MO  
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Bovine Serum Albumin  Sigma  St. Louis, MO  
Agarose  Sigma  St. Louis, MO  
Ammonium Acetate  Sigma  St. Louis, MO  
Agarase  Sigma  St. Louis, MO  
1,9-Dimethylmethlyene Blue  Sigma  St. Louis, MO  
Hoechst 33258 Dye  Sigma  St. Louis, MO  
Chondroitin Sulfate  Sigma  St. Louis, MO  
Calf Thymus DNA  Sigma  St. Louis, MO  
Hydroxyproline  Sigma  St. Louis, MO  
Goat Serum  Sigma  St. Louis, MO  
Rabbit Serum  Sigma  St. Louis, MO  
Safranin O Sigma  St. Louis, MO  
Tris Base Sigma  St. Louis, MO  
Glycine Sigma  St. Louis, MO  
Sodium Chloride Sigma  St. Louis, MO  
Sodium Fluoride Sigma  St. Louis, MO  
Sodium Orthovanadate Sigma  St. Louis, MO  
Sodium Cyanoborohydride Sigma  St. Louis, MO  
SB431542 Tocris  
No. 12 Razor Blades  VWR Scientific  West Chester, PA 
#22 Scalpel Blade  VWR Scientific  West Chester, PA 
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APPENDIX B TISSUE CULTURE METHODS 
 
 
B.1 ARTICULAR CHONDROCYTES IN GEL CULTURE 
Bovine articular chondrocytes were isolated from the stifle joints of immature (<5 
weeks) donor animals.  Tissue was excised from the patellofemoral grooves, minced and 
digested in DMEM with 0.2% collagenase for 24 h in a 37°C, 5% CO2 incubator.  After 
centrifugation at 160 x g, cells were washed twice with Ca2+, Mg2+ -free PBS and counted 
with either a Coulter counter or a Vi-Cell Cell Viability Analyzer.  Cells were seeded into 
a hydrogel or on polyglycolic acid (PGA) felts. 
Media were changed every two days.  After culture period, the constructs were 
weighed, lyophilized, reweighed, and digested in 1ml of 100mM ammonium acetate 
buffer with 250 µg/mL Proteinase K at 60°C for 24 hours.  Portions of each digest were 
assayed for total DNA using the Hoechst 33258 assay with calf thymus DNA as a 
standard and sGAG using the DMMB assay with shark cartilage CS as a standard. 
 
B.2 BONE MARROW STROMAL CELLS ISOLATION AND PASSAGING 
BMSCs were isolated from both the femoral and tibial diaphyses of 2-4 week old 
calves obtained within 24 hours of slaughter.  After removal of all fascia and muscle from 
the bones, the bones were cut at the mid-diaphysis with a sterile bone saw.  Marrow was 
removed from the medullary canal and transferred to a 50ml conical with sterile PBS plus 
1% antibiotic/antimycotic (A/A; 100U/mL penicillin, 100ug/mL streptomycin, 250 
ng/mL Amphotericin).  Marrow was sequentially passed through large bore (25mL) and 
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small bore (5mL) pipets to disrupt large pieces.  Marrow was then sequentially passed 
through 16- and 18-gauge needles for further homogenization.  Marrow suspension was 
centrifuged at 300 x g for 15 minutes.  The separated fatty layer was removed and 
discarded.  The cell pellet was resuspended in Ca2+, Mg2+ -free PBS, passed through a 20-
gauge needle and filtered through a 100µm nylon filter.  Mononuclear cells were counted 
using a hemacytometer using the Trypan Blue exclusion method after lysing red blood 
cells with the addition of 4% acetic acid. 
Cells were plated in T-flasks at 5 x 103 mononuclear cells per cm2 in passaging 
medium (consisting of low glucose DMEM, 10% FBS, 1% A/A, 1ng/mL bFGF).  
Nonadherent cells were removed during media change three days later.  Medium was 
changes every three days thereafter.  Cells were cultured until confluent (~ 2 weeks, P1), 
detached with 0.05% trypsin/1mM EDTA, and replated at 5 x 103 cells per cm2.  Cells 
were cultured until confluence and either replated or seeded into either 2% alginate gels 
or 3% agarose.  Media were changed every two days.  After 20 and 40 days, constructs 
were weighed, lyophilized, reweighed, and digested in 1ml of 100mM ammonium acetate 
buffer with 250 µg/mL Proteinase K at 60°C for 24 hours.   
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B.3 TISSUE ENGINEERING SCAFFOLDS AND MEDIA 
Specific Aim 1 
Agarose constructs were assembled by autoclaving 3% LMP agarose in 1X Ca2+, 
Mg2+ -free PBS and then cooling the solution to 42°C.  An equal volume of cells 
suspended at 30 x106 cells/mL in 2X DMEM and 20% FBS was added, and the solution 
was cooled in custom molds.  Alginate constructs were similarly assembled by 
autoclaving 1.5% alginic acid in 1X Ca2+, Mg2+ -free PBS to solubilize and sterilize the 
alginate, cooling the solution to 37°C, adding 30x106 cells/mL in Ca2+, Mg2+ -free PBS 
and polymerizing the gels in the molds with 102 mM CaCl2.  Collagen constructs were 
assembled by suspending 15x106 cell/mL in a solution containing 10% FBS, 0.5x DMEM 
and 2 mg/mL acid solubilized rat tail collagen type I and  titrating the solution to neutral 
pH with 0.1M NaOH.  Constructs were allowed to polymerize in a 37°C, 5% CO2 
incubator for 30 minutes before transfer to 24 well plates with 2ml of media.  Fibrin 
constructs were assembled by suspending cells in a solution of bovine fibrinogen, FBS, 
aminocaproic acid (ACA), and DMEM.  Bovine thrombin was dissolved in 40 mM 
CaCl2, and 100 µl of the thrombin solution was placed into each well of a polycarbonate 
mold (12 mm diameter by 3 mm deep), followed by 200 µl of the cell/fibrinogen mixture.  
Final concentrations in the constructs were 50 mg/mL fibrinogen, 50 U/mL thrombin, 
10% FBS, 2 mg/mL ACA, and 15x106 cells/mL.  Constructs were allowed to polymerize 
in a 37°C, 5% CO2 incubator for 30 min and then removed from the molds and 
transferred to 24-well culture dishes containing 2 mL of culture medium (described 
below).  PGA felts (45 mg/cm3 polymer density; 12-15 µm fiber thickness; 10 mm 
diameter by 2 mm thickness) were prewetted overnight in high-glucose DMEM 
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containing 10% FBS.  PGA felts were then seeded by repeatedly pipetting 1 mL of cell 
suspension (1.2x106 cells/mL) onto each felt and culturing on a shaker plate at 300 rpm 
for 24 hours.  The felts were then transferred to 2 mL each of culture medium in culture 
dish wells that had been pre-coated with a thin layer of 1% agarose.   
Constructs and native cartilage samples (n=8 per group per endpoint) were 
cultured in 24 well plates with 2 mL of DMEM containing 10% FBS, 0.1mM NEAA, 
4mM L-glutamine, 5 µg/mL gentamicin sulfate and 50 µg/mL ascorbic acid.  As in 
previous studies on dorsal root ganglia, smooth muscle cells and chondrocytes, 
aminocaproic acid (2 mg/mL) was added to the media of fibrin constructs to inhibit 
proteolytic degradation.   
 
Specific Aim 2 
Agarose constructs were assembled by autoclaving 4% LMP agarose in 1X Ca2+, 
Mg2+ -free PBS and then cooling the solution to 42°C, for a final agarose concentration of 
2%.  An equal volume of BAC cells were suspended at 20x106 cells/mL in 1X Ca2+, 
Mg2+ -free PBS, and the solution was cooled in custom molds.   
Constructs were cultured in 24 well plates with 2 mL of DMEM containing 10% 
FBS, 0.1mM NEAA, 4mM L-glutamine, 5 µg/mL gentamicin sulfate and 50 µg/mL 
ascorbic acid.  Inhibitors were added as specified in chapter 4. 
 
Specific Aim 3 
Agarose constructs were assembled by autoclaving 3% LMP agarose in 1X Ca2+, 
Mg2+ -free PBS, cooling the solution to 42°C, and suspending the BAC cell pellet in the 
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appropriate volume yielding 20x106 cells per mL of agarose.  Agarose constructs were 
cast in 3mm thick sheets between two electrophoresis plates and punched to a 4mm 
diameter using biopsy punches. 
Constructs were cultured in 24 well plates with 2 mL of DMEM containing 10% 
FBS, 0.1mM NEAA, 4mM L-glutamine, 5 µg/mL gentamicin sulfate and 50 µg/mL 
ascorbic acid.  The inhibitor SB431542 was added as specified in chapter 5. 
 
Specific Aim 4 
 Alginate constructs were assembled by autoclaving 2% LVG Pronova Alginate in 
Ca2+, Mg2+-free PBS and then cooling the solution to 37°C.  Cells were pelleted down 
and resuspended in the alginate solution.  The cell solution was polymerized using 
100mM CaCl2 solution in 11mm diameter by 3mm thick constructs.  Once polymerized, 
the constructs were washed in PBS to remove any excess CaCl2 solution before being 
moved to media. 
Gels were cultured in 24 well plates containing basal media consisting of high 
glucose DMEM plus antibiotic/antimycotic, non-essential amino acids, 1% ITS+ Premix, 
50µg/mL ascorbate and 0.4mM proline (BASAL), basal media plus 10ng/mL TGF-β1 
(TGF-β1), or basal media plus 10ng/mL TGF-β1 and 100nM dexamethasone (TGF-
β1+DEX).  Media were changed every two days. 
For the passaging study, BMSCs were expanded in monolayer for 2, 3 and 4 
passages (P2, P3, P4 respectively).  After each passage, cells were seeded at 25x106 
cells/mL and cultured in BASAL, TGF-β1or TGF-β1+DEX medium for 7 days.  For the 
seeding density study, passage 3 BMSC consructs were seeded at three concentrations:  
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12.5x106 (LOW), 25x106 (MED) and 50x106 (HIGH) cells/mL.  Gels were cultured in 
BASAL, TGF-β1or TGF-β1+DEX medium for 10 days.  For the time course study, 
passage 3 BMSC gels were seeded at 25x106 cells/mL and cultured in BASAL or TGF-
β1+DEX medium for 2, 4, 7 and 14 days.   
 
Specific Aims 5 
Agarose constructs were assembled by autoclaving 3% LMP agarose in 1X Ca2+, 
Mg2+ -free PBS, cooling the solution to 42°C, and suspending the BMSC cell pellet in the 
appropriate volume yielding 20x106 cells per mL of agarose.  Agarose constructs were 
cast in 3mm thick sheets between two electrophoresis plates and punched to a 6mm 
diameter using biopsy punches. 
 Constructs were cultured in 24 well plates containing basal media consisting of 
high glucose DMEM plus antibiotic/antimycotic, non-essential amino acids, 1% ITS+ 
Premix, 50µg/mL ascorbate and 0.4mM proline (BASAL), basal media plus 10ng/mL 
TGF-β1 (TGF-β1), or basal media plus 10ng/mL TGF-β1 and 100nM dexamethasone 
(TGF-β1+DEX).  Media were changed every two days.   
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Glycosaminoglycan preparation from gels, tissues and proteoglycans 
 
1. Proteinase K (>20 Units/mg) 
2. 100 mM ammonium acetate, pH 7.0, freshly prepared 
3. Absolute ethanol, pre-cooled to –20°C 
4. Microcon Centrifugal Filter Devices (YM-3) [Amicon] 
5. Tabletop micro-centrifuge 
 
Glycosaminoglycan lyase digestion  
 
a.    Looking at chondroitin sulfate disaccharides: 
1. Chondroitinase ABC (Proteus vulgaris) [Calbiochem 230681], dissolved in tissue 
culture water at 1.5 units/mL (or comparable) and stored in 100 µl aliquots at –
80°C for up to 3 months 
2. Chondroitinase AC II (Arthrobacter aurenscens) [Calbiochem 230683], dissolved 
in tissue culture water at 1.5 units/mL (or comparable) and stored in 100 µl 
aliquots at –80°C for up to 3 months 
3. Hyaluronidase (Streptomyces hyaluronlyticus) [Calbiochem 389561], dissolved in 
tissue culture water at 20 units/mL (or comparable) and stored in 100 µl aliquots 
at –80°C for up to 3 months 
4. 50 mM ammonium acetate, pH 7.0, freshly prepared 
5. Micro-centrifuge tubes (1 mL capacity) 
 
b.    Looking at keratan sulfate disaccharides: 
1. Keratanase (Pseudomonas) [Calbiochem 422402], dissolved in tissue culture 
water at 5 units/mL (or comparable) and stored in 100 µl aliquots at –80°C 
2. Hyaluronidase (Streptomyces hyaluronlyticus) [Calbiochem 389561], dissolved in 
tissue culture water at 20 units/mL (or comparable) and stored in 100 µl aliquots 
at –80°C for up to 3 months 
3. 50 mM ammonium acetate, pH 7.0, freshly prepared 
4. Micro-centrifuge tubes (1 mL capacity) 
 
c.    Looking at dermatan sulfate disaccharides: 
1. Chondroitinase B (Flavobacterium heparinum) [Calbiochem 230684], dissolved 
in tissue culture water at   5 units/mL (or comparable) and stored in 100 µl 
aliquots at –80°C 
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2. Hyaluronidase (Streptomyces hyaluronlyticus) [Calbiochem 389561], dissolved in 
tissue culture water at 20 units/mL (or comparable) and stored in 100 µl aliquots 
at –80°C for up to 3 months. 
3. 50 mM ammonium acetate, pH 7.0, freshly prepared 
4. Micro-centrifuge tubes (1 mL capacity) 
 
Fluorescent labeling of lyase digestion products 
 
1. 2-aminoacridone (AMAC) [Molecular Probes Inc.] 
2. Dimethylsulfoxide (DMSO) (99.7%) 
3. Acetic Acid (ACS grade, absolute) 
4. Sodium cyanoborohydride (95%) [Sigma Chemical Co] 
5. Oven or heating block at 37°C 
 
FACETM gel electrophoresis of fluorotagged lyase digestion products 
 
1. MonoTM composition gel cassettes [Glyko, Inc.], stored at 4°C until use 
2. MonoTM gel running buffer [Glyko, Inc.], freshly prepared in 1.5 L di-H2O and 
cooled to 4°C 
3. Electrophoresis apparatus [Glyko, Inc.] 
4. High voltage power supply  
 
Gel imaging and product quantification 
 
1. UV transilluminator (300-360 nm) 






C.2 EXPERIMENTAL PROCEDURE 
 
Glycosaminoglycan preparation from gels, tissues and proteoglycans 
 
1. Digest gels, tissue or proteoglycans normally using either 500 µl proteinase K or 
papain solution. 
2. After full digestion, remove 250 µl of the digest solution to reserve for the DNA and 
sGAG assay (for determination of total sGAG amount, see note C.1).  This 250 µl 
amount will not be referenced anymore in this protocol. 
3. To the remaining 250 µl of digest solution, add 750 µl of ice-cold ethanol (for a final 
concentration of 75% v/v) and store at –20°C for a minimum of 4 hours. 
4. Pellet precipitate in a tabletop micro-centrifuge at 15,000g for 20 minutes. 
5. Re-dissolve pellets in tissue culture water (volume depending on amount of expected 
sGAG, see note C.1). 
6. Using the DMMB assay, quantify the amount of sGAG in the re-dissolved solution. 
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Glycosaminoglycan lyase digestion 
 
a.    Looking at chondroitin sulfate disaccharides: 
1. Aliquot 5 µg portions of GAG into micro-centrifuge tubes and dry in the 
speedvac.  (See note C.2) 
2. Re-suspend dried aliquots in 100 µl of 50 mM ammonium acetate buffer and 
digest at 37°C for 16 hours with 10 mUnits of Chondroitinase ABC, 10 mUnits of 
Chondroitinase AC and 10 mUnits of Hyaluronidase.  (See note C.2) 
3. Cool the digests on ice.  Add 900 µl of ice-cold ethanol (for a final concentration 
of 90% v/v) and store at  –20°C for a minimum of 2 hours. 
4. Pellet precipitate in a tabletop micro-centrifuge at 15,000g for 20 minutes.  The 
∆disaccharides are recovered in the supernatant and dried in the speedvac. 
 
b.    Looking at keratan sulfate disaccharides: 
1. Aliquot 5 µg portions of GAG into micro-centrifuge tubes and dry in the 
speedvac.  (See note C.2) 
2. Re-suspend dried aliquots in 100 µl of 50 mM ammonium acetate buffer and 
digest at 37°C for 16 hours with 20 mUnits of Keratanase and 10 mUnits of 
Hyaluronidase.  (See note C.2) 
3. Cool the digests on ice.  Add 900 µl of ice-cold ethanol (for a final concentration 
of 90% v/v) and store at –20°C for a minimum of 2 hours. 
4. Pellet precipitate in a tabletop micro-centrifuge at 15,000g for 20 minutes.  The 
∆disaccharides are recovered in the supernatant and dried in the speedvac. 
 
c.    Looking at dermatan sulfate disaccharides: 
1. Aliquot 5 µg portions of GAG into micro-centrifuge tubes and dry in the 
speedvac.  (See note C.2) 
2. Re-suspend dried aliquots in 100 µl of 50 mM ammonium acetate buffer (pH 7.0) 
and digest at 37°C for 16 hours with 20 mUnits of Chondroitinase B and 10 
mUnits of Hyaluronidase.  (See note C.2) 
3. Cool the digests on ice.  Add 900 µl of ice-cold ethanol (for a final concentration 
of 90% v/v) and store at –20°C for a minimum of 2 hours. 
4. Pellet precipitate in a tabletop micro-centrifuge at 15,000g for 20 minutes.  The 
∆disaccharides are recovered in the supernatant and dried in the speedvac. 
 
Fluorescent labeling of lyase digestion products 
 
1. Check for prepared AMAC solution.  If none is available, make up a 0.1 M solution 
of AMAC by adding 1 mL of DMSO/acetic acid (85:15, v/v) to 25 mg of AMAC 
reagent.  Aliquot 50 µl portions for storage at –80°C for a maximum of 3 months.  
(See note C.3) 
2. Add 5 µl of AMAC solution to the dried lyase products.  Vortex samples and set 
aside. 
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3. Prepare a 0.5 M solution of Na-cyanoborohydride in tissue culture water.  Add a 10 
µl portion to each sample.  Vortex to mix and centrifuge for a few seconds to force 
the samples to the bottom of their tubes. 
4. Fluorotag for 16-20 hours at 37°C.  Make sure samples are covered with foil to keep 
out light.  (See note C.3) 
5. After completion of fluorotagging, cool samples to room temperature.  Add 15 µl of 
heated glycerol.  Heating the glycerol makes pipeting much easier.  The samples can 
be analyzed immediately or stored for up to 6 months at –80°C.  (See note C.3) 
 
 
FACETM gel electrophoresis of fluorotagged lyase digestion products  
 
1. Fill the electrophoresis tank with pre-cooled running buffer and set into a large 
container of ice to maintain tank and buffer temperature as close to 4°C as possible 
before and during the run. 
2. Remove the pre-cast MonoTM composition gel from its package.  Wash the loading 
wells extensively with running buffer, making sure not to leave any air bubbles in the 
wells.  Place the cassette into the electrophoresis tank. (See note C.4) 
3. Load a 5 µl portion of the standard mixture and a 4-6 µl portion of the samples per 
well.  Electrophoresis is carried out at 500 V, with a starting current of ~25 mA per 
gel and a final current of ~10 mA per gel. 
4. Terminate electrophoresis when the salt front nears the bottom of the gel, which is 
usually achieved after ~60-65 minutes, depending on temperature of the running 
buffer.  (See note C.4) 
 
Gel imaging and product quantification 
 
1. After completion of the electrophoresis, one gel cassette at a time is removed from 
the tank.  Turn the cassette upside down (well down) and wash the wells extensively 
with de-ionized water to remove any excess fluorotag.  Keeping the cassette upside 
down, wash the glass plates as well.  (See note C.5) 
2. Place the gel cassette on the transilluminator box with the appropriate light guard, 
placing the wells on the light guard.  (See note C.5) 
3. Turn the camera on.  Open the software and acquire the camera.  Settings are as 
follows: SYBR Green, 8.5”x11.5”, and 1s exposure.  It is a good idea to take 
numerous pictures varying the exposure time from 0.5s to 1.5s.  (See note C.5) 
4. Take picture/pictures.  After straightening and cropping image, save these images. 
5. Using the image analysis software, export the net intensities to Excel.  Based on the 





Glycosaminoglycan preparation from gels, tissues and proteoglycans 
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1. Traditional methods of digestion using proteinase K, papain and/or agarase 
(suspended in tissue culture water) may be employed in this step in place of the 
ammonium acetate buffer solution.  The purpose of the ammonium acetate buffer is to 
provide an optimal environment for the enzymatic digestion with proteinase K, but 
may have an effect on other assays (Hoechst).  Longer digestion times may need to be 
employed with other methods. 
2. The GAG precipitation step using 75% ethanol may lose a small percentage of the 
overall GAGs.  Unprocessed digest solution should be reserved for the DNA assay 
and sGAG assay to get an accurate quantification. 
3. The separation of GAGs from other protease products, such as collagen peptides, is 
usually required.  These protease products can interfere with the lyase digestion and 
the recovery of products.  However, unsulfated chondroitin and/or short chains of 
hyaluronan and chondroitin/dermatan sulfate are poorly recovered after ethanol 
precipitation.  Buffer salts and protein products can be alternatively removed by the 
centrifugation of digests in MicroCon 3 devices (15 minutes at 9,500g at room 
temperature).  The GAG peptides are retained on the filters, recovered in water and 
dried for further processing. 
4. The volume used to re-suspend the GAGs in tissue culture water should be 
determined based on experience.  When a high content of sGAGs is expected, more 
suspension volume may be used.  An acceptable starting volume for unknown 
amounts is 0.5 mL. 
 
Glycosaminoglycan lyase digestion 
 
1. Anywhere from 1-10 µg portions of sGAG can be analyzed using the FACE method.  
The enzyme amounts have been optimized for 5 µg portions of sGAG. 
2. Using the speedvac is preferable over the lyophilizer.  The speedvac keeps the GAGs 
at the bottom of the tubes, as opposed to drying the GAGs onto the sides of the tubes. 
3. Disaccharide digestion may not proceed to completion if the GAGs are insufficiently 
dissolved before digestion.  This can be improved by several short cycles of agitation 
using a vortex mixer and a 10-minute incubation at 37°C prior to the addition of the 
lyase. 
4. Different enzymes have different levels of pH that optimize digestion.  The pH 7.0 
was chosen because it is between the pH optimums for the different enzymes.  
Depending on the specific aim with digestion, the pH may be altered to optimize one 
enzyme over another.  Information about the specifics of the different enzymes can be 
found in the manufacturers’ catalogs.  The pH can be monitored by the inclusion of 
10 µl of 0.05% phenol red in the digestion buffer. 
5. Additional lyases are commercially available.  It should be noted that each enzyme 
has distinct substrate specificity and cleavage modes that will result in a mixture of 
∆di- and oligosaccharide products from the GAG chain interior.  Conditions for 
optimal resolution of products generated by these enzymes by FACE will need to be 
established. 
 
Fluorescent labeling of lyase digestion products 
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1. AMAC is a fluorescent reagent.  It should not be handled under the fluorescent lights 
of the lab.  Take care to dim the direct light when handling the AMAC.  Always wear 
gloves and a lab coat as the AMAC tends to get everywhere. 
2. If the AMAC is not stored in –80°C conditions, the acetic acid solution will evaporate 
off, leaving the solution at an unknown concentration. 
3. The Na-cyanoborohydride (Na-CBH) solution should be made up fresh every time 
and with extreme caution.  Na-CBH will turn to cyanide if inhaled, so it is a good 
idea to wear a face mask and work in the fume hood when preparing this solution.  
Fresh reagents minimize the decomposition of the reducing agent prior to 
fluorotagging.  There is a Na-CBH waste under the sink in the Levenston lab.   
4. Once the samples have begun the fluorotagging process, they should be kept out of 
direct light.   
5. The glycerol can be heated in a 1.5 mL tube to make its addition easier and quicker. 
6. After the addition of glycerol, they can be stored at –80°C for up to 6 months.  At any 
temperature less that –80°C, the solution may evaporate off of the samples 
 
FACETM gel electrophoresis of fluorotagged lyase digestion products 
 
1. Glyko recommends mixing the packet of MonoTM buffer with 1000 mL of di-H2O, 
rinsing the packet with 100 mL of di-H2O and bringing the solution up to a final 
volume of 1.5 L di-H2O.  This is to insure the correct concentration of buffer. 
2. Every time a gel or pair of gels is to be run, freshly chilled running buffer should 
replace the previous buffer.  New ice should be used to keep the electrophoresis tank 
chilled.  The duration of the electrophoresis is dependent on the temperature of the 
running buffer and tank.  Also, the 40% PAGE gels will tend to melt if great care is 
not taken to always replace the running buffer with freshly chilled buffer and to re-
pack the tank in ice.  It is a good idea to practice with only running one gel at a time 
(and using the glass plate on the opposite side), as two gels tends to heat up rather 
quickly. 
3. Electrophoresis times should be monitored to adjust for variable rates of sample 
migration on different gel batches, obtained from the supplier.   
 
Gel imaging and product quantification 
 
1. Excess fluorotag will mask the intensity of the samples if it isn’t washed away.  The 
cassette should be placed on the light guard with the wells overlapping the guard. 
2. A shorter exposure time will allow for the quantification of brighter band and a longer 
exposure time will allow for the quantification of less intense bands.  If bands run 
together (as is occasionally the case with chondroitin-4 and chondroitin-6 sulfates), 
the software separates them using a Gaussian distribution.  As long as the software 
can distinguish the bands repeatably and the intensity of the bands fall within the 
linear standard curve, the results can be considered trustworthy.  If the bands are in 
general too bright, the gel should be re-run loading less sample in the wells. 
3. A sample containing a range of concentrations (20-300 pmol) of ∆disaccharide 
standards are to be included on every face gel to generate a standard curve of pixel 
densities per pmol of saccharide for product identification and quantification in 
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experimental samples.  It is recommended that the amount of each individual 
∆disaccharide as provided by the supplier be validated first.  This can also be 
performed by FACE analysis.  Portions of ∆disaccharide standards (1 nmol of each) 
and 1 nmol of glucose should be fluorotagged and electrophoretically separated.  
Based on the known glucose standard, the actual amounts of the ∆disaccharide 










The mechanical loading system was custom designed (Figure 12) to impose the 
compression protocols (all designing done by Stacy Imler and Andrew Martinez, Georgia 
Institute of Technology).  The entire system fit on a shelf within an incubator (Forma 
Scientific, Marietta, OH) maintained at 37ºC and 5% carbon dioxide.  The compression 
chambers were made of polysulfone (all materials and machining done by JM Machining, 
Lawrenceville, GA), and a single chamber held up to eight samples.  The samples resided 
in the individual wells of the bottom part of the assembly that were 0.620” in diameter 
and 0.50” deep.  Four chambers could either be loaded into the mechanical loading frame 
or used alone to impose static compression.  The top part of the chamber assembly 
contained stainless steel platens that were 0.375” in diameter by 0.50” long.  To impart 
static compression, spacers made of stainless steel were machined to specific heights in 
order to compress the samples to a given height.  To impart oscillatory compression, the 
translation of motion from the table to the samples was done using an L-shaped bracket 
that was made of 6061 aluminum.  The tops of the chambers affixed directly to the 
bracket, while the bottom of the chamber sat stationary on the base plate. 
The application of oscillatory compression was attained by controlling the motion 
of the 404XR square rail linear table (Parker Automation, Irwin, PA).  The BE231 servo 
motor was driven by the VIX500AE servo drive (both Parker Automation, Rohnert Park, 
CA).  Using the Galil WSDK Programming Software, the sinusoidal input for table 
motion was sent to the Galil DMC-2113 servo controller (Galil Motion Control, Rocklin, 
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CA).  The position of the bracket was detected using a linear encoder that was mounted 
external to the linear table. 
    
Figure X: Custom designed compressive loading system 
 
 
D.2 SET-UP PROTOCOL FOR DYNAMIC LOADING 
 
1. Check the system out before you load your samples  
a. If the control box and computer are OFF, power them both ON.  
b. Open up WSDK  
c. Open up the terminal in the top toolbar  
2. Type in MO to disable the motor  
3. Check the PID parameters by typing in KP?, KI?, and KD?  
4. Set P/I/D parameters to 3/0/30 by typing KP3, KI0, KD30 [BLUE frame]  
2.5/0/18 by typing KP2.5, KI0, KD18 [GOLD frame]  
5. Set the voltage offset to -0.055 by typing OF-0.055 [BLUE frame]  
0.055 by typing OF0.055 [GOLD frame]  
6. Set the mode to single loop by typing DV0  
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7. In the right window (program window), open the program for the oscillatory 
compression = CIRCLES_FORE_ORIGINAL_SLOW  
8. Download the program to the controller by hitting the download button  
9. Type in XQ to execute the program to check for stability  
a. If stable, type in ST to stop the execution. The motor will still be enabled at this 
point until you type in MO. Continue to step 10.  
b. If unstable, hit the kill switch and exit out of all software. Cycle the power on 
the control box and start from the beginning.  
10. Raise the platform to a location that is reasonable for you to get your cassettes loaded.  
a. Do this by setting the speed to 3000 counts/sec by typing SP3000  
b. Set acceleration and deceleration to 25600 counts/sec
2 
by typing AC25600 and 
DC25600  
c. Also, disable the Off-on-error command that was in the oscillatory compression 
program by typing in OE0. 
d. Remember ↑- and ↓+ AND 1 count = 0.1 µm. I usually raise the platform by 
5000 or 10000 counts at a time  
e. Define current position as 0 by typing DP0  
f. Raise platform by typing in PAxxx and then BG  
11. Disable the motor by typing MO  
12. Load your cassettes in the hood  
13. Take the rig out of the incubator and place cassettes in the RIG  
14. Manually push down on the platform until it is in contact with the tops of the 
cassettes. Simultaneously, type in DP0 to reset the new zero position.  
15. Enable the motor by typing SH  
16. Raise platform by typing PA-40000 and then BG so that you can get your cassettes 
out  
17. Return platform to the zero point by typing PA0 and then BG. Check position by 
typing in TP because it often doesn’t make it all the way to zero. Retype PA0 to 
get the platform as close to zero as possible.  
18. Download the CIRCLES program  
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19. Type in XQ to check for stability  
20. Type in ST. Also, disable the Off-on-error command that was in the oscillatory 
compression program by typing in OE0  
21. Raise platform by typing PA-40000 and then BG so that you can get your cassettes in 
the RIG  
22. Place cassettes in the RIG and return the platform close to the tops of the cassettes 
(within 1000 counts). Do this gradually until you get to -1000 counts.  
23. Disable the motor by typing MO.  
24. Lightly screw in the large bolts (5/16” allen wrench) such that they are attached to the 
cassette tops  
25. Unscrew the small alignment screws (M4 allen wrench) and take them out of the 
assembly  
26. Fully tighten the large bolts  
27. Enable the motor by typing SH  
28. Slide the spacers out from the assembly  
 a. If the spacers don’t slide out so easily, raise the platform by 1000 counts 
to release the pressure from the assembly.  
 b. Do not raise the platform beyond 2000 counts! This corresponds to 200 
µm from the 10% static offset. Your samples my float out from under the 
platens if they are raised too high!  
29. Return the platform to the zero point by typing PA0 and then BG.  
30. Check that the tuning parameters and the binary parameters (from Useful Commands) 
are correct.  
31. Download the CIRCLES program  




D.3 DYNAMIC COMPRESSION PROGRAM 
This program is written in the Galil WSDK software and programming language. 
The program utilizes the circle (CR) function to impart a sinusoidal motion. The 
commands that control the specific motion are: vector speed (VS) and circle (CR). Vector 
speed is an integer that is a product of: 1.024*(2πRf). R is the radius in linear encoder 
counts (1 count = 0.1 µm) of the circle. In the sinusoidal application, R represents the 
amplitude of the sine wave. f is the frequency in Hz. The value of 1.024 represents 
necessary compensation for a lag in time between the controller and the command, as 
stated in the Galil literature. The circle command is composed of three arguments: CR 
R,θ,∆θ. R is the same value from the VS command. θ is where on the circle the motion 
will begin from in degrees. ∆θ is the number of degrees around a circle that the command 
will follow. In the program θ is set at -90° to begin at a 0 position, and ∆θ is set at 360° to 
complete a single circle. The CR command exists in a jump (JP) loop, and therefore is 





ER 1200  
DP0  
VA 680000  
VD 680000  
VS 5787  
CR 900,-90,360  
BGS  
#L  
CR 900,-90,360  





APPENDIX E WESTERN BLOTTING PROTOCOL 
 
 
E.1 BUFFERS AND SOLUTIONS 
RADIOIMMUNOPRECIPITATION (RIPA) BUFFER 
Pre-made solution:  150mM Tris (pH 7.2), 150mM NaCl, 1% Triton X-100, 1% 
deoxycholate, 0.1% SDS, 5mM NaF 
Add fresh:  2mM Na3VO4 (activated), 1% Calbiochem protease inhibitor stock 
 
ELECTRODE BUFFER 
50mM Tris Base, 384mM Glycine, 0.2% SDS 
 
TRANSFER BUFFER 
25mM Tris Base, 192 mM Glycine, 200mL MeOH 
 
10X TRIS BUFFERED SALINE (TBS) 
200mM Tris Base, 1.37M NaCl, pH to 7.6 
 
TBS WITH TWEEN 
1X TBS, 0.1% TWEEN-20 
 
BLOCKING SOLUTION 
1X TBS, 0.1% TWEEN-20, 1% dry non-fat milk 
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BLOTTO WITH TWEEN 
1X TBS, 0.1% TWEEN-20, 5% dry non-fat milk 
 
SAMPLE BUFFER 
200µL Tris-glycine SDS 2X buffer (Invitrogen #LC2676), 200uL 6M Urea, 0.012g DTT  
 
 
E.2 AGAROSE GEL TAKE-DOWN 
Preparation 
1. Prepare RIPA buffer.  Make sure to add protease inhibitors. 
2. Aliquot out RIPA buffer into 1.5 mL Eppendorf tubes that have been labeled.   
a. Use 0.5 mL of RIPA buffer for a 6 mm diameter x 3 mm thick gel.   
b. Store aliquots at 4°C until needed. 
3. Have liquid nitrogen and ice on hand. 
 
Take-down Part I 
4. Immediately after experiment has completed, put gels into RIPA buffer. 
a. Using a non-serrated blunt nose forceps, crush the agarose gel until it is 
semi-homogenized.  Work quickly. 
b. Clean forceps between groups to minimize cross-contamination. 
c. After homogenization, seal all caps. 
d. Place into liquid nitrogen until frozen. 
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e. Move out of nitrogen and onto ice. 
 
Take-down Part II 
5. Homogenize samples. 
a. Take samples off of ice to thaw, but keep cool once thawed. 
b. Vortex each sample for 15 seconds.  Use a timer to be consistent. 
c. Let sit on ice for 10 minutes. 
d. Vortex each sample again for 15 second. 
6. Concentrate samples. 
a. Quickly centrifuge agarose to the bottom of the tube. 
b. Pipet the supernatant (with as little agarose as possible) into a Microcon 
filter device (YM-30 used for Smads and TGF-β Receptor I).  
c. Centrifuge for 30 min at 14,000 x g. 
d. Remove assembly from centrifuge.  Separate vial from sample reservoir. 
e. Place sample reservoir upside down in a new vial. 
f. Centrifuge for 3 minutes at 2000 x g to transfer concentrate to vial. 
 
Quantify protein or DNA 
7. Use either a µ-BCA kit to quantify total protein OR the Hoechst dye assay to 
quantify total DNA. 
a. Protein cannot be quantified after sample loading buffer is added (with 
reducing agent), but DNA can. 
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Storage of sample 
8. Add sample loading buffer (either 2X or 6X depending on concentration). 
9. Store at -20°C. 
 
 
E.3 WESTERN BLOTTING 
1. Boil samples for 4 minutes prior to loading for separating. 
2. SDS-PAGE:  Run samples on a Novex 4-12% gel in electrode buffer at 180 volts 
for approximately 1 hour at room temperature. 
a. On each gel was a molecular weight standard, as well as a standard for 
included for normalization purposes.  A consistent amount of the same 
standard was loaded onto each gel for comparison between gels.  The 
standard was processed in the same way as the samples and consisted of 
unloaded gels seeded with BMSCs and treated to 10ng/mL TGF-β1. 
3. Transfer:  Transfer proteins onto nitrocellulose membrane in transfer buffer at 30 
volts for 90 minutes at room temperature. 
4. Block membrane for 1 hour in blocking solution at room temperature. 
5. Incubate membranes in primary antibody (in Blotto with TWEEN) overnight at 
room temperature.  Working concentrations of antibodies used: 
a. Smad 2/3 1:1000 
b. pSmad 2/3 1:1000 
c. TGF-β Receptor I 1:1000 
6. Wash in TBS with TWEEN three times for 5 minutes each. 
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7. Incubate for 1 hour in secondary antibody in Blotto with Tween.  
a. Secondary antibody used: Biotin SP-conjugated anti-rabbit IgG 
b. Dilution of secondary: 1:10,000 
8. Wash in TBS with TWEEN three times for 5 minutes each. 
9. Incubate for 1 hour in tertiary antibody in Blotto with Tween. 
a. Secondary antibody used: AP conjugated anti-Biotin 
b. Dilution of tertiary: 1:10,000 
10. Wash in TBS with TWEEN three times for 10 minutes each. 
11. Develop with ECL for 7 minutes. 
a. 1mL ECL per membrane 
12. Dry membranes. 
13. Image using the Fuju Film Phosphoimager 
a. Plate used: FLA Fluor State 2340 
b. Software used: Image Reader Software 
c. Sample mode: Fluor 473, Filter Y520, 16 bit gradation, 50 resolution, F10 
sensitivity 
14. File exported to a bitmap and analyzed using Photoshop. 
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APPENDIX D IMMUNOHISTOCHEMISTRY PROTOCOL 
  
 
D.1 FIXED FROZEN SAMPLE PREPARATION 
At time of harvest, constructs were rinsed in PBS and fixed in 10% neutral 
buffered formalin (NBF) for 4hr at room temperature.  Samples were then transferred to 
30% sucrose for 48hrs at 4C, embedded in OCT, and frozen in liquid nitrogen-cooled 
isopentane.  Frozen blocks were sectioned to 7µm using a cryostat and placed on 
superfrost plus slides.  Prior to immunostaining, frozen sections were thawed and dried 
for 20min. at room temperature.  Following fixation in acetone for 5min., slides were 
dried for at least 5 min., and rehydrated in PBS.  
 
D.2 FORMALIN FIXED, PARAFFIN EMBEDDED SAMPLE PREPARATION 
At time of harvest, constructs were rinsed in PBS and fixed in 10% NBF for 48hr 
at 4C.  Samples were then processed for dehydration and infiltration by paraffin in a 
Thermo Shandon Pathcenter, sectioned to 4µm on a rotary microtome, placed on 
superfrost plus slides, and dried at 37C overnight.  Prior to immunostaining, sections 
were deparaffinized and rehydrated through xylene and graded alcohols in a Leica 
Autostainer XL.  Slides probed for Smad2/3 and p-Smad2 underwent antigen retrieval 





Slides were loaded into Sequenza staining racks with ~500µL PBS and rinsed 3 
times with 300µL PBS.  Frozen sections probed for collagen I and collagen II underwent 
enzymatic antigen retrieval with 0.5x trypsin at 37C for 15min.  Paraffin-embedded 
sections probed for Smad2/3 or p-Smad2 were treated with 0.1U/mL chondroitinase ABC 
at 37C for 30min.  Slides were then rinsed 3 times with 300µL PBS and blocked for 1hr 
at room temperature with 2% normal goat serum, 0.1% gelatin, 0.5% Tween-20, and 1% 
BSA in PBS.  A solution of rabbit anti-collagen II (1:100) and mouse anti-collagen I 
(1:100) was prepared with 1% BSA/0.1% Gelatin/PBS.  Alternatively, rabbit anti-
Smad2/3 (1:100) or rabbit anti-p-Smad2 (1:1000) was prepared.  Similar solutions were 
prepared with 10µg/mL non-immune rabbit IgG (collagen co-stained slides were also 
treated with 10µg/mL non-immune mouse IgG) as negative controls.  Samples were 
incubated with 150µL of primary antibody solution for 1hr at room temperature, and then 
rinsed 3 times with 300µL PBS.  A secondary antibody solution was prepared with goat 
anti-rabbit AlexaFluor488 (1:100) in PBS with 1.25µg/mL DAPI as a nuclear 
counterstain.  For collagen I/II co-stained slides goat anti-mouse AlexaFluor594 was 
included (1:100), and for Smad2/3 and p-Smad2 stained slides Alexafluor 546-Phalloidin 
was added at 100µg/mL.  Samples were incubated with 200µL of secondary antibody 
solution for 1hr at room temperature in the dark.  Slides were then rinsed 3 times with 




Images of individual channels were captured using a Nikon E600 epifluorescent 
microscope fit with a CCD camera and filters for FITC, TRITC, and DAPI.  QCapture 
software was used to adjust exposure times for each channel.  Adobe Photoshop image 
analysis software was used to consistently apply brightness and contrast adjustments and 
to combine images. 
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APPENDIX E STATISTICAL ANALYSIS 
 
 
Unless specified, the data were analyzed with a multi-factor General Linear 
Model using Minitab Release 12.23 (Minitab Inc., State College, PA).  A Tukey’s Test 
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